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ABSTRACT 
Cytochrome P450 monooxygenases (CYPs or P450s) are heme-thiolate proteins distributed 
across biological kingdoms. P450s show multiple and diverse catalytic activity on a wide 
range of substrates, and as such the use of these enzymes have been prompted in various 
areas such as the production of human valuable chemicals, pharmaceutical compounds, 
antibiotics, fragrances and the degradation of xenobiotic compounds. If P450s are to be used 
on a large-scale production, it is imperative that they are able to resist extreme industrial 
conditions, including thermostability. Considering the fact that P450s are weak and less 
stable enzymes, research has focused on identifying thermostable P450s. Furthermore, P450s 
have been used as a drug target against pathogens. However, a study revealed that pathogens 
are developing drug resistance against currently available drugs. To tackle and address this 
emerging dilemma to drug resistance, novel drug targets need to be discovered and identified.  
The current study is the first of its kind that focuses on two aspects, which are 
identifying a common alternative anti-fungal drug target and structural characterization of 
thermostable P450 CYP53A and its redox partner cytochrome P450 reductase (CPR) from 
biomass-degrading thermophilic ascomycete Thielavia terrestris. This study also marks the 
beginning of our understanding on thermostable P450s from eukaryotes.  
Part of the study has been published as an article in PLoS ONE journal (impact factor 
3.5). Below are the details of the manuscript: 
Jawallapersand P, Mashele SS, Kovačič L, Stojan J, Komel R, Pakala SB, Kraševec N, 
Syed K. Cytochrome P450 monooxygenase CYP53 family in fungi: Comparative structural 
and evolutionary analysis and its role as a common alternative anti-fungal drug target. PLoS 
One. 2014 Sep 15;9(9):e107209. doi: 10.1371/journal.pone.0107209. eCollection 2014. 
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CHAPTER 1  
LITERATURE REVIEW 
1.1. Introduction to cytochrome P450s 
1.1.1. Cytochrome P450 monooxygenases: General aspects 
Cytochrome P450 monooxygenases (CYPs or P450s) comprise of a very extensive 
superfamily of diverse heme-thiolate proteins (Nelson, 2013). P450s exist in nature in all 
phylogenetic domains of life ranging from microscopic prokaryotes such as archaea and 
bacteria to lower eukaryotes such as protists, fungi and insects and ultimately to more 
complex eukaryotes including plants and animals (Nelson, 2013). Plants have the greatest 
number of P450 genes with animals, fungi, protists, archaea and bacteria having lower 
numbers of P450s (Nelson, 2011). Fungal genomes have lower numbers of P450s compared 
to plants. However, fungal genomes express the highest P450 diversity among all other 
phylogenetic domains, with about 399 P450 families located throughout the 2784 annotated 
fungal P450s (as of 2011) in comparison to plant genomes having only 129 P450 families 
located throughout 4267 annotated plant P450s (Nelson, 2009; Nelson, 2011).  
Currently, there are more than 21039 P450s (as of 2013) that have been sequenced, 
annotated and described (Nelson, 2009). P450s have existed for billions of years and have 
played pivotal roles from insecticide resistance in mosquito disease-carrying vectors to bio-
remediation of hexahydro-1,3,5-trinitro-1,3,5-triazine (Royal Demolition Explosive, RDX) 
on contaminated soil (Rylott et al., 2011 (a, b); Nelson, 2013). P450s are indeed primordial 
and have played key role in organisms adapting to various types of ecological niches, by even 
adapting to extreme conditions such as elevated hydrostatic pressures and temperatures of 
solfataric hot springs (Park et al., 2002; Nelson, 2013) and adaption to utilize 
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photosynthetically fixed carbon such as wood (Syed et al., 2014a). Hence, if P450s were 
wiped out, life on Earth would probably relapse to only a pool of primitive organisms 
(bacteria) with all other life forms dwindling or ceasing to exist (Nelson, 2013). 
 
1.1.2. Terminology and nomenclature of cytochrome P450s 
The term ―Cytochrome P450‖ was derived by Omura and Sato (1962-1964) who referred this 
protein as ‗pigment 450‘. This is due to P450s are hemeproteins by nature and display 
unusual spectral properties in a reduced state of CO-bound (carbon monoxide-bound) 
complex at a maximum absorption peak at a wavelength of 450 nm (Figure 1.1) (Omura and 
Sato, 1962; Omura and Sato, 1964; Klingenberg, 2003; Bernhardt, 2006; Luthra et al., 2011). 
Hence, ―Cytochrome P450‖ actually stands for: cytochrome meaning hemoprotein, P is an 
abbreviation for pigment and 450 indicates the absorption peak spectra of the CO-bound 
complex at a wavelength of 450 nm (Figure 1.1) (Bernhardt, 2006; Guengerich et al., 2009; 
Luthra et al., 2011). The cysteine-thiolate group is the prime reason for this phenomenal 
spectral display observed in P450s, whereby there is formation of the fifth ligand of the 
heme-iron. Hence, the name heme-thiolate proteins or hemoproteins is given to P450 
enzymes (Hannemann et al., 2007). The first occurrence of the P450 absorption spectrum was 
described in 1958 (Klingenberg, 1958). 
The nomenclature of P450s is dependent and classified according to the percentage 
homology of their individual amino acid sequence, and by precept, are assigned the letters 
CYP for cytochrome P450 followed by a family number ( 40% sequence homology), an 
alphabetical letter for the subfamily (55% sequence homology) and a unique number for the 
individual enzyme within the designated subfamily (Nebert et al., 1987; Nebert et al., 1991; 
Nelson, 2009). Although P450s show low sequence similarity, their secondary topography 
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and structural fold are highly conserved (Poulos et al., 1987) indicting that P450s share 
similar mechanisms of oxygen activation (Denisov et al., 2005). Hence, P450s are 
categorized according to their respective clans (large group of P450s families or genes) 
instead, which is becoming more acknowledged, since genes within respective clans have not 
originated from a single common ancestor, but rather diverged from a common ancestor and 
are thus more likely to share mutual functional traits and features (Nelson, 1998 (a, b); 
Nelson, 1999). Nevertheless, a conventional criterion concerning the classification of P450s 
into their respective clans has not firmly been established yet (Nelson, 1998b; Nelson, 1999; 
Nelson, 2006). 
 
 
 
 
 
 
 
 
 
Figure 1.1. Typical cytochrome P450 reduced-CO difference spectrum. The P450 
spectral assay is based on the principle that the ferrous form (Fe
2+
) of the hemoprotein reacts 
with carbon monoxide (CO) to form a CO-bound complex that distinctively generates a 
spectrum with a maximum absorption at a wavelength of 450 nm (shown in red), as a result 
of the cysteine-thiolate axial ligand bound to the heme iron molecules present in the P450 
enzymes. (Taken from Guengerich et al., 2009). 
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1.1.3. Cytochrome P450 monooxygenases and the chemistry of oxygen 
activation 
P450s are well known for their monooxygenation of substrates hence they are classified or 
described as monooxygenases in literature (Urlacher and Girhard, 2012). Monooxygenases 
(previously known as mixed function oxidases) are unique enzymes that catalyse molecular 
oxygen by inserting the first oxygen atom into a substrate with the second oxygen atom 
reduced to a water molecule, whereby two electrons are used in the process provided by the 
cofactors NADH or NADPH (reduced nicotinamide adenine dinucleotide phosphate) by 
means of an external reductase protein (Figure 1.2) (Denisov et al., 2005). P450s are 
biocatalysts that also catalyse a wide variety of chemo-, regio- and stereo-specific oxidation 
reactions such as the activation of sp
3
 hybridized C atoms, dehalogenation, hydroxylation of 
aliphatic and aromatic hydrocarbons, sulphoxidation, deamination, desulphuration, 
epoxidation, peroxidation, N-, O- and S- dealkylation (Sono et al., 1996; Bernhardt, 2006). 
Additionally, P450s carry out more unusual chemical reactions, examples being C-C and C-O 
phenol coupling, C-C bond cleavage, Baeyer-Villiger oxidation, re-arrangement reactions 
(such as ring formation and oxidative aryl migration)and isomerisation (Sono et al., 1996; 
Bernhardt, 2006). 
Diverse catalytic reactions performed by P450s suggest that P450s have the remarkable 
ability to accept and bind to a diverse range of substrates. The assortment of substrates 
include important natural compounds like fatty acids, terpenes, steroids, prostaglandins, 
eicosanoids, fat-soluble vitamins, bile acids, aliphatic compounds, aromatic compounds and 
hetero-aromatic compounds as well as xenobiotics such as drugs, organic solvents, polycyclic 
aromatic hydrocarbons (PAHs), antibiotics, pesticides, herbicides, anaesthetics, alkyl aryl 
hydrocarbon products, ethanol, carcinogens, toxins and even explosive military compounds 
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Figure 1.2. A typical cytochrome P450 catalytic reaction. RH and ROH represent the 
substrate and product respectively. (Taken from Denisov et al., 2005). 
(Roberts et al., 2002; Bernhardt, 2006; Urlacher and Eiben, 2006;Rylottet al., 2011(a, b); 
Urlacher and Girhard, 2012; Syed et al., 2014a). Over the past five decades, studies have 
proven that P450s are indeed ―versatile biocatalysts‖ with the presence of flexible substrate 
recognition sequences/regions (SRS). Hence, P450s are able to exhibit extraordinary 
chemical reactivity and catalyse a diverse range of substrates (Carmichael and Wong, 2001; 
Meunier et al., 2004; Bernhardt, 2006; Guengerich, 2006; Urlacher and Eiben, 2006; 
Hanneman et al., 2007; Grogan, 2011; Urlacher and Girhard, 2012). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.1.4. Cytochrome P450 reductase (CPR) 
In general, nearly all eukaryotic P450s require one or more redox partner proteins also known 
as cytochrome P450 reductases (CPRs) during catalytic reactions for a plethora of substrates 
© Central University of Technology, Free State
CHAPTER 1: LITERATURE REVIEW 
6 
 
for the transfer of electron equivalents provided by pyridine cofactors NADH or NADPH to 
the heme centre of P450s (Denisov et al., 2005). The general chemical scheme applied by 
P450s is shown as: 
 
 
where RH represents the substrate, R–OH is the hydroxylated product and NAD(P)H is 
usually the electron donor (Munro et al., 2013). However, the chemical equation can be 
sometimes misleading, as the mechanisms employed by P450s is much more complex 
(Munro et al., 2013).  
P450s function as terminal electron acceptors in various reactions involving multiple 
constituent P450 contingent monooxygenation systems (Hannemann et al., 2007; Lah et al., 
2008). In eukaryotic organisms both the P450 and CPR are situated in the membrane of the 
endoplasmic reticulum (ER) by a single transmembrane anchor with the catalytic domain 
positioned towards the cytosol and the hydrophobic area of the catalytic domain protruding 
into the phospholipid bilayer (Cojocaru et al., 2011). The P450 is anchored by a monotopic 
N-terminal transmembrane α-helix (Cojocaru et al., 2011). Experiments conducted using site-
directed antibodies against peptides of the human CYP2B1 and the rabbit CYP2B4, proposed 
a suitable model that shows the microsomal topography of the P450 within the ER (De 
Lemos-Chiarandini et al., 1987; Black et al., 1994). 
Previous studies conducted on P450s, suggested that these enzymes fall into two distinct 
classes namely, the mitochondrial/prokaryote type (class I) and the microsomal type (class II) 
(Mclean et al., 2005; Bernhardt, 2006; Hannemann et al., 2007). At present, P450s are 
categorized into different classes (Figure 1.3 and Table 1.1) and sub-classes based on their 
RH + O2 + 2e
–
+ 2H
+  R–OH + H2O 
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auxiliary external redox partner proteins (Benhardt, 2006; Hannemann et al., 2007; Urlacher 
and Girhard, 2012). The different P450 redox classes are discussed here briefly. 
Class I P450s are situated in the inner mitochondrial membrane and are predominantly 
bacterial P450s (Bernhardt, 2006). Mitochondrial P450s are soluble enzymes of the cell 
matrix, and acquire electrons for catalysis from a NADH-dependent FAD-containing 
reductase constituting of an iron-sulphur [2Fe-2S] ferredoxin (adrenodoxin) and a flavin 
adenine dinucleotide (FAD) containing reductase (adrenodoxin reductase) (Mclean et al., 
2005; Bernhardt, 2006; Hannemann et al., 2007; Urlacher and Girhard, 2012). Historically, 
the first bacterial P450 system belonged to a camphor hydroxylase, CYP101 (P450cam) from 
Pseudomonas putida, which was also the first microbial P450 to be enzymatically and 
structurally characterized (Mclean et al., 2005; Bernhardt, 2006; Hannemann et al., 2007). 
The electron donating mechanism in CYP101 involves electrons being transferred from 
NADH via a FAD-containing reductase (putidaredoxin reductase) and an iron–sulphur 
protein (putidaredoxin) to CYP101. Bacterial P450s are responsible for the metabolism of 
carbon compounds, xenobiotics, fatty acids and for the synthesis of secondary intermediates 
such as antibiotics and anti-fungal compounds (Hannemann et al., 2007). Mitochondrial 
P450s in mammals catalyze the side-chain cleavage of cholesterol, 11-hydroxylation of 11-
deoxycortisol and are involved in the biosynthesis of vitamin D and aldosterone (Bernhardt, 
2006). 
In contrast, class II P450s are integral membrane proteins that bind to the endoplasmic 
reticulum by an N-terminal membrane anchor and obtain electrons via membrane-anchored 
NADPH-dependent reductase containing both FAD and FMN cofactors (CPR) (Mclean et al., 
2005; Bernhardt, 2006; Hannemann et al., 2007). 
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However, the discovery of CYP102 (P450-BM3) isolated from Bacillus megaterium in 
the 1980s, revealed a unique, yet unusual characteristic, whereby the P450 system was that of 
a fused P450 protein to a reductase component, into one catalytically self-sufficient single-
polypeptide chain (Roberts et al., 2002; Mclean et al., 2005; Bernhardt, 2006; Hannemann et 
al., 2007). Consequently, since then, an explosive range and variety of P450s have been 
characterized, with novel and different P450 redox systems still being discovered today, that 
belong to neither class I or class II, but rather a class of their own (Figure 1.3) (Mclean et al., 
2005; Hannemann et al., 2007; Urlacher and Girhard, 2012). 
Apart from microsomal reductase such as CPR, some microsomal P450s are able to take 
a second electron from cytochrome b5 (Bernhardt, 2006). Cytochrome b5 is a 17 kDa heme 
protein coupled mainly with the microsomal and mitochondrial components of eukaryotic 
cells together with its redox protein partner NADH-cytochrome b5 reductase (Lederer et al., 
1983; Hannemann et al., 2007). Cytochrome b5 and its reductase component are both 
electron transport elements that partake in various biochemical process from electron transfer 
to desaturases involved in the biosynthesis of unsaturated fatty acids, plasmalogen and sterols 
(Vergeres and Waskell., 1995; Hannemann et al., 2007).  
P450s, with the exception of self-sufficient P450s, interact with their corresponding 
redox protein partners of the catalytic cycle, as this specificity and criterion assures that an 
adequate reaction rate of catalysis results that prevents the systems from changing to shunt 
pathways (Bernhardt, 2006). The recognition of the auxiliary reductase by the P450 enzyme 
occurs as a result of salt bridges (Bernhardt, 2006). These salt bridges allow discrimination 
between potential electron donors and acceptors, whereby the correct orientation of the P450 
to the reductase will be favoured (Bernhardt, 1996 & 2006). 
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Figure 1.3. Schematic representations of different types of P450 redox systems. (A) Class I, bacterial 
system., (B) Class I, mitochondrial system., (C) Class II microsomal system.,(D) Class III, bacterial system., 
example P450cin., (E) Class IV, bacterial thermophilic system., (F) Class V, bacterial [Fdx]–[P450] fusion 
system., (G) Class VI, bacterial [Fldx]–[P450] fusion system., (H) Class VII, bacterial [PFOR]–[P450] fusion 
system., (I) Class VIII, bacterial [CPR]–[P450] fusion system., (J) Class IX, soluble eukaryotic P450nor., (K) 
Independent eukaryotic system, example P450TxA. (Taken from Hannemann et al., 2007). 
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Table 1.1. Different classes of P450 redox systems. (Taken from Hannemann et al., 2007). 
 
 
Class/source Electron transport chain Localization/remarks 
Class I   
Bacterial NAD(P)H  [FdR]  [Fdx] a [P450] Cytosolic, soluble 
Mitochondrial NADPH  [FdR]  [Fdx]  [P450] P450: inner mitochondrial membrane 
FdR: membrane associated 
Fdx: mitochondrial matrix, soluble 
Class II   
Bacterial NADH  [CPR]  [P450] Cytosolic, soluble, Streptomyces carbophilus 
Microsomal A NADPH  [CPR]  [P450] Membrane anchored, ER 
Microsomal B NADPH  [CPR]  [cytb5] [P450] Membrane anchored, ER 
Microsomal C 
 
NADH  [cytb5Red]  [cytb5]  [P450] 
 
Membrane anchored, ER 
 
Class III   
Bacterial NAD(P)H  [FdR]  [Fldx]  [P450] Cytosolic, soluble, Citrobacter braakii 
   
Class IV   
Bacterial Pyruvate, CoA  [OFOR]  [Fdx]  [P450] Cytosolic, soluble, Sulfolobus tokadaii 
   
Class V   
Bacterial NADH  [FdR]  [Fdx–P450] Cytosolic, soluble, Methylococcus capsulatus 
   
Class VI   
Bacterial NAD(P)H  [FdR]  [Fldx–P450] Cytosolic, soluble, 
 
 
 
 
Rhodococcus rhodochrous strain 11Y 
 
Class VII   
Bacterial NADH  [PFOR–P450] Cytosolic, soluble, Rhodococcussp strain 
  NCIMB 9784, Burkholderia sp., 
  Ralstonia metallidurans 
   
Class VIII   
Bacteria, fungi NADPH  [CPR–P450] Cytosolic, soluble, Bacillus megaterium., 
 
 
 
 
Fusarium oxysporum 
 
Class IX   
Only NADH dependent, fungi NADH  [P450] Cytosolic, soluble, Fusarium oxysporum 
   
Class X   
Independent in plants/mammals [P450] Membrane bound, ER 
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Table notes: 
Abbreviated protein components with redox centres:  
Fdx, Ferredoxin (iron–sulphur-cluster) 
a
Fdx, Ferredoxin containing iron–sulphur-cluster of [2Fe–2S], [3Fe–4S], [4Fe–4S], [3Fe–4S]/ [4Fe–4S] type. 
FdR, Ferredoxin reductase (FAD) 
CPR, Cytochrome P450 reductase (FAD, FMN) 
Fldx, Flavodoxin (FMN) 
OFOR, 2-Oxoacid ferredoxin oxidoreductase (thiamin pyrophosphate, [4Fe–4S] cluster) 
PFOR, Phthatate-family oxygenase reductase (FMN, [2Fe–2S] cluster).  
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1.2. Role of P450s in the generation of human valuables  
P450s have immense biotechnological potential, due to their innate ability to catalyze 
important reactions on a diverse range of substrates (Bernhardt, 2006). Today, research on 
P450s has become a field of extreme interest and curiosity because of the remarkable 
chemical properties of P450s, especially in areas such as biotechnology, pharmacokinetics, 
pharmacology, toxicology and environmental sciences (Miners, 2002, Carmichael and Wong, 
2001; Meunier et al., 2004; Bernhardt, 2006; Guengerich, 2006; Urlacher and Eiben, 2006; 
Hanneman et al., 2007; Grogan, 2011; Urlacher and Girhard, 2012). P450s have been used 
for the production of fine chemicals, fragrances, pharmaceutical products as well as in bio-
fuel production, bio-sensing and bioremediation (Miners, 2002, Carmichael and Wong, 2001; 
Meunier et al., 2004; Bernhardt, 2006; Guengerich, 2006; Urlacher and Eiben, 2006; 
Hanneman et al., 2007; Grogan, 2011; Zhang et al., 2011; Urlacher and Girhard, 2012). Here 
the role and importance of P450s have been explored and briefly described. 
A practical example whereby P450s have been used for large-scale market production is 
of transgenic plants, namely, the blue roses (Bernhardt, 2006). Scientists from Florigene, 
Australia and from Suntory, Japan managed to synthesize delphinidin, which currently 
accounts for the blue colour, in roses (Holton et al., 1993; Ogata et al., 2005; Bernhardt, 
2006). The technique used involves the incorporation of the respective P450 gene (CYP75A). 
This initiative has taken flower cultivation to an entirely new dimension, where not only can 
the colour of roses, but also carnations be successfully changed to different shades ranging 
from blue to purple depending on the clientele (Bernhardt, 2006). The demand for cut flowers 
is significantly high, whereby the global flower market is valued at an approximate amount of 
US$27 billion per annum, which demonstrates that flower production does indeed have a 
huge economic impact (Bernhardt, 2006). 
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P450s have also been widely applied in the specialized field of drug discovery and 
development, for the biotransformation of steroids to drugs (Bernhardt, 2006; Guengerich, 
2006; Urlacher and Eiben, 2006). In the Mycobacterium sp. strain HXN-1500, hydroxylation 
of 1-limonene in the 7-position into perillyl alcohol having anti-carcinogenic properties is 
produced (van Beilen et al., 2005). The transformation of compactin into pravastatin by 
microbial oxidation in Streptomyces sp., produces a drug that lowers the level of cholesterol 
in blood by inhibition of biosynthesis of cholesterol (Park et al., 2002). In the Curvularia sp., 
Reichstein S is transformed into hydrocortisone, due to the process of 11β-hydroxylation, 
where there is enantio- and regio- selective insertion of an oxygen molecule into Reichstein S 
(van Beilen et al., 2003). Another example is the biotransformation of progesterone to 
cortisone (Peterson et al., 1952; Hogg, 1992; Syed and Yadav, 2012). An example of an 
antibiotic producing P450, CYP107A1 (P450eryF) from Saccharopolyspora erythraea, 
involved in the initial hydroxylation of 6S-hydroxylation of 6-deoxyerythronolide B in a 
multiple erythromycin synthesis pathway, eventually converting 6-deoxyerythronolide B into 
erythromycin (Cupp-Vickery and Poulos, 1995; Sen and Thiel; 2014). The role of P450s for 
the biosynthesis of biological molecules of medicinal value is indeed exceptional and current 
innovative results clearly demonstrate the importance of P450s in pharmaceutical 
development and technology. 
P450s are applied in vivo to test drug toxicity to evaluate the effects of prodrugs, toxic 
substances and xenobiotic compounds on human metabolism (Isin and Guengerich, 2007). 
P450s have also been applied for the design of biosensors, a technology with potential long-
term benefits (Paternolli et al., 2004). Currently, the average cost of introducing a novel drug 
to the market takes about 10-15 years of laborious development and clinical trials, at an 
estimated cost and investment of US$750 million to more than US$5 billion, with the 
regrettable probability that 95% of the experimental drugs that are studied in humans, being 
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ineffective and unsafe (Myszka and Rich, 2000; Herper, 2013). The solution to this vicious 
cycle could be the implementation of biosensors based on P450s as potential and cost-
effective screening tools in the multi-million dollar pharmaceutical industry. The reason why 
P450s are suitable candidates for the design of biosensors is due to the fact that more than 
1,000,000 different xenobiotic and endobiotic liphophilic substrates as well as approximately 
75% of all drug compounds are metabolized by P450s (Baj-Rossi et al., 2011). Therefore, 
biosensors based on P450s could be used in the multiple phases of the drug discovery 
procedure to increase sample throughput and reduce costs simultaneously producing 
substantial new information about potential drug candidates, as the biosensors could be 
designed to be more sensitive and specific for the detection of drug molecules (Myszka and 
Rich, 2000; Rouse and Hardiman, 2003). Such an example are biosensors that have been 
developed using mammalian P450s namely; CYP1A2, CYP2B4 and CYP11A for the 
detection of drugs (clozapine), xenobiotics (styrene) and steroids (cholesterol) (Paternolli et 
al., 2004). In an interesting study, different P450 isoforms were used to detect drug 
compounds using nanoparticles or carbon nanotubes for enhancing the device sensitivity so 
as to target therapeutic ranges in the serum of patients, whereby the drug concentration was 
indirectly measured via a reduction potential obtained with the cyclic voltammetry technique 
(Baj-Rossi et al., 2011). The remarkable abilities of P450s are not limited to drug synthesis 
alone. On the contrary P450s have been introduced in bioremediation for the removal of toxic 
and synthetic compounds from the environment. CYP101 of P. putida capable of 
hydroxylating camphor was engineered using site-directed mutagenesis (Poulos et al., 1987; 
Bernhardt, 2006). Various mutations on the known three-dimensional structure to induced 
and re-orientate the stereochemistry have been reported, such as mutations in F87 and Y96 
that optimized the activity of CYP101 for the oxidation of polycyclic aromatic hydrocarbons 
such as phenanthrene, fluoranthene and pyrene, as well as polychlorinated benzenes 
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(Urlacher et al., 2004; Benhardt, 2006). Strategic bio-engineering of both CYP101 and 
CYP102 have been reported, whereby the substrate diversity catalyzed by these enzymes 
have been increased for the purpose of bioremediation of environmental pollutants (Harford-
Cross et al., 2000; Carmichael and Wong, 2001). XplA (Corynebacterineae: Rhodococcus 
sp.) is another unique example of a P450 used in bioremediation (Rylott et al., 2011a). XplA 
is involved in the microbial biodegradation of the synthetic military explosive and pollutant 
RDX on contaminated soil (Rylott et al., 2011(a, b)). 
For the past few decades scientists have been striving to find renewable sources of 
energy that will reduce world petroleum exploitation as well as decrease carbon dioxide 
emissions, which are also the main cause of global warming (Zhang et al., 2011). Biofuel 
production using P450s is a promising area of research and a potential solution against the 
struggle for finding biodegradable, sustainable and renewable biofuels. Mutated P450, 
CYP153A6 from Mycobacterium sp. HXN-1500 is capable of terminal alkane hydroxylation 
of alkanes to 1-alkanols such as the biotransformation of butane to 1-butanol (Funhoff et al., 
2006). In contrast, OleTJE an engineered P450, from the CYP152 family from the bacteria 
Jeotgalicoccus, is able to decarboxylate and to hydroxylate fatty acids (Rude et al., 2011). 
 
1.3. Thermostable P450s 
1.3.1. Introduction to thermostable P450s 
There exists a unique and elite group of remarkable organisms that thrive in deep-sea 
hydrothermal vents, hot springs and solfataric areas called extremophiles that have adapted to 
harsh enviromental conditions through the gradual process of evolution and natural selection 
(Demirjian et al., 2001). Extremophiles consist of various classes such as thermophiles, 
acidophiles and peizophiles (barophiles) to mention a few (Table 1.2) (Demirjian et al., 
2001). Thermostable enzymes are categorized into three respective groups based on the 
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property of temperature stability of these enzymes namely: low temperature (35-45C), 
moderate thermophiles (temperature range: 45-65C), thermophiles (65-85C), and 
hyperthermophiles (>85C) (Demirjian et al., 2001). Thermostable enzymes are found in 
thermophilic organisms and are proteins that are able to resist high temperatures, without 
undergoing denaturation as the structural and chemical properties of these proteins are not 
affected. 
In the past, the need to culture thermophilic microorganisms for research purposes such 
as isolation of genetic material, proteins or even for observation was quite challenging, 
laborious, time-consuming and the microbial cultures did not survive long enough (Kushnar, 
1978, Rothschild and Mancinelli, 2001). Today, with the help of genomic tools, it has 
become easier to study thermophilic microorganisms. Extremophilic/thermophilic P450s 
were the first proteins to be unpredictably discovered by genomics in the species Sulfolobus 
solfataricus (CYP119) (Wright et al., 1996; Yano et al., 2000). In this section, focus will be 
on thermophilic enzymes namely thermostable P450s, which are important not only because 
of their bio catalytic activities, but because they possess a higher magnitude of 
thermotolerance compared to other P450s (Matsumura et al., 2008). 
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Table 1.2. Examples of extremophiles and the industrial applications of their isolated 
enzymes. (Taken from Demirjian et al., 2001; Van den Burg, 2003). 
 
Extremophile Habitat Enzymes Applications 
 High temperature (35- 45C) Amylase Glucose and fructose for sweeteners 
Thermophile 
Moderate thermophiles 
 (45-65C) 
Xylanases Paper bleaching 
Thermophiles  
(65-85C) 
Proteases 
 
Baking, brewing, detergents 
Hyperthermophiles 
(<85C) 
DNA polymerases Molecular biology (PCR), genetic 
engineering 
Psychrophile 
Low temperature 
(<15C) 
Proteases 
Dehydrogenases 
Amylases 
Cheese maturation, dairy production 
Biosensors 
Polymer degradation in detergents 
Acidophile 
Low pH 
Sulfur oxidation Desulfurization of coal 
(pH<2-3) Chalcopyrite concentrate Valuable metals recovery 
Alkalophile 
High pH 
(pH>9) 
Cellulases 
Polymer degradation in detergents, 
Ion exchange resin regenerant 
disposal 
Halophile High salt concentration 
Proteases Peptide synthesis 
Piezophile 
High pressure 
(130MPa) 
Whole micro-organism 
Formation of gels and starch granules, 
Food processing and antibiotic 
production 
Metalophile High metal concentration Whole micro-organism 
Ore-bioleaching, bioremediation, 
biomineralization 
Radiophile High radiation levels Whole micro-organism 
Bioremediation of radionuclide 
contaminated sites 
Microaerophile Growth in<21% O2 
To be defined To be defined 
 
As previously mentioned, P450s have immense catalytic activities and varied substrate 
recognition, which have encouraged the utilization of these enzymes as prospective 
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biocatalysts for the production of chemicals, pharmaceutical substances, antibiotics, 
fragrances, food flavourings and the detoxification of carcinogens/mutagens (Ingelman-
Sundberg, 2004; Guengerich, 2006, Urlacher and Eiben, 2006; Syed et al., 2014a). The 
criteria for biotechnological exploitation of P450s on an industrial scale requires that these 
enzymes express resistance to extreme industrial reaction conditions such as high pressure, 
high temperature, pH and organic solvents, in doing so the rate of reaction would be 
increased, reaction specificity could be controlled and the chances of contamination by 
micro-organisms could be reduced (Niehaus, 1999; Zeikus et al., 1998, Yano and Poulos, 
2003). However, due to complexity, lack of thermal and chemical stability as well as the 
limited substrate specificity of P450 enzymes, usage of these enzymes for industrial and 
biotechnological purposes is hindered (O‘Reilly et al., 2011). Moreover, thermostable P450s 
used at industrial conditions should not only be stable in vivo, but also in vitro, if they are to 
be used in future for biotechnological purposes. In view of the fact that P450s are structurally 
and chemically less stable at extreme conditions, research has focused on discovering and 
identifying novel thermostable P450s that exhibit thermostability (Nishida and Ortiz de 
Montellano, 2005). Thus, thermophilic P450 enzymes are of potential interest and can serve 
as potential biocatalysts in terms of their protein structure, catalytic mechanisms and 
biotechnological/industrial applications such as the biosynthesis of important organic 
metabolites or intermediates (Nishida and Ortiz de Montellano, 2005; Bernhardt, 2006). 
Currently, only a few thermostable P450s have been described in the literature and have 
been characterized, whereby most of them are of archaeal [CYP119, CYP119A2 (P450st) and 
CYP231A2] (Wright et al., 1996; Koo et al., 2000; Kawarabayasi et al. 2001; Ho et al., 
2008) and bacterial origin [CYP175A1] (Yano et al., 2003). These extremophiles have 
ecological niches in geothermal vents and areas of high solfataric activity (Wright et al., 
1996; Ho et al., 2008). CYP119 was first identified in the archael species S. solfataricus 
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(Wright et al., 1996). CYP119 has a melting temperature (Tm) of 91C and the substrates that 
this enzyme binds to specifically are lauric acid, cis- and trans-β-methylstyrenes and styrene 
(Koo et al., 2000). CYP119A2 or P450st was first identified in the archael species S. tokodaii 
strain 7 (Kawarabayasi et al., 2001). The Tm of P450st is yet to be determined and the 
substrates that this enzyme binds to specifically are lauric acid and styrene (Matsumura et al., 
2011; Matsumura et al., 2008; Kawarabayasi et al., 2001). CYP231A2 was identified in the 
archael species Picrophilus torridus and has a Tm of 65C (Ho et al., 2008). CYP175A1 
found in the bacterial species Thermus thermophilus HB27 and has a Tm of 88C (Mandai et 
al., 2009a; Yano et al., 2003). CYP175A1 binds specifically to β-carotene, however with 
bioengineering attempts of the 175RF domain and introduction of one mutant (Q67G/Y68I), 
CYP175A1 is now capable of hydroxylating and accepting testosterone as a substrate 
(Mandai et al., 2009b). 
 
1.3.2. Unravelling the lower eukaryote fungal genomes for thermostable 
P450s 
To date, no thermostable P450s from other biological kingdoms have been reported. Until, 
recently a study conducted by Syed et al. (2014b), unravelled a large number of thermostable 
P450s of biotechnological potential from the two thermophilic ascomycetes, Myceliophthora 
thermophila (Sporotrichum thermophile) (abbreviated as M. thermophila) and Thielavia 
terrestris (abbreviated as T. terrestris). In the study, comparative genome-wide P450 analysis 
was used to ―mine‖ for P450s exhibiting both the P450 signature domain motifs namely 
EXXR (heme-binding) and FXXGXXXCXG (oxygen-binding), whereby 50 families and 56 
subfamilies (T. terrestris) and 49 families and 53 subfamilies (M. thermophila) were 
identified (Table 1.3) (Syed et al., 2014b). Out of 70 and 79 P450s reported, only 14 and 11 
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P450s were considered as thermostable based on an aliphatic index cut-off of > 90, in M. 
thermophila and T. terrestris respectively (Figure 1.4 and Table 1.4) (Syed et al., 2014b). 
Among the P450s identified as exhibiting thermotolerance in T. terrestris, is CYP53A, where 
the melting temperature of CYP53A was predicted to be 55-65C (Syed et al., 2014b). 
CYP53A belongs to the CYP53 family known as benzoate para-hydroxylase, an enzyme 
capable of hydroxylating benzoate (Faber et al., 2001). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4. Phylogenetic tree of the P450ome of T. terrestris (Thite-red) and M. 
thermophila (Spoth-blue). A total of 108 sequences were analysed, whereby thermostable 
P450s CYP119 and CYP175A1 of archael and bacterial origin (green), were also included for 
evolutionary analysis. Protein IDs are presented in parenthesis, with the symbols S and T, 
next to the P450s depicting stability of the P450 in vitro and the thermostability respectively. 
(Taken from Syed et al., 2014b). 
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Table 1.3. Genome-wide comparative analysis of the P450omes of thermophilic and mesophilic ascomycetes. P450omes of thermophilic 
ascomycetes T. terrestris (TT) and M. thermophila (MT) were compared with P450omes of the 14 mesophilic ascomycete species, whereby the 
number of P450s present is indicated. Mycosphaerella fijiensis (MF), Uncinocarpus reesii (UR), Histoplasma capsulatum (HC), Coccidioides 
immitis (CI), Aspergillus clavatus (AC), Aspergillus niger (AN), Aspergillus flavus (AF), Aspergillus oryzae (AO), Aspergillus terreus (AT), 
Aspergillus fumigatus (AFu), Neurospora crassa (NC), Neurospora discrete (ND), Fusarium graminearum (FG) and Fusarium oxysporum (FO). 
(Taken from Syed et al., 2014b). 
 
P450 family Thermophilic 
Pezizomycetes 
Mesophilic 
Pezizomycetes 
 TT MT MF UR HC CI AC AN AF AO AT AFu NC ND FG FO 
CYP51 1 1 1 2 2 1 2 2 4 3 3 2 1 1 3 3 
CYP52   1 1 1 1 
  
2 5 4 5 4 3 
    
CYP53 1 1 1 1 
 
1 1 1 1 2 1 1 1 1 3 3 
CYP54  2 1 
          
1 1 1 1 
CYP55  1  
 
1 1 
  
1 1 
 
1 
 
1 1 1 4 
CYP56  1  2  1 1  1 1       
CYP61 1 1 1 1 1 1 2 2 2 2 3 1 
 
1 2 2 
CYP65   4 3 2 
 
7 1 5 14 9 10 8 3 2 2 4 2 
CYP68 1 1 
  
2 
 
1 3 1 2 3 1 1 1 5 2 
CYP505  2 1 3 
   
2 3 4 3 2 1 1 1 2 4 
CYP526 1 1 
        
1 
 
1 1 2 1 
CYP527  1 2 
     
1 
    
2 2 1 3 
CYP528 1 1 1 
         
1 2 1 
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CYP529 1 1 
          
1 1 
  
CYP530  1 
 
1 
 
1 
    
1 1 1 1 1 1 
CYP532 1 1 1 
    
2 1 1 1 
 
1 1 4 3 
CYP533 1 1 
          
1 1 
  
CYP534 1 1 1 
         
1 1 1 
 
CYP535 1  
      
1 1 
  
1 1 
  
CYP536  1 1 1 
         
1 1 
  
CYP537  1 1 
      
1 1 1 
 
1 
 
1 2 
CYP538  1  
          
1 1 
  
CYP539  1 1 1 1 2 1 2 1 1 
 
3 2 1 1 2 1 
CYP541    1 
    
1 1 1 1 1 1 1 1 
  
CYP543  1 1 1 
         
1 1 
  
CYP544   1 1 
          
1 1 1 1 
CYP546   1 1 
          
1 1 1 
 
CYP547 1 1 1 
    
1 1 1 2 1 1 1 1 1 
CYP548 2 1 3 2 1 2 4 6 2 3 3 1 1 1 2 6 
CYP549   1 1 
          
1 1 
  
CYP552  1 
      
1 
 
1 
 
1 1 3 3 
CYP559    1 1 2 
         
1 1 
 
1 
CYP563 1 1 
              
CYP570  1 2 1  1         3 5 
CYP578 1 1 3 2 1 2 2 3 3 2 2 2 
   
2 
CYP586  1 1 
  
1 
  
2 
  
1 1 
    
CYP606   1 
    
1 
   
1 
   
1 1 
CYP617   1 1 1 1 
  
5 3 1 1 1 3 
  
3 3 
CYP628   1 
  
1 
  
1 1 1 1 
   
1 4 
CYP629   1 
  
1 
         
1 1 
CYP631  2  
      
2 1 
    
1 
 
CYP634 1              1 1 
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CYP638  1 1 
  
1 
         
1 1 
CYP639 1              1 1 
CYP643  1  
     
1 1 
     
4 1 
CYP660     1 
   
1 1 1 2 2 1 1 
    
CYP663   2 1 1 
   
1 1 1 
 
1 
     
CYP682 3 2 1 4 1 6 2 2 3 2 2 1 
   
1 
CYP684  1  1 
    
2 1 1 3 
    
1 
CYP687  1  
      
1 
       
CYP5056  1               
CYP5065   1 1 
             
1 
CYP5070 1 1 
      
1 1 
      
CYP5071 1  
              
CYP5075 1 1 
     
1 2 2 
      
CYP5080  1               
CYP5104 1  
   
1 
 
2 
  
1 
     
CYP5105 1  
     
1 1 
       
CYP5129 1  
              
CYP5188     1 1 
             
CYP5249 2 1 
  
1 
           
CYP5272 1      1       1   
CYP6001 
 1 1 
 
1 1 2 2 3 
 
3 
  
1 
 
1 
Total no. of 
P450s in the 
genome 
61 53 89 38 47 40 91 154 162 142 124 74 41 43 109 140 
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Table 1.4. Analysis of thermostability of the P450omes of T. terrestris and M. thermophila. The aliphatic index and protein melting 
temperature (Tm) were used to measure the thermostablity of each P450. P450s having analiphatic index of > 90, implies that the P450 is 
thermostable. The aliphatic index of each thermostable P450 is compared with their homologous P450s from mesophilic ascomycetes (presented 
as reference species). Ascomycete thermostable P450s‘ aliphatic index and Tm were also compared with thermostable P450s CYP119 of S. 
Solfataricus and CYP175A1 of T. thermophilus. Abbreviations: PN, Phaeosphaeria nodorum; HC, Histoplasma capsulatum; AN, Aspergillus 
niger; AF, Aspergillus flavus; AT, Aspergillus terreus; NC, Neurospora crassa; ND, Neurospora discrete; FG, Fusarium graminearum; FO, 
Fusarium oxysporum; NS, new subfamily. (Taken from Syed et al., 2014b).  
P450 Aliphatic index Melting temperature (Tm) Homolog P450 from mesophilic ascomycetes 
 
Aliphatic index 
 
P450 and species name Tm Index Predicted Tm (
o
C) 
T. terrestris 
CYP538A 92.67 -0.1 ˂55 87.72 CYP538A1 NC 
CYP539A 91.17 0.6 55-65 86.63 CYP539A8P AT 
CYP643C 93.35 1.4 ˃65  89.09 CYP643C2 AF 
CYP684A 92.63 0.7 55-65 83.71 CYP684A4 AT 
CYP5070A 90.83 0.1 55-65 83.37 CYP5070A1 AF 
CYP5129A 100.43 1.21 ˃65 96.08 CYP5129A PN 
CYP65AW  92.64 0.78 55-65 88.00 CYP65AW1 FO 
CYP53A  95.1 0.8 55-65 85.13 CYP53A1 AN 
CYP5249A  91.09 1.17 ˃65 98.91 CYP5249A HC 
CYP5104B 91.33 - ˂55 86.22 CYP5104B1 AN 
CYP68D  92.31 0.5 55-65 88.31 CYP68D3 AN 
CYP5071A  96.83 1.2 ˃65 88.53 CYP5071A FG 
CYP547B  102.34 1.61 ˃65 100.8 CYP547B3 FO 
CYP54A  94.57 1.1 ˃65 86.05 CYP54A1 ND 
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M. thermophila  
CYP628C  93.3 0.5 55-65 89.66 CYP628C1 AF 
CYP617A  91.12 0.5 55-65 85.34 CYP617A3 FO 
CYP547B 101.3 1.07 ˃65 78.66 CYP547A5 FO 
CYP539A  92.33 0.8 55-65 86.63 CYP539A8P AT 
CYP5249NS  92.78 1.5 ˃65 99.84 CYP5249A1P HC 
CYP541A  91.88 1.0 55-65 92.89 CYP541A1 NC 
CYP606A  97.49 0.7 55-65 86.23 CYP606A3P AT 
CYP527A  93.25 0.7 55-65 81.03 CYP527A1 ND 
CYP54C  98.56 0.96 55-65 86.88 CYP54C5 FO 
CYP660NS  92.21 0.7 55-65 88.24 CYP660A4 AT 
CYP61A  96.74 1.3 ˃65 83.01 CYP61A1 AT 
T. thermophilus   
CYP175A1 97.20 1.39 ˃65   
S. Solfataricus   
CYP119* 96.63 0.94 55-65   
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1.4. Rationale and objectives of the study 
Cytochrome P450 monooxygenases (P450s) are heme-thiolate proteins distributed across 
biological kingdoms (Nelson, 2013). P450s perform a wide variety of reactions, such as 
activation of sp
3
 hybridized carbon (C) atoms, epoxidation, deamination and dehalogenation, 
aromatic hydroxylation and N-oxidation, as well as N-, O- and S-dealkylation, which 
suggests that these enzymes are capable of accepting diverse substrates (Bernhardt, 2006).  
P450s have immense catalytic activities and varied substrate recognition, which have 
encouraged the utilization of these enzymes as prospective biocatalysts for the production of 
chemicals, pharmaceutical substances, antibiotics, fragrances, food flavourings and the 
detoxification of carcinogens/mutagens (Guengerich, 2002; Ingelman-Sundberg, 2004; 
Guengerich, 2006; Urlacher and Eiben 2006; Syed and Yadav, 2012). The criteria for 
biotechnological exploitation of P450s on an industrial scale requires that these enzymes 
express resistance to extreme industrial reaction conditions such as high pressure, high 
temperature, pH and organic solvents (Niehaus, 1999; Zeikus et al., 1998; Yano and Poulos, 
2003). However, due to thermal and chemical instability as well as the limited substrate 
specificity of P450 enzymes, usage of these enzymes for industrial and biotechnological 
purposes is hindered (O‘Reilly et al., 2011). Moreover, thermostable P450s used at industrial 
scale should not only be stable in vivo, but also in vitro. Considering the fact, that P450s are 
structurally and chemically less stable at extreme conditions, research has focused on 
exploring and identifying novel thermostable P450s (Nishida and Ortiz de Montellano, 2005). 
The rationale for carrying out this study lies in the well documented findings in the 
literature that to date only a few thermostable cytochrome P450 monooxygenases have been 
described, whereby most of them are of archaeal [CYP119, CYP119A2 (P450st) and 
CYP231A2] (Wright et al., 1996; Koo et al., 2000; Kawarabayasi et al. 2001; Ho et al., 
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2008) and bacterial origin [CYP175A1] (Yano et al., 2003). The best and most studied 
thermostable P450 to date is CYP119 from S. solfataricus (Wright et al., 1996; Koo et al., 
2000). Hence, it can be observed from the literature that these bacterial and archael 
thermostable P450s show limited substrate specificity, that is, these P450s can only bind to a 
few or just one substrate molecule in their respective native configuration. Moreover, archael 
and bacterial thermostable P450s cannot generate human (eukaryotic) valuable products that 
are useful for commercialization. No thermostable P450s from other biological kingdoms or 
the eukaryotic domain have been reported. Until, recently a study conducted by Syed et al. 
(2014), unravelled a large number of thermostable P450s of biotechnological potential from 
two thermophilic biomass-degrading ascomycetes, M. thermophila and T. terrestris. Among 
the P450s identified as exhibiting thermotolerance in T. terrestris, is CYP53A, where the 
melting temperature of CYP53A was predicted to be 55-65C (Syed et al., 2014). CYP53A 
belongs to the CYP53 family known as benzoate para-hydroxylase, an enzyme capable of 
hydroxylating benzoate (Faber et al., 2001). 
In this study, the distribution of CYP53 in fungal species was assessed. Genome-data 
mining was performed to ―fish out‖ CYP53 from four fungal phyla (Ascomycota, 
Basidiomycota, Chytridiomycota and Zygomycota). Subfamilies were assigned to identified 
CYP53 proteins in the fungal phyla. The main goal of analysis was to identify whether 
CYP53 can serve as novel common anti-fungal drug target. Structural analysis of CYP53A 
and CPR was performed to assess whether these P450s possess characteristic signature motifs 
of P450 and redox enzymes. Three dimensional (3D) models for CYP53A and CPR was 
constructed to locate specific amino acids that are highly conserved that might be used as 
antifungal drug target site for future studies (in case of CYP53A) and analysis of cofactor 
binding properties (in case of CPR). Consequently, it could be determined, whether this 
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CYP53 family could be used to unravel the molecular basis for thermostability of eukaryote 
P450s.  
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CHAPTER 2 
GENOME-WIDE IDENTIFICATION, ANNOTATION 
AND COMPARATIVE ANALYSIS OF CYP53A 
FAMILY IN FUNGI 
2.1. Introduction 
Among microorganisms fungi, the largest biological kingdom comprising of diverse lower 
eukaryotic microorganisms, acquired a special place owing to their ability to be pathogens for 
not only humans but also other animals and plants (Table 2.1). These lower eukaryotes 
developed or are constantly developing new strategies to adapt to diverse ecological niches. 
In order to develop novel drugs by identifying potential novel drug targets and harnessing 
their potentials for the production of human valuables, a large number of fungal genomes 
have been sequenced and many fungal genome sequencing projects are in progress. Efforts of 
the Broad Institute of MIT and Harvard (http://www.broadinstitute.org/), Wellcome Trust 
Sanger Institute (https://www.sanger.ac.uk/) and Joint Genome Institute (JGI) United States 
Department of Energy (US-DOE) (http://genome.jgi.doe.gov/programs/fungi/index.jsf) 
resulted in genome sequencing of a large number of fungal species. 
Genome sequencing analysis of fungal species revealed the presence of a large number of 
cytochrome P450 monooxygenases (P450s) in their genomes, with some exceptions. P450s 
are heme-thiolate proteins ubiquitously present across the biological kingdoms (Nelson, 
2013). In fungi P450s are known to be involved in both primary and secondary metabolic 
processes (Črešnar and Petrič, 2011; Hlavica, 2013) and in the degradation of xenobiotic 
compounds (Syed and Yadav, 2012). P450s have been explored as anti-fungal drug targets 
owing to their key role in fungal physiology through involvement in stereo- and regio-specific 
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oxidation of substrates (Yoshida, 1988). Among fungal P450s CYP51, also known as sterol 
14α-demethylase, the highly conserved P450 across the biological kingdoms (Lepesheva and 
Waterman, 2004), is the primary target of conventional antifungal azole drugs (Kelly and 
Kelly, 2013). CYP51 performs demethylation of lanosteol, a key step in biosynthesis of cell 
membrane ergosterol (Lepesheva and Waterman, 2004). Studies have indicated that fungal 
organisms are developing resistance to azole drugs (Hof, 2001; Sanglard, 2002). Furthermore, 
the currently available anti-fungal drugs have limitations because of the metabolic pathways 
similarity between fungi and other organisms (mainly mammals) and hence researchers are in 
search of alternative novel fungal drug targets (Sangamwar et al.,2008).  
 
Table 2.1. Genome-wide comparative analysis of CYP53 family in fungi. Twenty-three 
species from ascomycota and 28 species from basidiomycota were used in this study. 
Identification of CYP53 members in fungal species was carried out as described in the 
―Materials and methods‖ section. If no CYP53 member was found in the species, the space 
was left blank. The abbreviation NS indicates a new subfamily. Fungal species capable of 
causing diseases in humans were indicated with the word ―human‖ in the table. 
Species Lifestyle 
CYP53 subfamily 
Total 
count 
A B C D H NS 
Ascomycota 
Magnaporthe grisea Plant pathogen 1      1 
Neurospora crassa Model organism 1      1 
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Species Lifestyle 
CYP53 subfamily Total 
count 
A B C D H NS 
Ascomycota 
Neurospora discreta 
Distantly related to 
Neurospora crassa 
1      1 
Fusarium graminearum Plant pathogen 3      3 
Fusarium solani f. batatas 
(Nectria haematococca) 
Plant pathogen and animal 
pathogen (opportunistic 
human pathogen) 
2      2 
Fusarium verticillioides 
Plant pathogen and animal 
pathogen (opportunistic 
human pathogen) 
2      2 
Fusarium oxysporum 
Plant pathogen and animal 
pathogen (opportunistic 
human pathogen) 
2   1   3 
Neosartorya fischeri 
Animal pathogen 
(including human) 
1      1 
Aspergillus nidulans 
Model organism for study 
of eukaryotic cell biology 
1      1 
Aspergillus fumigatus 
Animal pathogen 
(opportunistic human 
pathogen) 
1      1 
Aspergillus terreus 
Human, animal and plant 
pathogen 
1      1 
Aspergillus oryzae 
Economically important, 
used for fermentation 
2      2 
Aspergillus flavus 
Plant and animal pathogen 
(human pathogen) 
1      1 
Aspergillus niger 
Plant and animal pathogen 
(human pathogen) 
1      1 
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Species Lifestyle 
CYP53 subfamily Total 
count 
A B C D H NS 
Ascomycota 
Aspergillus clavatus 
Animal pathogen (human 
pathogen) 
1      1 
Coccidioides immitis 
Animal pathogen (human 
pathogen) 
1      1 
Histoplasma capsulatum 
Animal pathogen (human 
pathogen) 
0      0 
Uncinocarpus reesii Non-pathogen 1      1 
Mycosphaerella fijiensis Plant pathogen 1      1 
Zymoseptoria tritici(formerly 
named as Mycosphaerella 
graminicola) 
Plant pathogen 1      1 
Thielavia terrestris Non-pathogen 1      1 
Myceliophthora thermophila Non-pathogen 1      1 
Cochliobolus lunatus 
Plant and animal pathogen 
(human pathogen) 
1      1 
Total count (Ascomycota) 28   1   29 
Basidiomycota 
Phanerochaete chrysosporium 
Model white rot fungus – 
study of wood degradation 
  1    1 
Postia placenta 
Model brown rot fungus – 
study of wood degradation 
  1 7   8 
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Species Lifestyle 
CYP53 subfamily Total 
count 
A B C D H NS 
Basidiomycota 
Ustilago maydis Plant pathogen   1    1 
Cryptococcus neoformans Animal pathogen (human)       0 
Cryptococcus gattii Animal pathogen (human)       0 
Laccaria bicolor 
Symbiotic fungus 
(ectomycorrhizas) 
      0 
Malassezia globosa Animal pathogen (human)       0 
Puccinia graminis Plant pathogen  1     1 
Sporobolomyces roseus Non-pathogen  1     1 
Phanerochaete carnosa 
Model white rot fungus - 
study of soft wood 
degradation 
  6   1 7 
Bjerkandera adusta 
Wood-degrading white rot 
fungus 
  1  7  8 
Ceriporiopsis subvermispora 
Wood-degrading white rot 
fungus 
  4    4 
Ganoderma sp. 
Wood-degrading white rot 
fungus 
  1    1 
Ganoderma lucidum 
Medicinal mushroom 
(wood-degrading white rot 
fungus) 
  1    1 
Phlebia brevispora 
Wood-degrading white rot 
fungus 
  1    1 
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Species Lifestyle 
CYP53 subfamily Total 
count 
A B C D H NS 
Basidiomycota 
Agaricus bisporus Litter-degrading fungus   2    2 
Serpula lacrymans 
Model fungus known as 
dry rot fungus – study of 
dry wood degradation 
  1    1 
Stereum hirsutum 
Wood-degrading white rot 
fungus 
  1    1 
Trametes versicolor 
Wood-degrading white rot 
fungus 
  2    2 
Wolfiporia cocos 
Wood-degrading brown-
rot fungus 
  9    9 
Auricularia delicata 
Wood-degrading white rot 
fungus 
1  1    2 
Coniophora puteana 
Wood-degrading brown rot 
fungus 
1  2    3 
Dacryopinax sp. 
Wood-degrading brown rot 
fungus 
  1    1 
Dichomitus squalens 
Wood-degrading white rot 
fungus 
  1    1 
Fomitiporia mediterranea 
Wood-degrading white rot 
fungus 
  9   1 10 
Fomitopsis pinicola 
Wood-degrading brown rot 
fungus 
  4    4 
Gloeophyllum trabeum 
Wood-degrading brown rot 
fungus 
  1    1 
Punctularia strigosozonata 
Wood-degrading white rot 
fungus 
1  1    2 
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Research on fungal P450s revealed that the P450 family CYP53 could serve as a novel 
alternative anti-fungal drug target (Podobnik et al., 2008). CYP53 family members are well 
known as benzoate para-hydroxylases that are involved in the detoxification of a benzoate 
molecule (Faber et al., 2001). Benzoate is a naturally occurring anti-fungal plant material and 
a naturally occurring intermediate in the degradation of aromatic compounds in fungi 
(Durham et al., 1984; Jensen et al., 1994; Lapadatescu et al., 2000; Amborabe et al., 2002). 
Benzoate exhibits its toxicity by disruption of the membrane, inhibiting essential cellular 
processes, changing pH balance and inducing stress response in fungi (Brul and Coote, 1999; 
Amborabe et al., 2002). CYP53 mediated para-hydroxylation of benzoate is the only known 
pathway in fungi that ultimately channels this toxic compound into the β-ketoadipate pathway 
(Harwood and Parales, 1996). Furthermore, the CYP53 gene was found to be essential for 
fungal species’ survival (Fraser et al., 2002). The CYP53 gene-knock out fungal strain 
growth was found to be inhibited by the accumulation of toxic intermediate benzoate (Fraser 
et al., 2002). This clearly suggests that this P450 is critical in the survival of fungal species, 
by playing a key role in the detoxification of benzoate. 
Considering the fungal resistance to the currently available drugs, especially CYP51 
enzyme-based azoles and a preliminary study suggesting that CYP53 P450 family members 
can serve as novel alternative fungal drug targets (Sanglard, 2002; Podobnik et al. 2008 ), the 
present study aimed to understand the role of CYP53 members in fungal physiology, 
performing comparative evolutionary and structural analysis of CYP53 members to check 
their distribution and structural conservation in fungi. In this way, one can determine whether 
Total count (Basidiomycota) 3 2 52 7 7 2 73 
Total CYP53 members  
in fungi 
31 2 52 8 7 2 102 
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this P450 family can serve as a common drug target against a broad range of fungal 
pathogens. Furthermore, its role in adaptation of basidiomycetes to diverse ecological niches 
such as colonization on wood were also assessed.   
 
2.2. Materials and methods 
2.2.1. Genome data mining and annotation of CYP53 members 
Fifty-one fungal species were selected for the analysis of CYP53 member P450s. As shown in 
Table 2.1, 23 species from ascomycota and 28 species from basidiomycota were included in 
this analysis. CYP53 members of the basidiomycete species, such as Phanerochaete 
chrysosporium, P. carnosa, Bjerkandera adusta, Ganoderma sp., Phlebia brevispora, and 
Ceriporiopsis subvermispora, and ascomycete species, such as Thielavia terrestris and 
Myceliophthora thermophila, were retrieved from published and publicly available literature 
(Fernandez-Fueyo et al., 2012; Floudas et al., 2012; Suzuki et al., 2012; Syed and Yadav, 
2012; Syed et al., 2013; Syed et al., 2014 (a, b)). CYP53 members in the remaining 20 
ascomycetes were obtained from the Cytochrome P450 Homepage (Nelson, 2009). Two 
basidiomycete species, namely Agaricus bisporus and Serpula lacrymans CYP53 members, 
were obtained from the Fungal Cytochrome P450 Database (FCPD) (Moktali et al., 2012). 
CYP53 members belonging to Postia placenta were taken from published literature (Ide et 
al., 2012).  
To identify CYP53 members in the basidiomycete species, such as Wolfiporia cocos, 
Auricularia delicata, Coniophora puteana, Dacryopinax sp., Dichomitus squalens, 
Fomitiporia mediterranea, Fomitopsis pinicola, Gloeophyllum trabeum, Punctularia 
strigosozonata, Stereum hirsutum, and Trametes versicolor, genome data mining was 
performed using the established procedure described elsewhere with slight modifications 
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(Syed et al., 2014a;Syed and Mashele, 2014). BLAST analysis was performed at the 
respective species’ genome data base that is publicly available, using P. chrysosporium 
CYP53C2 (protein ID: 130996) (Grigoriev et al., 2011). Considering the presence of CYP53 
members in low copies (one or two numbers) in ascomycetes and basidiomycetes, the top 20 
hit proteins were selected for further analysis. The hit proteins were subjected to the NCBI 
Batch Web CD-Search Tool to separate proteins belonging to the P450 superfamily 
(Marchler-Bauer et al., 2011). This software groups the proteins into different super families 
based on the conserved domain characteristics of the protein family. The proteins that are 
grouped under the P450 superfamily were selected for further assignment to the P450 family 
and subfamily. Assigning the family and subfamily names to the P450 proteins was 
performed using the standard procedure established in the laboratory (Syed et al., 2014a; 
Syed and Mashele, 2014). Briefly, individual proteins were blasted against all named fungal 
P450s at the Cytochrome P450 Homepage (Nelson, 2009). A family and subfamily were 
assigned to the P450 proteins based on standard International P450 Nomenclature criteria, i.e. 
>40% homology for a family and >55% homology for a subfamily. Among the selected 
proteins, those grouped under the CYP53 family were used in the analysis (Appendix A). The 
Cytochrome P450 Homepage (Nelson, 2009) was visited to check for the presence of CYP53 
members, if any, in the basidiomycetes Ustilago maydis, Cryptococcus neoformans, 
Cryptococcus gattii, Laccaria bicolor, Malassezia globosa, Puccinia graminis and 
Sporobolomyces roseus. A CYP53 member for Cochliobolus lunatus was obtained from the 
published literature (Podobnik et al., 2008). 
 
2.2.2. Phylogenetic analysis 
Phylogenetic analysis of CYP53 members was carried out using the Molecular Evolutionary 
Genetics Analysis (MEGA) software (Tamura et al., 2011) following the protocol described 
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elsewhere  (Syed et al., 2014(a, b)). Phylogenetic analysis was inferred using the minimum 
evolution method (Rzhetsky and Nei, 2000). The minimum evolution method is widely used 
in P450 research, as it involves pairwise distance algorithms for the reconstruction of 
phylogenies (Chen et al., 2012; Syed et al., 2014 (a, b)). Hence, in the current study the 
minimum evolution method was used for phylogenetic analysis of CYP53 member P450s. 
The evolutionary distances were computed using the Poisson correction method and are in the 
units of the amino acid substitution per site (Zuckerkandl and Pauling, 1965). The minimum 
evolution tree was searched using the close-neighbor-interchange algorithm (Nei and Kumar, 
2000). The neighbor-joining algorithm was used to generate the initial tree (Saitou and Nei, 
1987).  
 
2.2.3. Intron-exon analysis 
Gene structure organization of CYP53 family members was carried using the established 
protocol described elsewhere (Syed et al., 2014b). Briefly, each CYP53 member gene was 
accessed at its genome data base at the JGI, US-DOE or Broad Institute of MIT and Harvard. 
For each P450 the size of the exons and the location of introns were recorded. A schematic 
diagram showing horizontal lanes representing the exons and vertical lanes representing the 
introns’ location were drawn. The length of the horizontal lane corresponds to the gene 
length. CYP53 members that showed high conservation in terms of the size of exons and the 
location of introns were shown in a figure.  
 
2.2.4. Analysis of homology 
To identify the percentage homology between CYP53 members, ClustalW2 multiple 
sequence analysis was performed (Larkin et al., 2007). CYP53 members in FASTA format 
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were included in the analysis and the result summary showing the percentage identity matrix 
was downloaded. After the file had been downloaded, the results were converted into table 
format and checked for the percentage homology between CYP53 members. 
 
2.2.5. Analysis of amino acid conservation 
The number of amino acids conserved in CYP53 members across the fungi and between 
ascomycota and basidiomycota was determined using PROfile Multiple Alignment with 
predicted Local Structures and 3D constraints (PROMALS3D) (Pei et al., 2008). 
PROMALS3D aligns multiple protein sequences and/or structures, with enhanced 
information from database searches, secondary structure prediction, 3D structures or user-
defined constraints and it will also give a conservation index (Pei and Grishin, 2001). The 
conservation index follows numbers above 4, where 9 is the invariantly conserved amino acid 
across the input sequences.  
 
2.3. Results and discussion 
2.3.1. CYP53 distribution in fungi 
The CYP53 family is one of the P450 families apart from CYP51 and CYP61 that are 
conserved between the phyla ascomycota and basidiomycota (Črešnar and Petrič, 2011; 
Moktali et al., 2012). In this study, 51 fungal species belonging to ascomycota (23 species) 
and basidiomycota (28 species) were screened for analysis of CYP53 family members. 
Genome data mining of ascomycetes (23 species) and basidiomycetes (28 species) revealed 
the presence of one to nine copies of CYP53 members in their genomes (Table 2.1). The 
CYP53 family member count ranged from one to three in ascomycetes and one to ten in 
basidiomycetes. The basidiomycete species F. mediterranea showed the maximum number of 
© Central University of Technology, Free State
CHAPTER 2: GENOME- WIDE IDENTIFICATION, ANNOTATION AND COMPARATIVE ANALYSIS 
OF CYP53A FAMILY IN FUNGI 
51 
 
CYP53 members (10 CYP53 P450s) in its genome. No CYP53 member was identified in the 
ascomycete Histoplasma capsulatum and in the basidiomycetes C. neoformans, C. gattii and 
M. globosa or the symbiotic L. bicolor (Table 2.1). Overall, ascomycete species showed a 
lower number of CYP53 member P450s in their genomes compared to basidiomycete species 
(Table 2.1), suggesting a possible duplication of CYP53 members after the phylum 
divergence. Moreover, analysis revealed the complete absence of CYP53 member P450s in 
phyla zygomycota and chytridiomycota. Furthermore, in ascomycota only species belonging 
to subphyla pezizomycotina showed CYP53 members in their genomes and CYP53 member 
P450s were not found in species of the subphyla saccharomycotina (Kgosiemang et al., 2014) 
and taphinomycotina, which is in accordance with the smaller size of the P450ome in relation 
to the growth form of the fungus. Overall, contrary to the established assumption that this 
family is conserved in fungi, this study showed that CYP53 is not conserved across the fungal 
species. In future, further genome sequencing analysis of species belonging to 
chytridiomycota and zygomycota and the subphylum taphrinomycotina could be performed 
that may provide more information on the presence of this protein family in their genome. 
However, considering the life style and small size genomes of saccharomycotina species, the 
absence of CYP53 family members is expected.  
Analysis of the CYP53 family suggested the dominance of specific CYP53 subfamilies 
in ascomycota and basidiomycota (Table 2.1). Ascomycete species showed only the CYP53A 
subfamily in their genomes, with the exception of F. oxysporum, which showed a single copy 
CYP53 member belonging to the CYP53D subfamily (Table 2.1). In contrast to ascomycete 
species, basidiomycete species showed divergence in CYP53 subfamilies. Five subfamilies 
were observed in basidiomycetes, i.e. CYP53A, CYP53B, CYP53C, CYP53D, and CYP53H 
(Table 2.1). Analysis of CYP53 members in basidiomycetes revealed the presence of two new 
CYP53 subfamilies in P. carnosa and F. mediterranea. Among the CYP53 subfamilies 
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observed for basidiomycota, the CYP53C subfamily was dominant, with 52 members, 
followed by CYP53D (eight members) and CYP53H (seven members). A single copy of 
CYP53A members was found in A. delicata, P. strigosozonata, and C. puteana (Table 2.1). 
Considering the presence of CYP53A and CYP53D subfamilies in both phyla, one can 
assume that after the divergence of phyla, ascomycete species might have lost CYP53 
subfamilies such as CYP53B, C and H. On the other hand, basidiomycete species enhanced 
CYP53 numbers in their genome, possibly by genome duplication of CYP53 members in 
view of the possible requirement of these P450 family members to adapt to diverse ecological 
niches.  
 
2.3.2. Phylogenetic analysis of CYP53 P450 family 
In order to understand the evolution of the CYP53 family and its distribution in fungi, 
evolutionary analysis of the CYP53 family was performed using the minimum evolution 
method (Rzhetsky and Nei, 1992). Minimum evolution analysis of CYP53 members showed 
subfamily-specific and species-specific alignment/grouping of CYP53 members (Figure 2.1), 
suggesting that after divergence of phyla (ascomycota and basidiomycota) CYP53 members 
have been subjected to phylum-specific amino acid changes in their structure. The most 
striking feature was that CYP53 members belonging to a particular basidiomycete species 
were grouped together (Figure 2.1). This clearly indicates that paralogous evolution of 
CYP53 members, possibly via genome duplication, occurred in basidiomycete species. In a 
recently published study, the same phenomenon of genome duplication of member P450s in 
basidiomycete species was reported (Syed et al., 2014b). Furthermore, authors also showed 
that these P450 duplications were necessitated by the fungal species to adapt to diverse 
ecological niches (Syed et al., 2014b). Interestingly, CYP53D1 of F. oxysporum 
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(ascomycete) did not align with its counterpart present in P. placenta (basidiomycete) (Figure 
2.1), suggesting that extensive changes specific to phyla might have occurred in their primary 
structure. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1. Phylogenetic analysis of CYP53 family in fungi. The tree was constructed with 
101 CYP53 P450s belonging to six different CYP53 subfamilies. Phylogeny was inferred 
using the minimum evolution method and the tree was constructed using MEGA (5.05) 
software. For ease of visual identity, the tree branch color, protein name, protein ID 
(parenthesis) and species name were presented in unique color as per sub-family. Fungal 
species’ names were indicated with three letters, where the first letter is taken from the genus 
name and the other two letters from the species name.  
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2.3.3. High conservation of primary structure of CYP53 members in 
ascomycota 
From the above study, it is highly positive that after divergence of ascomycota and 
basidiomycota, CYP53 members have been subjected to phyla-specific changes or 
conservation in their primary structure. In order to understand these phyla-specific changes or 
conservations in CYP53 members, we followed two methods. Firstly, we analyzed the 
percentage homology and secondly we deduced amino acids conserved in CYP53 members in 
both ascomycetes and basidiomycetes.  
ClustalW2 analysis of CYP53 members revealed a high percentage homology among 
CYP53 members (Table 2.2) in ascomycota; some of the members showed >90% homology 
compared to CYP53 members in basidiomycota. The observed high percentage homology in 
CYP53 members of ascomycota (Table 2.2) might be due to the dominance of a single 
CYP53A subfamily. It is noteworthy that although the CYP53C subfamily is dominant in 
basidiomycota (Table 2.1), most of its members seem to be subjected to major amino acid 
changes, as the percentage homology between CYP53C members is not high with exception 
of a few P450s, as observed for CYP53A members for ascomycota (Table 2.2). 
 
Table 2.2. Analysis of homology between CYP53 members in fungi. The percentage (%) 
homology between CYP53 members was obtained from the Cytochrome P450 Homepage 
(Nelson, 2009) based on their highest hit to reference proteins and also estimated using 
ClustalW2 (Larkin et al., 2007). P450s showing more than 90% homology were selected and 
presented in the table. As shown in the table, a higher number of CYP53 members from 
ascomycota showed more than 90% homology, suggesting high conservation of the primary 
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structure in ascomycete species CYP53 members compared to basidiomycete species CYP53 
members. For each P450 protein, IDs were shown in parenthesis.  
 
CYP name Species name 
Homology 
(%) 
CYP name Species name 
Ascomycota 
CYP53A4 
(7508) 
Neurospora crassa 98 
CYP53A4 
(88466) 
Neurospora discreta 
CYP53A 
(2107910) 
Thielavia terrestris 91 
CYP53A 
(2301715) 
Myceliophthora 
thermophila 
CYP53A19 
(9543) 
Fusarium verticillioides 98 
CYP53A19 
(14206) 
Fusarium oxysporum 
CYP53A8 
(12085) 
Fusarium graminearum 95 
CYP53A19 
(9543) 
Fusarium verticillioides 
CYP53A8 
(12085) 
Fusarium graminearum 95 
CYP53A19 
(14206) 
Fusarium oxysporum 
CYP53A20 
(6367) 
Fusarium verticillioides 99 
CYP53A20 
(10443) 
Fusarium oxysporum 
CYP53A7 
(10227) 
Fusarium graminearum 97 
CYP53A20 
(6367) 
Fusarium verticillioides 
CYP53A7 
(10227) 
Fusarium graminearum 97 
CYP53A20 
(10443) 
Fusarium oxysporum 
CYP53A12 
(8190) 
Neosartorya fischeri 98 
CYP53A12 
(3003) 
Aspergillus fumigatus 
CYP53A12 
(3003) 
Aspergillus fumigatus 94 
CYP53A21 
(1341) 
Aspergillus clavatus 
CYP53A13 
(5958) 
Aspergillus oryzae 99 
CYP53A13 
(26719) 
Aspergillus flavus 
Basidiomycota 
CYP53C4 
(47512) 
Ganoderma sp. 95 
CYP53C4 
(GL08839-
P1.1) 
Ganoderma lucidum 
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CYP53D3 
(60352) 
Postia placenta 95 
CYP53D5 
(46728) 
Postia placenta 
Basidiomycota 
CYP53C 
(104855) 
Wolfiporia cocos 67 
CYP53C 
(154237) 
Wolfiporia cocos 
 
To link the high percentage homology observed for CYP53 members of ascomycetes 
towards conservation of amino acid in their primary structure, amino acid conservation 
studies were performed using PROMALS3D (Figures 2.2). PROMALS3D analysis of CYP53 
members across fungi suggested conservation of eight amino acids. Conservation of only 
eight amino acids in CYP53 members across fungi is understandable, considering the high 
diversity of CYP53 members across fungal species (five subfamilies and two new 
subfamilies). The most striking difference was observed in the number of amino acids 
conserved in the CYP53 members of ascomycota and basidiomycota (Figures 2.2). A hundred 
and three amino acids were found conserved in CYP53 members of ascomycota compared to 
CYP53 members of basidiomycota (Figure 2.2A), which showed only seven amino acids 
conserved in their primary structure (Figure 2.2B). This strongly suggests that the observed 
high percentage homology between CYP53 members of ascomycota is due to the high 
conservation of amino acids in their primary structure.  
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Figure 2.2. Analysis of amino acid conservations in CYP53 family members of 
ascomycota (A) and basidiomycota (B). Analysis of amino acid conservations was carried 
out using PROMALS3D (Pei et al., 2008). CYP53A from T. terrestris and CYP53C2 from P. 
chrysosporium were presented as a representative of ascomycota (A) and basidiomycota (B) 
CYP53 members. The residues conserved in CYP53 members of ascomycota (A) and 
basidiomycota(B) are shown with the conservation index on top of the amino acid residue 
(Pei and Grishin, 2001). 
 
© Central University of Technology, Free State
CHAPTER 2: GENOME- WIDE IDENTIFICATION, ANNOTATION AND COMPARATIVE ANALYSIS 
OF CYP53A FAMILY IN FUNGI 
58 
 
One can argue that the high conservation of amino acids (103 amino acids) in CYP53 
members of ascomycota (Figure 2.2A) is due to the presence of a single CYP53A subfamily 
whereas five subfamilies and two new subfamilies exist in basidiomycota. To rule out this 
argument, two types of evidence were presented in this study. Firstly, CYP53A members 
from ascomycete species belonging to 11 different genera were used in this study (Table 2.1), 
suggesting the high diversity of host species, which should thus reflect in CYP53A primary 
structure as well. However, this was not true, as ascomycete CYP53 members showed high 
conservation in the primary structure (Figure 2.2A). Secondly, estimation of the number of 
amino acids conserved in the CYP53C subfamily was performed (Figure 2.2B), which is the 
subfamily that is the most dominant in basidiomycota. Interestingly, analysis revealed that 
there was conservation of only 20 amino acids in CYP53C subfamily members in 
basidiomycota (Figure 2.3), further consolidating the hypothesis that basidiomycota CYP53 
members have been subjected to extensive primary structure changes. Further studies were 
carried out to map the location of conserved amino acids to extrapolate the effect of the 
conservation in CYP53 substrate specificity or catalytic activity, if any. 
 
 
Figure 2.3. Analysis of amino acid conservations in CYP53C subfamily of 
basidiomycota. Analysis of amino acid conservations was carried out using PROMALS3D 
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(Pei et al., 2008). CYP53C from F. pinicola is presented as a representative of CYP53C 
members. The residues conserved in CYP53C members are shown with the conservation 
index (Pei and Grishin, 2001) on top of the amino acid residue. 
 
2.3.4. Gene conservation and genome duplications of CYP53 members 
The above study indicated high conservation of CYP53 members’ primary structure (at a 
protein level) in ascomycetes compared to basidiomycetes. To gain insight into this aspect, 
further analysis was carried out on the gene structure of CYP53 members (Figure 2.4). 
Analysis of the size of exons and the location of introns indicated high conservation of the 
gene-structure in CYP53 members belonging to both fungal phyla ascomycota (Figure 2.4.) 
and basidiomycota (Figure 2.4). Gene structure analysis suggested that some ascomycete 
species, such as F. oxysporum, F. solani f. batatas (Nectria haematococca), F. verticillioides, 
and F. graminearum, contain two types of ortholog P450s in their genome. The first type 
contains a single intron and the second one contains three introns (Figure 2.4). Paralog P450s 
were found in F. graminearum (protein IDs: 10234 and 10227) and A. oryzae (protein IDs: 
2107 and 5958), suggesting the genome duplication of these P450s. Overall, ascomycete 
species CYP53 members showed simple gene structure with single and triple introns (Figure 
2.4). 
It is evident from Figure 2.5, especially considering the exon sizes and location of 
introns, that basidiomycete species enriched CYP53 members in their genome by genome 
duplications (paralogous evolution). The high conservation in the size of exons and location 
of introns of CYP53 members of basidiomycetes strongly suggests that CYP53 members are 
genome-duplicated. In comparison to ascomycete species (Figure 2.4), CYP53 members of 
basidiomycete species showed more introns in their structure (Figure 2.5). An interesting 
discovery was that basidiomycete species selectively enriched a single type of CYP53 
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member in their genome (Figure 2.5). Some conclusion were presented in support of this 
argument: (i) in P. placenta two orthologs, of which one duplicated seven times while no 
duplication was observed for the second ortholog (protein ID: 110015); (ii) in W. cocos three 
orthologs were found: one ortholog duplicated seven times whereas no duplications were 
observed for the remaining two orthologs (protein IDs: 138909 and 27029); (iii) in F. 
pinicola, P. carnosa and F. mediterranea two orthologs were found in their genomes; in these 
species one ortholog was duplicated whereas no duplication was observed for the second 
ortholog protein ID: 1025718 (F. pinicola); protein ID: 183190 (P. carnosa); protein ID: 
162664 (F. mediterranea); (iv) B. adusta showed three orthologs; two orthologs (protein IDs: 
318949 and 118978) have remained the same since the divergence of this species. 
From the above results it is clear that the higher number of CYP53 members in 
basidiomycetes is due to the genome duplication of selective CYP53 members. Despite the 
conservation of gene structure and the paralogous evolution of CYP53 members in 
basidiomycete species, the low percentage of homology among them suggests that during the 
genome duplication events, extensive changes in the primary structure occurred. Most of the 
changes might be destined to acquire novel functions to serve fungal species (basidiomycete) 
to adapt to diverse ecological niches.  
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Figure 2.4. Gene-structure analysis of CYP53 family in ascomycete species. Horizontal 
lines indicate gene size and vertical lines indicate introns. For each CYP53 gene the size of 
the exons (base pairs) and protein ID from the JGI US-DOE is shown in the figure (Grigoriev 
et al., 2011). 
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Figure 2.5. Gene-structure analysis of CYP53 family in basidiomycete species. Horizontal lines indicate gene size and vertical lines indicate 
introns. For each CYP53 gene, the size of the exons (base pairs) and protein ID from the JGI US-DOE is shown in the figure. 
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2.3.5. Functional significance of CYP53 family and its potential role 
as a common antifungal drug target 
CYP53 family members play a key role in fungal primary metabolism, by using the β-
ketoadipate pathway (Faber et al., 2001; Fraser et al., 2002), and secondary metabolism, 
which is the detoxification of phenolic compounds (Ide et al., 2012; Fujii et al., 1997). The β-
ketoadipate pathway is a convergent pathway for aromatic compound degradation (Harwood 
and Parales, 1996) that is widely distributed in soil bacteria and fungi. Fungal-mediated 
degradation of aromatic compounds such as phenylalanine, toluene, and cinnamic acid leads 
to the formation of benzoate (Lapadatescu et al., 2000; Durham et al., 1984; Jensen et al., 
1994). As part of the β-ketoadipate pathway CYP53 is involved in detoxification of this toxic 
compound and key intermediate molecule. CYP53 hydroxylates benzoate to 4-
hydroxybenzoate (Faber et al., 2001), the prime reaction in the benzoate metabolism that 
subsequently leads to protocatechuate as the ring fission substrate (Wright, 1993). This 
reaction is critical for fungal organisms in order to detoxify the benzoate; to date this 
hydroxylation reaction carried out by CYP53 is the only way to detoxify this compound. 
Further support of CYP53’s critical role in fungal primary metabolism can be obtained from a 
study where CYP53 deletion proved to be lethal for fungal organisms’ survival (Fraser et al., 
2002). This suggests that the CYP53 family can serve as a novel alternative drug target 
against fungal pathogens, especially ascomycete pathogens. Results from this work showing 
high conservation of the primary structure of CYP53 members (Figure 2.4) across the 
ascomycetes (consisting of animal and plant pathogen fungal species) indicate that any 
inhibitor developed against a CYP53 member could serve as a novel common drug against a 
large number of pathogenic ascomycete fungi. Literature data suggested that inhibitors 
directed at this P450 effectively inhibited CYP53 activity and also growth inhibition of 
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different fungal species such as C. lunatus, A. niger and Pleurotus ostreatus (Podobnik et al; 
2008; Korošec et al., 2014). Furthermore, this P450 family offers an advantage over the 
CYP51 family, the currently exploited target against fungal infections, as CYP53 does not 
have a homolog in higher eukaryotes. This will offer researchers the opportunity to design 
selective and potent inhibitors of pathogenic fungi. 
Overall, the facts discussed above, such as (i) the critical role of CYP53 in fungal 
primary metabolism, (ii) high conservation of the primary structure of CYP53 members in 
ascomycetes and (iii) CYP53 not having any homolog in higher eukaryotes (advantage over 
CYP51 family), this strongly support the suggested hypothesis that the CYP53 family can be 
a potential novel alternative anti-fungal drug target and an inhibitor designed against this 
P450 family can serve as a common drug against pathogenic ascomycetes. The most 
interesting aspect of the CYP53 family’s role in basidiomycete fungi extends beyond 
detoxification of benzoate. The current study showed that most of the ascomycetes contain a 
single CYP53 member in their genomes, whereas basidiomycetes showed multiple CYP53 
members (Table 2.1). Results from this study (Figure 2.5) revealed that the number of CYP53 
members increases in basidiomycete species’ genomes, by duplication of CYP53 members 
after speciation (paralogous evolution) occurs.  
Several lines of evidence can be found on the critical role of these CYP53 members in 
basidiomycetes that forced basidiomycetes to enhance this P450 family member in their 
genomes. First, basidiomycetes are well known for their role as bio-degraders of wood 
(Martinez et al., 2005). Wood is composed of many aromatic compounds, including benzoic 
acid derivatives and other phenolic compounds, among others eugenol, isoeugenol and 
guaiacol (Haupert et al., 2012). Most of these compounds are anti-fungal and toxic to fungi 
(Amborabe et al., 2002). The multi-factorial phenomenon of toxicity of these compounds, 
including membrane disruption, inhibition of essential metabolic reactions, changes in pH 
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homeostasis, and accumulation of toxic anions, has been proposed toward fungi (Brul and 
Coote, 1999). Basidiomycete species require an enzyme that can detoxify the benzoate 
molecule, if they want to colonize on wood, as this molecule is an intermediate in 
detoxification of wood components comprising of many aromatic compounds. Since there is 
an enormous need for successful wood colonization, wood-degrading basidiomycetes 
amplified the number of CYP53 members in their genomes.  
Secondly, synthesis of aryl-metabolites, including veratryl alcohol by basidiomycete 
fungi, involves the formation of benzoate and para-hydroxybenzoic acid as intermediate 
molecules (Lapadatescu et al., 2000). Veratryl alcohol is a secondary metabolite and plays a 
key role in lignin-peroxidase-mediated oxidation of wood components (Ten Have et al., 
1998). In a recent study, veratryl alcohol was shown to be the dominant extracellular 
ligninolytic oxidant in decaying wood (Hunt et al., 2013). The presence of a high number of 
CYP53 members and the generation of benzoate and para-hydroxybenzoate as an 
intermediate in the biosynthesis of veratryl alcohol suggest that in basidiomycete species 
CYP53 members also play a role in the generation of veratryl alcohol and help basidiomycete 
species directly in the degradation and subsequent colonization of wood.  
Thirdly, demethylation of stilbene, a class of molecule found in plants, by CYP53D 
subfamily members from P. placenta (basidiomycete) indicates that CYP53 family members 
play a critical role in the detoxification or degradation of plant compounds and help fungi in 
the colonization of wood (Ide et al., 2012). It is noteworthy that CYP53D members are 
present in the highest numbers (seven P450s) in P. placenta and all evolved via paralogous 
evolution (Figure 2.5). This strongly indicates that P. placenta duplicated CYP53D members 
in its genome in order to colonize successfully on wood.  
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The above-mentioned role of CYP53 in wood-degrading basidiomycete species 
physiology (primary or secondary metabolism) is based on the available data and further 
experimentation would provide more insight into this aspect. Collectively, the above results 
indicate that in ascomycetes the CYP53’s role is limited to the detoxification of toxic 
molecules, whereas in basidiomycetes CYP53 plays an additional role, in the generation of 
veratryl alcohol and degradation of wood-derived compounds. 
 
2.4.  Conclusion 
In this advanced scientific era, understanding of animal (including human) and plant 
pathogenic fungal organisms in terms of controlling their causative diseases and developing 
effective drugs is still poorly understood. Currently available drugs and drug targets are 
becoming ineffective because fungal species develop resistance. Genome sequencing analysis 
of the fungal species gives researchers the opportunity to look for novel drug targets against 
these pathogens and to search for novel enzymes for the generation of human valuables. The 
present study is such an example where fungal genome sequencing results were explored to 
understand the role of a P450 family (CYP53) in serving as a common drug target against 
pathogenic ascomycetes and in basidiomycetes, particularly in terms of the wood-degradation 
process. The CYP53 family plays a key role in the detoxification of the toxic molecule 
benzoate and this family has proven to be essential for the organism’s survival. Findings from 
this study suggest that this P450 family can serve as a common anti-fungal (toward 
pathogenic ascomycetes) drug target in view of its highly conserved primary protein structure 
and gene-structure organization in ascomycetes. Moreover, this study identified CYP53 
P450s can play an additional role in basidiomycetes, that is, in the generation of the wood-
degrading oxidant veratryl alcohol and degradation of wood-derived compounds. This 
additional role of basidiomycetes seems to have enriched this P450 family by extensive 
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duplication of CYP53 members in their genomes (paralogous evolution). During the 
duplication process, extensive changes in the protein primary structure occurred to 
enhance/acquire novel functions, such as involvement in wood degradation. 
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Appendix A 
P450 Sequences for CYP53 Family: 
>1CYP53A5 (120117) Mgrs 
MAIVNLVFTPLGLASLGAFMLVAYYVVPYFTTFGHLRSIQPASPLAGFSNLWLLYTSRVGKRSLLVDEAHARLGPVLRVQPNHVSIADDEAINI
IYGHGNGFLKSSFYDAFVSIRRGLFNTRDRAEHTRKRKLISHTFAPKSVGQFEPYIHGNLELFAKKWDELIERTKKSDGWAPVECLQWFFGAPF
GMLNAGADIAEVRMSVDSEPIYAPAVEILNRRGEVSATLGTLPELKPYAGYLPDSFFSKGLAAVQNLAGIAIARVKSRLENPPDVNRKDLLARL
QEGRDAKGEPLGFEELTAEALTQLIAGSDTTSNSSCALLYWTARTPGVLAKLQAELDAAIPDGVFAPAFDMIRNLPYLEAVINETLRIHSTSGI
GLPRQIPADSPGVTIRGQYYPPGTVLSVPTYTIHHSKEIWGPDADEFRPERWIENGGLTDRQKNAFIPFSYGPRACVGRNVAEMEMKMIAATWA
RRYDVEVRQDVMEVREGFLRKPLALEIGLKRRS 
>2CYP53A4 (7508) Ncr 
MAIISLLMSPWAPVVLLAGVAFYYLVPYFVTYSALRKIPSPFPAQFTDLWLLSVCRRGNRYQRVDELHKKLGPVVRIQPNHVSICDDAAIPTIY
GHGNGFLNDFYDAFVSIRRGLFNTRDRAEHTRKRKIVSHTFSAKSVQQFEPYMHSNLELFVKQWDSMIKNSKNPDKAAHLDCLEWFNYLAFDVI
GDLSFGQPFGMLSSGADMAEIRSSPDAAPIYAPAIEILNRRGEVSATLGIHPALKPFAKYLPDPFFTKGLAAVENLAGIAIACVKSRLDNPPPV
TRKDLLQRLMEGRDEKGEPLGREELTAEALTQLIAGSDTTSNSSCALLFHAVRTPGVMQKLQAELDANIPPEVDVPTYDMVKELPYLEAVINEV
LRFHSTSGIGLPRQIPHDASQGVHIQGYYLPPGTVLSVPTYSIHHSKEIWGPDADEFKPERWERLTARQKNAFIPFSHGPRSCVGRNVAEMEMK
LIVATWARRYEVKLLQDYMDTREGFLRKPLGLKVGLKLRK 
>3CYP53A4 (88466) Ndi 
MAIISLLMSSWAPVVLLAGVAFYYLVPYFVTYSALRKIPSPFPAQFTDLWLLSVCRRGNRYQRVDELHKKLGPVVRIQPNHVSICDDAAIPTIY
GHGNGFLKSDFYDAFVSIRRGLFNTRDRAEHTRKRKIVSHTFSAKSVQQFEPYMHSNLELFVKQWDSMIKNTKNPDKAAHLDCLEWFNYLAFDV
IGDLSFGQPFGMLSSGADMAEIRSSPDAAPIYAPAIEILNRRGEVSATLGIHPALKPFAKYLPDPFFTKGLAAVENLAGIAIACVKSRLENPPP
VTRKDLLQRLMEGRDEKGEPLSREELTAEALTQLIAGSDTTSNSSCALLFHAVRTPGVMQKLQAELDANIPSEVDVPTYDMVKDLPYLEAIINE
VLRFHSTSGIGLPRQIPCDAAQGVHIQGYYFPPGTVLSVPTYSIHHSKEIWGPDADEFKPERWERLTPRQKNAFIPFSHGPRSCVGRNVAEMEM
KLNVATWARRYEVKLLQDYMDTSEGFLRKPLGLKVGLKLRK 
>4CYP53A6 (10234) Fgr 
MAMFTVLPLIWLAPLGLISLFFYYIIPYFWNYRHLRSIPGPLFARLSNWWLVYACREKSRWKYVNDAHTRYGPVVRIQPNHVSIANEEVINAIY
GHGNGMLKSSFYDASVITTYSIFTSRDRAEHSRKRKVVSHSFAPQSMRNFEPFIQQHLNVFLQKWDAMAANEAKFDGYADVESRVWLNYLVLDI
IGDLAFGAPFGVLAKGSEVVDFETEKGPSSLPVITSLSTRSEIAATVGALPELKPYLKWSPDPFFRTGFNGMINLRTLGTSRITDRLNNPPGDE
REKDLLERVREGRDHKGQPFGKGELIAEALTVLIAGTDTTSSTMAALLYHVVRTPGVLKKLQAELDEAIPADVSIPSFEMVKNLKYLGFVVNEA
LRHHSTISLGLPRLVPENGNGVTIAGYHFAPGTVLSIPIYTVHHLKEVWGPDADEFKPERWEDVTQRQKQAFIPFSHGPRACLGRNLAEMELKV
ITATWARRYDLIMRDDTMEILEGLARKPEAVNVGIRRRM 
>5CYP53A7 (10227) Fgr 
MAITELLVSPWAPVALVVAFVAWYILPWVSNKDLRGIPAPFPAQFSNLWLLSTCRRGKRYEIVDQVHKKLGPLVRIAPNHVSVADADAINTIYG
HGNGFLKADFYDTFVSIRRGLFNTRDRAEHSRKRKIVSHTFAPKSVLEFEPYIRQNLEIFVKQWDRISSNKERDGYGRVDCLNWFNFLAFDIIA
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DLAFGKPFGMLASGADIAEVKASPTSPTIYAPAVEIMNRRGEVSATLGCLPQLKPYAKYLPDPFFSQGLQAVENLAGIAIARVSERLERGGDST
RKDLLARLMQGRDEKGEPLGRDELTAEALTQLIAGSDTTSNSSCALLYHIVRTPGVMKKVYEEISAVMPDGVDIPDFESVKHLPYLGYCINETL
RIHSPSGIGLPREVPPNHKGVTIHGRYFGPGTVLSVPTYTIHHSTEIWGPDADDFKPERWETLTDKQKSAFIPFSYGPRSCVGRNLAEMQMRMI
AATWIKRYDVVLRQDVMETREGFLRKPMGLDVGLARR 
>6CYP53A8 (12085) Fgr 
MAIVDLLFTWWSLPIAAGLVAASYLYSYFITYGHLRDIPAPFPAQFSNLWLLYVCRRGERYRVVDQIHKELGPVVRIQPNHTSIADAEAIATIY
GHGNGFLKSEFYDAFVSIRRGLFNTRDRAEHTRKRKLISHVFSAKSISQFEPYIHANLELFVKQLDKLVASGQMAKNGKREALMDCLPWFNYLA
FDVIGDLAFGVPFGMLASGADVAEVRDTPDSPPIYASAIEILNRRGEVSATLGCFPQLKPYAQYLPDPFFSNGLNAVKNLAGIAIARVKNRLDN
PPSIERMDLLARLMEGRDEKGEPLGREELTAEALTQLIAGSDTTSNSSCALLYHVTRTPGVLEKLQSELDNAIPSEVSVPTYDMVRDLPYLANV
INETLRYHSTSGIGLPRQIPPNSPGVTIKDHFFPPGSILSVPTYTLHHSKEIWGADADDFRPERWENPTELQKTAFNPFSHGPRACVGRNVAEM
EMKLIAATWARRYVPELRQGVMETREGFLRKPLGLDIALMMRE 
>7CYP53A10 (35086) Nhe 
MALINLLISPWAPVALVVLFVGWYLVPYFGANRGLRGIPAPFPAQFSNLWLMSTCRRGKRFEVVDQVHKRLGTVVRIAPNHVSIADADAINVIY
GHGNGFLKSDFYDPFVSIRRGLFNTRSRAEHSRKRKIVSHTFAPKSVLEFEPYIHQNLDLFVKQWDRASSNPEADGAGRLDCLSWFNYLAFDVI
ADLAFGKPFGMLATGADIAEVKASPTSPAIYAPAVEIMNRRGEVSATLGCMPWLKPYAKWLPDPFFSQGLQAVENLAGIAIARVSERLERGADT
TRKDLLARLMQGRDEKGEPLGRDELTAEALTQLIAGSDTTSNSSCALLYHVVKTPGVLQKLQQEIDEATADEGVIPSYESVKHLPYLGMCINET
LRHHSPSGIGLPREIPAKSKGVTLHGRYFGPGTVLSVPTYTVHHSTEIWGPDAEEFKPERWENITDKQKIAFIPFSHGPRSCVGRNLAEMQMRL
IAATWIKRYNIFLRQEKMETREGFLRKPLGVEIGVSRR 
>8CYP53A11 (50496) Nhe 
MAIVDLLLSWWTLPIGVAVLVGTYLYAYFVTYGYLRGIPAPFPAQFSNLWLLYVCRRGERYDVMDKIHKKMGPVVRIQPNHVSIADDEAIPIIY
GHGNGFLKSEFYDAFVSIRRGLFNTRDRAEHTRKRKLISHTFSTKSISQFEPYIHSNLELFVKQLDKLITSGTTKDNQGHQQALIDCLPWFNYL
AFDVIGDLAFGAPFGMLANGADVAEVRATPESPPIYASAIEILNRRGEVSATLGCFPQLKPYAKWLPDPFFSNGLNAVQNLAGIAIARVKARLD
NPPPEERMDLLARLMEGRDEKGEPLGREELTAEALTQLIAGSDTTSNSSCALLYHVTRTPGVLEKLQAELDASIPSHVSVPTFDMVRDLPYLNC
VINETLRYHSTSGIGLPRQVPEGSPGVTIRGHFFPAGSVLSVPTYSIHHSKEIWGPDADDFKPERWEDVTPRQKNAFIPFSHGPRACVGRNVAE
MEMKLIAATWARRYNVELKQEIMETREGFLRKPLGLDIALKIR 
>9CYP53A19 (9543) Fve 
MAVVDILFTWWSIPIATGVLIATYLYSYFVTYGHLRDIPAPFPAQFTNLWLLYVCRRGERYRVVDGIHKRLGPVVRIQPNHTSIADPDAIATIY
GHGNGFLKSDFYDAFVSIRRGLFNTRDRAEHTRKRKLISHVFSAKSISQFEPYIHANLELFVKQLDKLVASGQTTDKNGKRQALIDCLPWFNYL
AFDVIGDLAFGVPFGMLANGADVAEVRATPDSAPIYASAIEILNRRGEVSATLGCWPQLKPYAQWLPDPFFSNGLNAVKNLAGIAIARVKARLD
NPPSVERKDLLARLMEGRDEKGEPLGREELTAEALTQLIAGSDTTSNSSCALLYHVTRTPGVLEKLQAELDEAIPADVSVPTYDMVRDLTYLNN
VISETLRYHSTSGIGLPRQIPDNSPGVTIKGHYFPPGSVLSVPTYTLHHSKEIWGPDADDFKPERWDSLNELQKTAFNPFSHGPRACVGRNVAE
MEMKLIAATWARRYTPELKQEVMETREGFLRKPLGLDIALKMR 
>10CYP53A20 (6367) Fve 
MALTELLISPWAPLALAVALVAWYILPWISNSNLRGIPAPFLAQFSNLWLLSTCRRGKRYEIVDQVHKKLGVLVRIAPNHVSVADADAINTIYG
HGNGFLKADFYDTFVSIRRGLFNTRDRAEHSRKRKIVSHTFAPKSVLEFEPYIRQNLDIFINQWDRIASNKEADGYGSVDCLNWFNFLAFDIIA
DLAFGKPFGMLSTGADIAEVKVSPTSPTIYAPAVEIMNRRGEVSATLGCLPQLKPYAKYLPDPFFSQGLQAVENLAGIAIARVSERLERGGDST
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RKDLLARLMQGRDEKGEPLGRDELTAEALTQLIAGSDTTSNSSCALLYHVVRTPGVMQKLYEEISAVVPEDVAIPDYESVKHLPYLGHCINETL
RIHSPSGIGLPREIPPNHKGVTLHGRYFGPGTVLSVPTYTIHHSTEIWGPDADEFKPERWESLTDKQKNAFIPFSYGPRSCVGRNLAEMQMRLI
AATWIKRYDVRLRQDIMETREGFLRKPMGLDVGLARR 
>11CYP53A19 (14206) Fox 
MAVVDILFTWWSIPIAACVLIATYLYSYFVTYGHLRDIPAPFPAQFTNLWLLYVCRRGGRYRVVDEIHKRLGPVVRIQPNHTSIADPDAIATIY
GHGNGFLKSDFYDAFVSIRRGLFNTRDRAEHTRKRKLISHVFSAKSISQFEPYIHANLELFVKQLDKLVASGQTTDKNGKRQALIDCLPWFNYL
AFDVIGDLAFGVPFGMLANGADVAEVRETPDSAPIYASAIEILNRRGEVSATLGCWPQLKPYAQWLPDPFFSNGLNAVKNLAGIAIARVKARLD
NPPSVERKDLLARLMEGRDEKGEPLGREELTAEALTQLIAGSDTTSNSSCALLYHVTRTPGVLEKLQAELDEAIPADVSVPTYDMVRDLTYLNN
VISETLRYHSTSGIGLPRQIPDNSPGVTIKGHYFPPGSVLSVPTYTLHHSKEIWGSDADDFKPERWDSVNNLQKTAFNPFSHGPRACVGRNVAE
MEMKLIAATWARRYTPELKQEVMETREGFLRKPLGLDIALKMR 
>12CYP53A20 (10443) Fox 
MAITELLISPWAPLALAVALVAWYILPWISNSNLRGIPAPFPAQFTNLWLLSTCRRGKRYEIVDQVHKKLGVLVRIAPNHVSVADADAINTIYG
HGNGFLKADFYDTFVSIRRGLFNTRNRAEHSRKRKLVSHTFAPKSVLEFEPYIRQNLDIFINQWDRIASNKDADGYGSVDCLNWFNFLAFDIIA
DLAFGKPFGMLSTGADIAEVKASPTSPTIYAPAVEIMNRRGEVSATLGCLPQLKPYAKYFPDPFFSQGLQAVENLAGIAIARVSERLERGGDST
RKDLLARLMQGRDEKGEPLGRDELTAEALTQLIAGSDTTSNSSCALLYHVVRTPGVMQKLYEEISAVVPEDVAIPDYESVKHLPYLGYCINETL
RIHSPSGIGLPREIPPNHKGVTLHGRYFGPGTILSVPTYTIHHSTEIWGPDADEFKPERWENLTDKQKTAFIPFSYGPRSCVGRNLAEMQMRLI
ATTWIKRYDVRLRQDIMETREGFLRKPMGLDVGLARR 
>13CYP53D1 (9015) Fox 
MSLDSLLLSPWAPLAVLLCVLLFYILPYFYTYRHLRGIPGPLLARFSDLWLLYICRQSKRSYTVYDLHERLGPVVRIQPNHVSIVDERAINLVY
GHGNGLEKSSWYDSSISLTRSIFTARKRAEHARKRRYIAHSFAPKSSRAAEGPIADKVELLVRKWDEIIDKGPQFDGFTQLECRRWFTYLSFDI
TGDLLFSEPFGMLENGSDLVKIDNKPRSYVSMMNSLAQRSAAVATLGVLPWLKPHAHHLPDPFFHRGMDGLQNLLGVTSAHVKERMAAGQDNHD
DWLSLLLRARDDQGELLKFEEIASESLTLFMAAIETVSNTLSAMMYYLATSPSSLQKLQAEVDSIDIPGTVPPFTNVRALPYLDAVLNETMCLH
SVLGIGLPREVLPGSKGVHLDSFYFPPGTVLSVPIYAIHRSRDIWGQDANNFRPERWEKLSDRQKTSFIPFGHGPAACVGRNLAEVEMKIIAAT
LIKRYNFCMMDSEIESTEGTTRKLIKVNIGIKRRQ 
>14CYP53A12 (8190) Nfi 
MITDLLTPQNTGFILLGLIAAYYIVPYLQKWHLHDIPSPSFAAFSNLWLLLQARRGRRFLKVDEAHKKYGKLVRIAPRQVSIADDAAIQAIYGH
GNGFLKSDFYDAFVSIRRGLFNTRDREEHTRKRKTVSHTFSMKSIGQFEQYIHQNVELFVQQWTKLAKLNGNPRSGYATIDALNWFNYLAFDII
GDLAFGAPFGMLEKSKDIAEMRKAPDSDPTYVQAVEVLNRRGEVSATLGCLPRLIPYAKYLPDRFFKDGIQAVENLAGIAVARVNERLKPEVME
KNTRVDLLSRLMEGKDSNGNKLGREELTAEALTQLIAGSDTTSNTTCAILYWCMSTPGVIPKLQKVLDEAIPDDVDVPTHAMVKDIPYLQWVIW
ETMRIHSTSAMGLPREIPPGNPPVTISGHTFYPGDVVSVPSYTIHRSKEIWGPDAEEFVPERWDPARLTARQKAAFIPFSTGPRACVGRNVAEM
ELLVMTGTIFRLFEFEMQQDGPMETREGFLRKPLGLIVGMKRRAVHASV 
>15CYP53A3 (3425) Anid 
MITDFLTPENITPERIALALLGLLAAYYVVPYLQTWRLSDIPAPGLAAWTNFWLLLQTRLGHRFISVDNAHKKYGKLVRIAPRHISIADDAAIQ
AVYGHGNGFLKSDFYDAFVSIRRGLFNTRDRAEHTRKRKTVSHTFSAKSIGQFEQYIHHNIENLVKQLTRISNLQRNPKNGYATVDALNWFNFV
AFDIIGDLAFGAPFGMLDKGQDIAEMRKSPDSPPQYVQAVEVLNRRGEVSATLGCYPALKPFAKYLPDRFFRDGLEAVENLAGIAIACVNERLK
PEVMANNTRVDLLARLMEGKDANGNKLGRAELTAEALTQLIAGSDTTSNTSCAILYYCLRTPGVIDKLHKVLDEAIPQDVEVPTHAMVKEIPYL
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QWVIWETMRIHSTSAMGLPREIPEGNPPVEISGHIFKPGDILSVPTYTIHHSKEIWGADADEFIPERWAPERLTARQKAAFIPFSTGPRACVGR
NVAEMELLVICSTVFRMFDWELQQKGPMETREGFLRKPLGLTVGVKRRTIV 
>16CYP53A12 (3003) Afu 
MITDLLSLQNAGLILLGLIAVYYVIPYLQKWHLHDIPSPRFAAFSNLWLLLQARRGRRFLKVDEAHKKYGKLVRIAPKHVSIADDAAIQAIYGH
GNGFLKADFYDAFVSIRRGLFNTRDRAEHTRKRKTVSHTFSMKSIGQFEQYIHQNVELFVQQWTKLAKLNGNPRSGYATIDALNWFNYLAFDII
GDLAFGAPFGMLEKGKDIAEMRKTPDSEPTYVQAVEVLNRRGEVSATLGCLPRLIPYAKYLPDRFFKDGVQAVENLAGIAVARVNERLKPEVME
KNTRVDLLSRLMEGKDSNGNKLGREELTAEALTQLIAGSDTTSNTTCAILYWCMSTPGVIPKLQKVLDEAIPDDVDVPTHAMVKDIPYLQWVIW
ETMRIHSTSAMGLPREIPPGNPPVTISGHTFYPGDVVSVPSYTIHRSKEIWGPDAEKFVPERWDPARLTARQKAAFIPFSTGPRACVGRNVAEM
ELLVMTGTIFRLFEFEMQQDGPMETREGFLRKPLGLIVGMKRRAVHASV 
>17CYP53A22 (2015) Ate 
MIADLAAINPAYLLLAAVAAYYIVPYLKRWHLRSIPTPSVAGFTNLWLLIQARRGNRFEVVDNLHKKHGKLVRLAPRHVSIADDAAINAIYGHG
NGFLKALSDFYDAFVSIRRGLFNTRDRAEHTRKRKTVSHTFSMKSIGQFEQYIHHNIELFVKQWTRLSETQGNPRSGYATIDALNWFNFLAFDI
IGDLAFGAPFGMLEKGQDIAEMRKSADAAPTYVQAVEVLNRRGEVSATLGTLPALIPYAKYIPDRFFKDGIQAVENLAGIAIARVNERLRPEVM
ANNTRVDLLARLMEGKDANGNKLGREELTAEALTQLIAGSDTTSNTACAILYWCMSTPGVIDKLHKVLDEAIPADVDVPTHSMVKDIPYLQWVI
WETMRIHSTSAMGLPREIPAGSPPINISGHVFYPGDVVSVPSYTIHRSREIWGPDAEKFVPERWDPARLTPRQKAAFIPFSTGPRACVGRNVAE
MELLVMAGTVFRLFDFEMQQKGPMETREGFLRKPLGLIVGMKRRTPA 
>18CYP53A13 (5958) Aor 
MIAELLTPTGAAYVLTAAVIVYYILPYLQLWRLRDIPSPGFAAFSNLWLMLQYRKGNRFVTVDNAHKKYGKLVRIAPRHVSIADDEAIQAIYGH
GNGFLKADFYDAFVSIRRGLFNTRDRAEHTRKRKTVSHTFSMKSIGQFEQYIHGNAELFVKQWNRIADTQSNPKTGYATIDALNWFNYLAFDII
GDLAFGAPFGMLEKGQDIAEMRKSPNDKPSYVQAVEVLNRRGEVSATLGACPSLIPWAKYIPDRFFRDGLEAVENLAGIAVARVNERLRPEVMA
NNTRVDLLARLMEGKDSNGNKLGREELTAEALTQLIAGSDTTSNTSCAILYWCLRTPGVIEKLHKVLDESIPKDVDVPVHAMVKDIPYLQWVIW
ETMRIHSTSAMGLPREIPAGNPPVTISGHTFYPGDVVSVPTYTIHRSKEIWGPDAEQFVPERWDPKRLTARQKAAFIPFSTGPRACVGRNVAEM
ELLVIVGTVFRLFDFEIQQDGPMETREGFLRKPLGLMVGMKRRSVAV 
>19CYP53A14 (2107) Aor 
MDGDSCPSCCSTCTSLNVFLCPHIPILTLGLLLVYYVTGYLKRWHLRDIPGPFIAGFSRIWLIVQVRQGYRSLVVHDLHRRYGKIVRLAPNHIS
IADESAIQAIYGHGNGFLETDFYNAFLNVDWSIFTTRSRAEHTRKRKIVSHAFSARSLAQVEQHAHNNMEHLVRQWRKMIDSEEGLDDPYAVID
ARVWCNYLTFDIIGDLAFGAPFGMLERENATVSMRKAPENPEVTLDAVEVLNHRGDVSAAFGICPDLIPYAKWLPDPFFRQGAEAIANLAGVAG
AAVDRRLKMDTSMTEKRGDLLALLIDAEDQAGAKLGHRELTGEAVTLIAAGSDTSSSTLCALLYWVSSTPRVLWKLQNVLDEVIPVDIEVPYLA
MVKKITYLQWVIWEALRIHSTFGQGLPREVPPERGPVEICGHTFYPGDVLSVPGYTMHHSADIWGIDVEDFVPERWDPRRLTQRQKDSFIPFSE
GPRACIGRNLAEMELFVGCATLFRLFEFRVEGQGPLKVRERWLRKPVSLQVGIRRRYLDARSS 
>20CYP53A13 (26719) Afl 
MIAELLTPTGAAYVLTAAVFVYYILPYLQLWRLRDIPSPGFAAFSNLWLMLQYRKGNRFVTVDNAHKKYGKLVRIAPRHVSIADDEAIQAIYGH
GNGFLKADFYDAFVSIRRGLFNTRDRAEHTRKRKTVSHTFSMKSIGQFEQYIHGNAELFVKQWNRIADTQSNPKTGYATIDALNWFNYLAFDII
GDLAFGAPFGMLEKGQDIAEMRKSPNDKPSYVQAVEVLNRRGEVSATLGACPSLIPWAKYIPDRFFRDGLEAVENLAGIAVARVNERLRPEVMA
NNTRVDLLARLMEGKDSNGNKLGREELTAEALTQLIAGSDTTSNTSCAILYWCLRTPGVIEKLHKVLDESIPKDVDVPVHAMVKDIPYLQWVIW
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ETMRIHSTSAMGLPREIPAGNPPVTISGHTFYPGDVVSVPTYTIHRSKEIWGPDAEQFVPERWDPKRLTARQKAAFIPFSTGPRACVGRNVAEM
ELLVIVGTVFRLFDFEIQQDGPMETREGFLRKPLGLMVGMKRRSVAV 
>21CYP53A1 (50153) Ani 
MLALLLSPYGAYLGLALLVLYYLLPYLKRAHLRDIPAPGLAAFTNFWLLLQTRRGHRFVVVDNAHKKYGKLVRIAPRHTSIADDGAIQAVYGHG
NGFLKSDFYDAFVSIHRGLFNTRDRAEHTRKRKTVSHTFSMKSIGQFEQYIHGNIELFVKQWNRMADTQRNPKTGFASLDALNWFNYLAFDIIG
DLAFGAPFGMLDKGKDFAEMRKTPDSPPSYVQAVEVLNRRGEVSATLGCYPALKPFAKYLPDSFFRDGIQAVEDLAGIAVARVNERLRPEVMAN
NTRVDLLARLMEGKDSNGEKLGRAELTAEALTQLIAGSDTTSNTSCAILYWCMRTPGVIEKLHKALDEAIPQDVDVPTHAMVKDIPYLQWVIWE
TMRIHSTSAMGLPREIPAGNPPVTISGHTFYPGDVVSVPSYTIHRSKEIWGPDAEQFVPERWDPARLTPRQKAAFIPFSTGPRACVGRNVAEME
LLVICGTVFRLFEFEMQQEGPMETREGFLRKPLGLQVGMKRRQPGSA 
>22CYP53A21 (1341) Acl 
MITEILTPQNTGYVLLGLLTAYYIIPYLQTWHLHDIPSPGFAAFSNLWLLLQARQGHRFLKVDEAHKKHGKLVRIAPGHISIADDGAIQAVYGH
GNGFLKADFYDAFVSIRRGLFNTRDRAEHTRKRKTVSHTFSTKSIGQFEQYIHHNIELFVKQWTKLSKLNGNPRSGYATIDALNWFNFLAFDII
GDLAFGAPFGMLEKGKDFAEMRKTPDSPPTYVEAIEVLNRRGEVSAALGCFPRLIPYAKWIPDRFFKDGLQAVENLAGIAVARVNERLKPEVMA
NNTRVDLLSRLMEGKDSNGNKLGREELTAEALTQLIAGSDTTSNTACAILYWCMQTPGVITKLQKVLDEAIPADVDVPTHSMVKEIPYLQWVIW
ETMRIHSTSSMGLPREIPPGNPPVTISGHVFYPGDVVSVPSYTIHRSREIWGPDAEQFVPERWDPARLTPRQKAAFIPFSTGPRACVGRNVAEM
ELLVMTATVFRLFEFEMQQDGPMETREGFLRKPLGLIVGMKRRAAHASV 
>23CYP53A18 (8044) Cim 
MLLSFLFNPYVLAGIFIFVFYIVPYLRLSYLRDIPSPFAAGFSNLWLLYQCRRGKRYQAVHDAHKKYGKLVRIQPDHVSVADADAIQTIYGHGN
GFLKSEYYDAFVSIRRGLFNTRSRAEHTRKRKTVSHTFSAKSVGQFEQYIHANLQLFFQQWTNISEVQRNPKSGYASIDALNWFNYLAFDIIGD
LAFGAPFGMLSKGRDVAEMRKSPDSPASYVPAIQVLNRRGEVSATLGCFPALKPFAKYLPDKFFRDGLEAVEHLAGIAVARVSERLRPEVMAKN
TRVDLLSRLMEGRDETGAKLGREELTAEALTQLIAGSDTTSNTSCAMLYWVLRTPGVIEKLQEALDEAVPAHVNVPSFSMVRDIPYLQWVIWET
MRIHSTSSLGLPREIPPNSPPVTIEGHVFHPGTILSVPAYTIHHSPEIWGPDVEEFVPTRWDPARLTPRQKAAFIPFSYGPRACVGRNVAEMEL
HCIAATVFKNFEFRLEQDGPMETSEGFLRKPLGLMVGIRRRQPNLN 
>24CYP53A17 (5031) Ure 
MLLAFLFNPYIIAGFTICYFYIVPYLQRWDLRDIPAPFPASLSHLWLLYQSRKGKRYQAVHNAHGKYGKLVRIQPNHVSVADADAIQTIYGHGN
GFLKSEYYDAFVSIRRGLFNTRNRAEHTRKRKTVSHTFSAKSIGQFEQYIHANLQLFLQQWTQICDLQRNPRSGYASIDALNWFNYLAFDIIGD
LAFGAPFGMLSKGRDVAEMKKSPNSPASYVPAIQVLNRRGEVSATLGCFPALKPFAKYLPDRFFRDGLEAVENLAGIAVARVAERLRPEVMAKN
TRVDLLSRLMEGRDETGAKLGREELTAEALTQLIAGSDTTSNTSCAMLYWVLRTPGVIEKLQEVLDEAIPAHVEVPTFSMVKDIPYLQWVILET
MRIHSTSSLGLPREIPQGSPPVTIQGHVFHPGTILSVPAYTIHHSSEIWGPDVEEFVPTRWDPARLTAQQKAAFIPFSHGPRACVGRNVAEMEL
HCIAATVFKNFEFQLEQNGPMETSEGFLRKPLGLLVGIKRRQLDPVVN 
>25CYP53A23 (71345) Mfi 
MFLSFLFTPWALLASPFLFYLLPFLRNWSIRDVPGPFLAKFTTLWYMYECRRCRRYYTVYKLHEKYGKFVRVQPNHVSIAEPEAIPIIYGHGTG
FLKSEYYDAFVSIQRGLFNTRDRAEHTRKRKTVSHTFSAKSVGQFEQYIHHNLELLAKRWDEIAKNTGAGKYTRFDALHWFNYVAFDIIGDLAF
GAPFGMLEKGADIAEVQLNPDGPVTYAPAIEVLNRRGEVSNAVGCWPAIKPYAKYLPDPFFSKGMEAIANLAGIATARVNQRLAAAERGEIDRV
DLLARLMEGKDENGNKLAKAELTAEALTQLIAGSDTTSNTSCALLFHCLKNPHVVKKLQAELDEALPSDDVPTYEQVKNLQYLDQVISETLRIH
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STSSQGLPRVVPPGDGVEVAGRHFPPGVVLSVPAYVMHHSKEIWGPDADEFRPERWEKVTERQKLAFIPFSYGPRACVGRNVAEMELALIVATV
FRRYEFELYQDELETREGFLRKPLGLQVGMRKRS 
>26CYP53A (2107910) Tte 
MAVINLILSPWAPAALLVAAVVYYVYPYLVTYRHLRHIPAPFPAQFTNWWLLLVCRRGDRYATVDKVHKKLGPVVRIQPNHVSILDDEAIQAIY
GHGNGFLKSDFYDAFVSIQRGLFNTRDRAEHTRKRKIVSHTFSVKSVAQFEPYIHSNLELFVRQLDDLIARSTSPDGAAHLDCLHWFNYLAFDV
IGDLAFGAPFGMLSSGADMAEVRASPDSPPIYAPAIEILNRRGEVSATLGILPQLKPYAKYLPDPFFSKGLSAVEKLAGIAIARVKARLENPPP
ASRKDLLQRLIDGRDEKGQPLGREELTAEALTQLIAGSDTTSNSSCALLFHAARTPGVLARLRAELDAAVPADLVVPTFDLVRDLPYLSAVVNE
TLRFHSTSGIGLPREVPRDGQGVHIAGHYFPPGTVLSVPTYSIHHSKEIWGPDADEFRPERWDNLTARQKNAFIPFSYGPRACVGRNVAEMEMK
LIVATWARRYDVSLQQDHMDTREGFLRKPLGLKIALKRRQ 
>27CYP53A (2301715) Mth 
MAIVNFILSPWAPVALLAAAVVYYVYPYLVTYRHLRHIPAPFPAQFTNWWLLLVCRRGNRYETVDKLHKKLGPVVRIQPNHVSLCDDAAIQVVY
GHGNGFLKSDFYDAFVSIQRGLFNTRDRAEHTRKRKIVSHTFSVKSVAQFEPYIHSNLELFVRQLDNLIARSTNPDGAAHLDCLHWFNYLAFDV
IGDLAFGAPFGMLSSGADMAEVRASPESPPIYAPAIEILNRRGEVSATLGILPALKPYAKYFPDPFFSRGLQAVENLAGIAIARVKARLENPPP
SHRKDLLQRLIEGRDEKGEPLGRQELTAEALTQLIAGSDTTSNSSCALLYHAVRTPGVMQKLQAELDAAIPADMDVPTFDMVRDLPYLSAVVNE
TLRFHSTSGIGLPRQVPPDGQGVHFGGHYFPPGTVLSVPTYSIHHSKEIWGPDADEFRPERWERLTPRQKNAFIPFSHGPRACVGRNVAEMEMK
LIVATWARRYDVSLRQAHMDTREGFLRKPLGLEIALKRRKRD 
>28CYP53C2 (130996) Pch 
MAVIEALTQLDLKSWLLLIPALAIVAHILIWLLDPHGIRSYPGPLLAKFSDAWLGYVAAQGHRSEVVHDLHKQYGTFVRIAPNHLSIADPDALQ
VVYGHGTGTLKSNFYDAFVSIQRGLFNTRSRSEHARKRKIVSHIFSQKSVLEFEPHVRLYVKQLIQQWDRLYEAGAKGLVWLDCLPWYNYLAFD
IIGDLAFGAPFGMLLAARDAAPVAVDHEQAMASYGKEKSEVQYIPAVQVINDRGTYSASLGVLPPWMRPIVKLFPWFRRGQKAVKQLAGIAVAA
VAQRLTTPTDRVDLLGKLQEGRDDDGNLMGKEELTAEALTQLIAGSDTTSNSSCAITYYLAKYPDAQRKLQQELDEALGSDDEPVSTFDQVKRL
PYLQAVIDEALRIHSTSGIGLPRLVPKGGMTVCGRFFPEGTVLSVPTYTIHRDEEVWGKDPEVFRPERWFEQDKNAVQKTYNPFSFGPRSCIGR
NLANMELLIIVSSILRRYDFVLEDPDKPFDTMEGFLRKPVECVVGIRRRTL 
>29CYP53C3 (110015) Ppl 
MSAPAALFTSNLVYGLAVIPVAVLLVHFVPYLLDPHGIRAYPGPFLARLSDIWLGWIAAQGHRSETVHELHKQYGTFVRIAPNHVSISDPEAIQ
YVYAHGNGTTKSNFYDAFVSIRRGLFNTRSRPEHARKRKIVSHIFSMKSVMEFEPYTRMHVAQLLKQWDRLYELGIKGASGEEGEGWKGRDGRV
WLDCLPWYNYLAFDIIGDLAFGAPFGMLHACADAAPVATEHKDAMASYGADNAPKVTYFPAVQVLNDRGEYSASMGVLPPHWRPLVVRFIPWYR
NGGKAVKRLAGIAIAAVSKRLTAPTDRADLLGKLQEGKDDEGNPMGREELTAEALTQLIAGSDTTSNSSCALTYHLAANPRVQQKLQRELDEAL
GSDDDPVATYEQVKRLPYLEAVVNEALRVHSTSGIGLPRVVPEGGLSVCGRFFPAGTVLSVPTYTVHRDAETWGADVDAFRPERWEERDKNAVQ
KAFNPFSFGPRSCVGRNLASMELLIIIASILRRYHFVLEEPKHKLETKEGFLRKPVACKVGLRRRSA 
>30CYP53D1 (108845) Ppl 
MDSSTPPLPPLGSIILAREGLTGLLLPGLSVLACLIATVIASSILLPYFNDPYKLRAYPGPFFAKFTSAWLSWIIGHNRWSETVYHLHRQHGPI
VRLGPDNVSISDPSALAAIYGHSSGALKSTFYDAISSIRIRNLFNTRDRAEHSRKRRIEAHMFSPRGIRALEDTARVHFQVLVRQWDTLCAHTD
KAIRGSAEGTIGTVHWKVHSGRVWFDCMPWFTFWSFDTISDLAFGHPFGMLEAAKDTAKISKSNIKGMQAISQGNSHSDEAELELEEIPAIEML
AEHLDIIVSLAFLPAWLQPIVGRLPSVRYGYDAAPKLAGLAVAAVANRFASKTKIDRADMLSELLRGRDEDGKPYGPEELSAEAELLIIAGGDT
TANSSCATTYHLARNPRIRAKLQAELDAALEGIDSDVAPYDAVKDLPYLDAVINEGLRLHSTIGAGLPRVVPPGGLTVLGQHLKEGTVVSSPLY
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CLHRNEVVWGENAHEFYPERWLEASADAKKEMMRSFAPFSVGPRACLGRNLALQQMHIVLATIFHRYNLVLESDAPLPLRDGFVRKPKNCVVGV
QRRK 
>31CYP53D2v1 (56013) Ppl 
MDSSTSLLPPLGSIILACEGLTSLVPLILSVMVCLIATVTISPTLLAYFNDPFELRAYPGPFLARFTSAWISWIISQNRWSETVDLMHRQHGPI
VRLSPDHVSVASPAAFAAVYGHSSGALKAPFYNAFANFKIRSIFNTRDRAEHSRKRRVEAHMFSPRSIRALEDTARVHFQVLVRQWDALCAPTG
KTVRGSAEGTLGTISWKVHGDRVWFDCMPWFNFWSFDTISDLAFGRPFGMLEAAKGSAHVSKSNTKSVQAVSQDTSHSNEAQSELLEIPAMEVL
SELLDFTVALAYLPAWVQPVFGRLPMFRDGYDAAPKLANLSLTAVANRVASQTDRADMLSELLRGRDEEGKPYGLEELSTEAELLIIAGGDTTA
NTSCATAYYIARDLQIQAKLQAELDVALDGVESDVAPYDAVKDLPYLDAVINEGLRLHSTIGAGLPRVVPSGGMTVLGQHLKEGTVVSSPIYTL
HRNEAVWGKNAYEFYPERWLEASADAKKEMMQSFAPFSVGPRACLGRSLALQQLHILLATIFHRYSLVLENNAPAQLPLRDGFARKPMKCIVGV
QRRK 
>32CYP53D2v2 (48082) Ppl 
MDSSTSLLPPLGSIILACEGLTSLVPLILSVLVCLVATVTISPTLLAYFNDPFELRAYPGPFLAKFTSAWISWIISQNRWSETVDLMHRQHGPI
VRLSPDHVSVASPAAFAAVYGHSSGALKAPFYNAFANFKTRSIFNTRDRAEHSRKRRVEAHMFSPRSIRALEDTARVHFQVLVRQWDALCAPTG
KTGRGSAEGTLGTISWKVHGDRVWFDCMPWFNFWSFDTISDLAFGRPFGMLEAAKGSAHVSKSNTKSVQAVSQDTSHSDEAQSELLEIPAMEVL
SELLDFTVALAYLPAWVQPVFGRLPMFRDGYDAAPKLANLSLTAVANRVASQTDRADMLSELLRGRDEEGKPYGLEELSTEAELLIIAGGDTTA
NTSCATAYYIARDLQIQAKLQAELDVALDGVESDVAPYDAVKDLPYLDAVINEGLRLHSTIGAGLPRVVPSGGMTVLGQHLKEGTVVSSPIYTL
HRNEAVWGKNACEFYPERWLEASADAKKEMMQSFAPFSMGPRACLGRSLALQQLHILLATIFHRYSLVLENNAPAQLPLRDGFARKPMKCIVGV
QRRK 
>33CYP53D3 (60352) Ppl 
MLTYDEALNFSTVLSALTCLSAGVITLSLLLPYFIDQLQLREYPGALLAKFTSGWISWIISRNQWSETVDRLHSAHSMGSFVRLAPNHVSVSGP
SAFEAIYSHPSSALKAPFYDIFSAGGAANIFTTRDRAEHARKRRVEAHMFSPQSIRTLESTVSVHFHALEDQWDALCAHIQKAGSGGAEGIIGS
VSWKVHDSRVWFDWFMFWSFDTIADLSFGRPFGMLVSAKDVVRIPKSNASGIQAIAEAASHSKKTELEMVEVPLIEVLVKRGKTIAALAYLPAW
AQPIIGRLPGFREGYGAIPKLNGIAIAAVADRLRSPNGRADMLTKLLEGRDGEGYRYGPQELSAEAKTLIAAGGDTTASASCAITYYIARDPRI
QAKLQAELDAALDGIGSEIAPYGTVKVLPYLEAVVNEGLRLHSGVGAGLPRVVPAGGMTILGHHLMEGTVVSSPIYTLHRSKAVWGANADEFYP
ERWIDASADTKKEMMSSFAPFSIGLRACIGRNLAMQQLQIVTATIFRRYSIVLQDDAPLEIQDSFGRKPKKCIIGVKRRDLKVL 
>34CYP53D4 (55859) Ppl 
MLSVLVCLIPTVIASTFLIPYFSDPYKLRAYPGPFLAKFTSVWASWVINHNRWSETVDLLHRKYGPIVRLGPDSVSIADPSAFAVIYGHSSGAL
KAPFYDAFANHRIRDLFNTRDRAEHSRKRRVEAHIFAPQSIRALEDTARVHFEILVRQWDAMCAHAEKAGRGSAEGAIGTVPWKVHDGRVFFNC
MLWFSFWSFDTIGDLAFGHPFGMLETGKDTAQTVKSDVRGMEAIAQATSNSEKTKLELVDIPAIEALTARADTLFVVAYLPAWLQPIVGHLPSL
QSGYNAAPKLAGLAVAAVANKFASKTDRADMLSKLLEGRDKNGNLYGPEELSAETWLLIIAGGDTTANTSCATTYYLARNPRIQAKLQAELDTA
LDGIDSDVASYDAVKDLPYLGAVINEGLRLHATVGVGLPCVVPPGGLTVLGHHLKEGSVVSSPIYSLQRSEAVWGENAREFYPERWLEASADAK
KEMMRSFAPFSVGPRACLGRNLALQQLYIMFATLFRRYDFVLENDAPLAVQDRLVQKSKECIIGVQRRKGLVSRQ 
>35CYP53D5 (46728) Ppl 
MLTFDEALNFSTILSALACLSAGVITLLLFLPYFIDQLQLREYPGALLAKFTSGWISWIISRNQWSETVDRLHVQHGSFVRLAPNHVSVSGPSA
FEAIYGHPSSAAKAPFYDIFSAGGAANIFTTRDRAEHARKRRVEAHMFSPQSIRTLESTVSVHFHALVDQWDALCAHIQKAGSGGAEGIIGSVS
WKVHESRVWFDCMPWFMFWSFDSIADLSFGRPFGMLVSAKDVVRIPKSNASGIQAIAEAASHSEKTELEMADVPLIEVLEIRGKTVAALAYLPA
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WAQPIIGRLPGFREGYGAIPKLNGIAIAAVANRLRSPNGRADMLTKLLEGRDGDGHSYSPQELSAEARTLIAAGGDTTASASCAITYYIARDPR
IQAKLQAELDAALDGTGSEIAPYGAVKVLPYLEAVVNEGLRLHSGVGAGLPRVVPAGGMTILGHHLMEGTVVSSPIYTLHRSKAVWGANADEFY
PERWIDASADTKKEMMSSFAPFSIGLRACIGRNLAMQQLQIVTATIFRRYSIVLQDGAPLEIQDSFGRKPKKCIIGVKRRDLKVL 
>36CYP53D6 (54877) Ppl 
MDSSTPPLPLLGGIILTREGLTGLLLPGLSVLACLIATVIASLILIPYFNDPYKLRAYPGPFLAKFTSAWISWTISHNPISEIVDHLHRQYGPI
VRLGPNNVSIADPSGSAFSVIYSHSSGVTKSAFYDTFANFRIRNIFNTRDRAEHSRKRRVEAHMFAPQSIRALEETARVHFQVLLRQWDAMCAH
AEKAGRGRADGAIGAVPWKVHGGRVWFNCMIWFSYWSFDTIGDLAFGHPFGMLETGKDVAQIAKSNARGMQAIAQGTSDSEKATLELVDIPAIE
VLTARADALFVVAYLPPWAQKIVGRLPSFRSGYAAAPKLAGMAVAAVANRLASQYDRADMLSKLLQGRDEDGKPYSPEELSAEAWVLIIAGGDT
TANSSCALTYHLARNPRVQAKLQAELDAALDGIDSDVAPYDAVKDLPYLDAVINEGLRLHSTVGGGLPRVVPAGGLTVLGQHLKEGTVVSSPIY
TLHTNEVVWGENAHEFYPERWLEASADAKKEMMRSFVPFSAGPRACLGRNLALQQLHVMFATIFRRYSFALENDAQLTIQESFVRKPKNCFVGV
QRRK 
>37CYP53C1 (5) Uma  
MVETDLVPRIGAAIQWSVESPAHVVITLLGAVVLFHVVPYITNTACIKYPGPFFAKFTDFWLLRTALIGHRFEEVHKQHQKYGKFVRIAPNHVS
IADHEALQPIYGHGTGTLKPAYYDAFVPPRPFPRGLFNTRDRAEHTRKRKIVSHTFAPKTIVAFEPFIRREVQLLLERWDEFCDKATKDNTEGP
RGIKGRAWLDSLMWLNYFAFDTIGALAFGKTFGMLENGVDQAKVEYEDANGNKQVDYCSAVQIINERGEFSGTMGLAPVWMRPYLIKLPWFSSR
LKSVKKLTGIALARVNDRLQNGSEREDLLAKLQAAKDDRGEPMGKMELTAEALTQLIAGSDTTSNTSCAIVYHLATHPDKMRKLQAELDRELEH
AEEVPLHADVQELPYLQAVLSESLRYHSTSAIGLPRVIPAGGATVCGQQFPSGTILSVPAYTLHRDKSVFGADAEEYNPDRWLAPNAKRDFEKA
FIPFSVGPRACVGRNVAMMELSILIAAIFRRYDIVLAEPDKPLDTFEGFLRKPVKLEVGLKRRN 
>38CYP53B3 (28617) Pgr 
MLVIGLIAAFLEYSILLGLVGISCYYLTGYLRNKHQLNRYPGPFLAKFSRLWLGYATRFGNRYQIIHQLHQKHGRFVRIAPNELSIADPDAVHI
VLGHGTGTTKSKFYDAFVAIHRGLFNTRDRADHTRKRKIISSTFSQKSILEFEPYIADTLACFLRKIDQVASEPNLVQLPSHSWDSKHLNERWR
IIDILPWFNYLAFDIIGDLAFGERFGMIERGADIAAVEKEGKVIYLPAIQILNERGEFSATQGQFDHIKFSKKKKEKKKYIDPWFSRGAASVQN
LTGIATNQVNLRISQTGQSRRDLLARLQTGQDADGNPMGKDELIAEALTQLIAGSDTTSNSSCAILWWVVKHPEVHKRLMEELDEHLGTEEGVI
SYADCKELKYLNACINETLRIHSTSSIGLPRILPQTVSFKGHILPKGLVCSVPTFEIHHDPDVWGDPFTFRPERWLEPNAKDREKAFMPFSCGP
RSCIGRNLAMMELYMITSTIFKRYEFALVDPDLAELETREGFLRKVGFSLQQKT 
>39CYP53B2 (32280)Sro 
MTQSHVFTDFFEPTTLAVYFLAAPLGAVFLYLFVPHFTSLAPLRRFPGPFWAGYTRLWLARTARVGKRSELVHREHLKHGKFVRIGPNEVSIAD
PAALPIVYAHGSGSIKADFYDAFVASPVRGLFNTRNRAEHTRKRKIVSHTFAPKSVREFEPYIASTVNLLLKKWDQLAAKAQKSPPSGTGGERM
KGYAVIDSLDWFNALAFDVIGELAFGTPFGMVERDAADIVTITKEDGTVIHAGGVQILNMRGEYSATLGCLPPWSRKYMKYIDPWFARGLESVK
NLTGIARTRVNDRLEKGALDRKDILSHLQAGRDENGQPMSKDELTMEALTQLIAGSDTTSNSSCAILFQIVSTPHAHKKLQQELDEAFSGKGMS
GVLEYEDVKALPYLGACINEALRRHSTSGIGLPRIMMDDTEVLGEVFPKGTVLSVPSYTIHWSTEFWGPDAAEFKPERWLESEEKTRQLEKQLN
VFSFGPRSCVGRNVAMIELFCFMATLVYRYDFKLVDPNQKELEVVEGFLRKPTGCQIGFKLRDATQ 
>40CYP53C (212558) Pca 
MEQYHFILPQIDLKSIAVIRAAALLAAWVIPFFVDKYGLRGYPGPLLAEFSGFWLASQAYKGTTTSAVHALHQKYGLNFGAFDVIGDLAFGAPF
GMLEAEKDTVPVPVSEEQAMKSYGQKDMDLEWSTLPAIKLLNETIPRTSFLGCLPPQGKPLSEQDLTSEALNLIVAGSDTTSRSFDWCYRLPCC
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AESGCPKRLQKELDDVLRVPNSTFNTDEVVASFDRVKNVAYLQDAINEGLRLHSTVGVGLPREVPQGGLTIAGKALLPGTHVSCPSYTLHRLKS
IWGDDADEFNPDRWTRRGDRNAILKYLAPFSIGPRACIGRNLVMMEMTICVATISHPYRLVLANPDQQLECSEGFVRKPKNVHVGSMQRRL 
>41CYP53C (212559) Pca 
MEQTHFLLPQLDLRLTAGLLAAALLAAWVVPFLIDRYRLKGIPGPLLAKFSCVWLASKAYKGTMSSAVHVLHEKYGPFVRISPKYVSIADPEAL
QAIYGYSSGALKTELYDAFVFFRPTMFSTRSRLEHSRKRKYTAHAMSMKYIMEFEPNVREHHHMLVKQLDTLCAAGAQGKDGILGTRPWTARDG
WAWFDCMPWFNYETFDIIGDLAFGAPFGMVEAGKDTASVPVSEKQAMKFYGQKGAEIEWSTAPAIKIVNEAVPWVFFLGCLPPHVRPLLSKLRS
FTTKASARALVKIAVAAVSKRLATGVTRRDFLSHLIAVRDDQGRPLTEQELTSEAISLIVAGSDTTSSSIAAIAYHVARNQDVQAKLQAELDDV
LGAPGSDSSTDDVVAPFDRVKNLTYLQDVINEGLRVHSTLGAGLPREVPEGGLTVAGKTLLAGTHVSCPSYTLHRLKSIWGDDADQFNPDRWTL
GDRNAMLKYFSPFSVGPRACIGRNLAMMELTICIATIFHRYRVVLASPDQRVSQLFNVLDKDVG 
>42CYP53C (102576) Pca 
MEQSHFILPQLDLKLITAILAASLLAAWIIPFLVDKYRLRGYPGPLLAKFSGFWLASKAYKGTTTSAVYALHQKYEGPFVRISPKYVSIADPEA
LQAIYGHTSGTLKTDFYDAFVTFRRNIFTSRSRLEHSRKRKYTSHAMSMKGITEFEPNVREYQHMLLKQLDTLCAVGAQGIDGVLGSCPWTTRD
GWVLFDCMPWLNFDTFDVIGDLAFGKPFGMLEAGKDAALVPVSEEQAMKSFGRQDTDLKWATIPAIKLLNETVPWTFFLGCLPPQARFLMSKLP
SFNAGTSRKLFVKLAVATVSKRLASEATRRDFLSHLVAARNDEGKPLSAQELTAEALNLIVGGSDTTSSSIGVVIYHVARNRDVQERLQKELDD
VLGVPNSTFSTDEVVAPFELVKNLTYLQDVINEGLRLHSTVGVGLPREVPEGGMTVAGKALLPGTHVSCPTYTLHRLKSIWGDDADEFNPDRWT
RGDRNMMLKYFAPFSIGPRACIGRNLAMMEMTICIATIVHRYRLVLANPDQQLECSEGFVRKPKNVHVGMQRRL 
>43CYP53NS (152212) Pca 
MSGTIVNLGLDLREWLSPARVVLCASALLIARVVLFVYAYIKARRQFPGPPVTNIWKGNLDETMTEDVHDKWRRWHRQYGPIYQTVRWNGLFSR
VIYVGDPRLIRKIANENWPKFPAQYAGFRPLSGSALFAQMDQARWKTQRRGLAPAFQPRTVHAQYPALHKYLLQFADTIDRSAAARGRAVDLAQ
LHVLLTLDFVGEVAFGAELRAVRDGAACRILQIFHAVLPELMKCGLFPLRAKVPVFESTRAMHRAIAELRGMARAAVEDARRAHEDSQEKDCGA
EKGKKIFEILAHHVPRRRRRSHGTHDDFCRGHRQLRNPAIHRKLRDELDALLPADCVVPSIEQVSRLPYLRLVIKETLRYNGPGFGTFRYTPAD
VEIEGVVLPANTTLALWNPQVHRCPNVWGADADTFRPERWMSTQGEGNEKAALPGSYFPFSYGPRKCMGEGLAMLEMSLTLATLFKRYDLELEP
GFEMDFQPSFTLCSRNGLPVYARLRK 
>44CYP53C (183109) Pca 
MAILEVLAQLNLTSWLVLIPALAIAAHVVHWLLDPHGIRSYPGPLLARFSDAWLGYVAAQGHRSEVVHDLHKKHGTFVRLAPNHVSISDPDALQ
VVYGHGTGTLKSDFYDAFVSIQRGLFNTRSRPEHARKRKIVSHIFSQKSVLEFEPHVRLYVNQLIRQWDRLYEAGAKGLSGDDGESGWTGRNGR
VWLDCLPWYNYLAFDIIGDLAFGAPFGMLLAARDAAPVAVNHEQAMASYGKEKSEVQYIPAVQVINDRGMYSASLGVLAPWMRPIVKLFPWFRQ
GQQAVKLLAGIAVAAVSQRLTTPTDRVDLLGKLQGGRDDDGNLMGKEELTAEALTQLIAGSDTTSNSSCAITYYLAKYPDVQRKLQQELDEVLG
YDDEPVSTYDQVKKLTYLPAVIDEALRVHSTSGVGLPRVVPEGGMTVCGRTFPEGTILSVPTYTIHRDEEVWGKDVEVFRPERWFSQDKNEVQK
TFNPFSFGPRSCVGRNLASMELLIIISSILRRYDFVLEEPDKPFDTMEGFLRKPVECLVGIKRRSL 
>45CYP53C (101826) Pca 
MIPFLVDKYGLRGYPGPLVAKFSSLWLASKAHKGKTTSAVHALHQKYGPFVRISSKHVSIADPEALQAIYGHNSGALKTDFYDAFVAFRHNIFT
SRSRLEHSRKRKYTAYAMSMKGIMEFEPNVREYQHMLVRQLDTLCAVGAQGIDGVLGSCPWTARDGWVLFDCMPWLNFATFDVIGDLAVGAPFG
MLEAGKDTALVPVSEEQAMKSFGQQDTDLEWATIPTIKLLNETVPWIFFLGCLPPQARFLMSKLQSFNAGASRKLFQKLGVAAVSKRLSSEATR
RDFLSQLVAARDDEGKPLSAQELTSEALNLIIAGSDTTSSSIGAIIYHIARNRDVQERLQKALDDVLGVPNSMFSTDEVVASFDLVKNLTYLQD
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VINEGLRLHSTVGVGLPREVPEGGMTVAGKTLLAGTHVSCPTYTLHRLKSIWGDDADEFNPDRWTRGDRNMMLKYFAPFSIGPRACIGRNLAMM
EMTICIATMFHRYRLVLASPDQQLECSEGFVSKPKDVYVGMQRRV 
>46CYP53C (256510) Pca 
MEQVRSLLPQLDLKLASVLLVAAPLFAWAVPFLVDKHGLMAFPGPLLAKFSSLWFALKAYKGTTSLTVHALHERYGPFVRLSPQHVSIADPEAL
RAIYGHSSGTLKTELYDAFVTFFLARKRKYTAHAMSVKGIMQFEPNVREHQQMLVKRLDTLCTVGAQGVDGVLGSCPWAARDGWVWFDCMPWFN
FETFDIIGDLAFGASFGMLEAGKDTAPVPVYTDQAMKSYGQKDTDLEWSTAPAVQILNEAIPWFFFLGCLPPQARRLVSTLQSFNAGGSRNLIG
KIAVAAVSKRLTSEVTRRDFLSHLVAAHDDQGRPLSQQELTSEAISLIVAGSDTTSTSIAAITYHVARTQDVQAKLQEELDDALGVPDASSNAD
NVVAPFDLVKNLAYLQDVINEGLRLHSTIGVGLPREVPEEGLTVAGKALLPGTHVSCPLYTLHRLKSIWGDDADEFNPDRWARGDRKAMLKYFA
PFSTGPRACVGRNLATMEMTICIATIFHRYRVVLASPDQQLECHEGLVRKPNSVPVGMRRRV 
>47CYP53C7 (118978) Bad 
MAVLDYVLSPLESLGLASSLLIIPCLVLAGHFIYFVIDPHRIRSYPGPLLAKLTDAWLGYVAAHGHRSEVVHGLHQKYGKFVRIAPNHVSIADP
DALPIVYGHGNGTLKSNFYDAFVSIERGLFNTRSRHEHARKRKIVSHIFSQKSVLEFEPNVRTYVGQLIGKWDRLYENGAKGLSGDEGEGGWTG
RNGRVWLDCLPWYNYLAFDIIGDLAFGSPFGMLQACRDAAPVAVSQEDAMAGYGGKQCDVVYIPAVQILNDRGNFSASLGVLPPWMRPIVKQLP
WFKKGQKAVKDLAGIAIAAVAKRLTTPSDRTDLLGKLQQGRDDEGNPMGRPELTAEALTQLIAGSDTTSNSSCAITYHLAKNPEVQRRLQKELD
DALGAHADEPVVTFEDVKRLPYLQAVIDEALRIHSTSGVGLPRLVPEGGLTVCGQYFQEGTVLSVPTYTIHRDKEIWGEDCEAFRPERWFEQDK
NGIQKTFNPFSFGPRSCVGRNLANMELLIIVASILHRYDFVLADPEKPFDTAEGFLRKPVDCQVGIKKRAN 
>48CYP53H1P (318949) Bad 
MSSPEHLLPKADPKQFTSLATNLGVGTVSFGGVVWPGSHELLHFLHHLLRLDVHLIPYAHHRHQLWAMEQAPSRRQRPSSPQPDRWAKGDRATL
MKAFTPFSIGPRSCIGRNLASMELLIVVANVFHRFEAELAYPGQIMEVREGFLQHPLSVAVSLKRRGML 
>49CYP53H2 (55123) Bad 
MDAAWGQIVTSGVKAVLLLISFVLLVHLVPYALDRLSLSSHPGPFLASLSDLWLGWYAARGKMVRAVWDAHRVYGPVVRIAPNHVSIADVAALR
TVYGHSAGILKADLYDVFNPFGRTTLFTTRSREEHARKRKIVAHTFARKTVLEFEPIVQRYIHAVVRQWEHMCAVAADGKGGVIGNASWTSQDR
RAVFNTLKWYNFMVFDIVGDLVFRNPFGMTERGSDMALIAKHPDQVMASYNSITEEKIQYDAVNAVDAVTALNVVLTAVGMLRPFWRPFILKLP
MPWIRAGNEGVAKIAMMAVAAVAQCSQHPASRNDILAKYFDAIDDRGEKMHDLELSAEAVGLLIAGTDTTSNSLGALTFYLAQHPSAQSKLQAE
LDGALGAPHAFGNDDVESVSYENIKNLQYLQDVVNEGLRLFSIAGFGLPRIVPEGGLTILGHHFAPGAVISVPLYVVHRDKSVWGDDAEVFNPD
RWAAGDRVAMTKAFAPFSIGPRACIGRNLAFMELLLVVANIFHRFEAKIVSAEQVMEVRDGFLRQPLSSVVSVKRRGVF 
>50CYP53H3 (318972) Bad 
MDENFAIPLSSGLKALVFIVLLTHVVPFLRDEHDVRSHPGPALAKLSDAWLAWCAACGKINRSIYEAHKVYGPIVRIAPNHISIADVSALQPIY
GHGSGILKAESYDTFVAFDTPSLFTTRSRDEHARKRKVVSNAFAQKSVLEFEPVVKQYVGAVLKHWSHMCNAASSGDGGIIGDMKWTAQGGRAT
FNVIKWYNFMVFDIIGDLVFRAPFGMTEHGTDIARIAKNRDHAMASYDSGEVKLEYDTVNAVQALLSQNKFLTVVAQLPAYLRPLLQSVPLPWV
RSGAEAFQKFSTLSVTAVANSQQYPAPRNDILGRYFEATDEKGQKMGNHELSSEAVSLLIAGTDTTSNSAAALTFYLAHNPAAQAKLQVELDKA
LGPPCALDGDNDPAIVSYDQVKNLSYLHDVVNEGLRLFSAVGLGLPRVVPESGLTVLGRTFAPGTVVSVPTHVLHHDKTIWGDDAESFNPDRWT
EGDKTAMMEAFAPFSVGPRACIGRNLALMELLIVVANVFYYFDAAPTSSDQPMEIWDGFLRQAFKCDVSLKSRGVA 
>51CYP53H4 (160054) Bad 
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MDPAVVLILSTGLKAAVALLAFAFLAHLVPFALDKFGVRQYPGPLLAKLSDIWLGWHAAHGKINQAVWNAHRAYGPIVRIAPNHVSVADASALH
QIYGHSTGILKADLYDAFVSFNRASIFSTRSREEHARKRKILAHTFSQKTTLEFEPVVRQYIGDMFKQWDRMCTAAVMGKGGVIGEMPWKDQDG
RAEFDTLKWYNFMVFDIIGDLVFRAPFSMTERGTDMARIVKRPEKAMSSYESVDTKLEYDTINAIEAVNARSAFLITLGVLPALWRPLIKKLPL
PWVRAGTEAFQKITKLTVTVVADRSHHSATRNDILAKYFDATDENGQKLDAQELSSEAITLLIAGTDTTSNSVAAMTFYIAHNPVVQARLQAEL
DEALGCPVCESREEPVLATYEQIKGLSYLQDVVNEGLRVFSTVGLGLPRIVPDGGLTVLGRTLSPGTVVSVPTYVLNRDKSIWGDDAEYFNPDR
WANGNKAAMSKAFAPFSTGPRACIGRNFAFMELLLVIANVFHRYEVVPGQSEPTMEVREGFLRKPLASTVAFKRRGAAL 
>52CYP53H5 (65034) Bad 
MDAIRDVLLPFGTVVAISTLLAYLLFSGFHRSYLSSFPGPLLARLSDAWIGWHTARGTVNRAVYEAHKAYGPFVRIAPNHISISHSSALQPIY
GHSVGILKSEFYDIFTSFNGTKSVFTTRSREEHARKRKILSHTFSQKSTLEFEPMMGQHIGDLIRQWDYMCAMAAEGKGGVVGETAWTSHEGR
AVVDTLDWYSFVIFDVIGELVFRIPFGMTNRGSDETLIVKHPNQTMALDESSSTKTEHDSVRAVQMMNERSALMVSLGMLPKYWRPLIERLPM
EWIRRGNAGVEKMSSLVMSAIADGSKNSSQRNDILSKYFNATDEDGRKMGISELYTEALVLLAAGADTTAHSLAALTFYLAQCPAAQTKLQVE
LDEALGWPNAVDDGNRPTIASYDSVKNLPYLQDVVNEGLRLFSAVGVGLPRVVPEGGLTILGRTLPPGTVVSVPAYVVHRDQAAWGDDVESFN
PDRWAKGDKTGMMRAFAPFSIGPRACIARNLASMEMLLFVANVFHRYEAKLASQLQMDIHDSFTRRPLASIVALKRRGL 
>53CYP53H6 (142452) Bad 
MALSFGAPDPTTLAVISLPLVFAILVHVLPYLADKLHLRRYPGPPLARFSDVWLAWHCARGSINRAVLEAHRTYGPVVRISPTQISVADVSALQ
PIYGHGSGAPKAESYDAFSGLGRPSIFTTRSREEHTRKRKSLAHTFALKTVLEFEPVVKEYVGSIIKKWDRMCAAATKGEGGTIGEMTWISQGG
RAVFDTLKWYNFMVFDIIGDLVFRAPFGMTERATEIAVIAKRRDKAIESYETSEQKLEYTTLPAVQAINKRGTFLATMGMLPKYWWPLLRKLPL
SWFSAGHAAAEMMLTLAITAVAHRSQHNAIRSDILGKYMEARDDRGQQLDNRELSSEALTLLIGGTDTTSNSAAALTFYLAQNTIVQARLQKEL
DEALGEPVYGDEDAERPVLVAYELIKNLPYLQDAVNEGLRLFSTIGLGLPRVVPESGLVVLGEAFTPGTVVSVPTYVTHHDEAIWGEDSWAFNP
ERWQTGDKAVMAKAFAPFSVGPRACLGRNLALMELLLVVANVFHRFEVRLADPAQTMEITDGFLRKPVSSVVALKRRVSA 
>54CYP53H7 (358536) Bad 
MTLNVPLPTAVWVMFLLSSLPVLAILFHVVSYLKDTLHLRRFPGPPLARLSDVWLAWHCGRGTINRAVLAAHRTYGPVVRIAPNHVSIADVSAL
HLVYGHGSGALKADFYDAFVGRATSSVFTTRSRHDHTRKRKALAHTFSPKSVLEFEPIIWEYLGAVIRRWDQMCTAASQGRGGVVGEMTWSSEG
GCAVFDAVKWYNFMVFDIIGHLVFRHPFGMTERATEMTLIVKQGRDDAMELQDKPGRELEYTSIPAVQSINTRSTFLATMGMLPKSWRPLLRKL
PLSWFNGGHLASEFMLSLAMTAVSHRLQHQTTFDDILGKYLEATDDRGQKMNDEELIAEALTLLIGGTDTTSSTVAALTFYLAQNPVVQAKLQK
ELDEAFGNPSAVAANDDDDGQPNLVKYERIKNLTHLQDVVNEGLRLFSTIGLGLPRVVPDGGLTVLGNTLAPGTVVSVPTYIIHHDEEIWGNDA
WSFNPNRWQTRDKDTMSKAFAPFSLGPRACIGRNLAFMELLLVVANIFHRFEASSPYPGREAHIHDGLPSKPLSSVIALRRRSGV 
>55CYP53C (118598) Csu 
MDWRMMIDGFTTLTSRETYTFSGFVSILLPLLFLCLSITLLLFPCVTYLLDFYGLRSYPGPFLAKFTDLWLAYKVWEGNRSPDIHLLHKKHGPF
MRIGPNHISVVSPAAISTIYSHIDPLPKSAFYDGLATFSVPDIFTTRDRVTHGRKQRMVSHLFAPKTVRLFEEDVQKYVGQLVAQWDDMCARAK
DGVVLTGHNGAMEWSTREGKVWFDCMPWFNLLAFDTISDLAFGSPFGMLIAGRDTARVARSVDIAMKNLGVAQTAQESDRIYEEEDIPAISANN
TRSDFLMFLAYLPEWLRPIVVRLPLFDDGVAAAGKIMSMAVTTVLRRLHALSSDSGDEKKNYEDFLIKLLQGHNDDGNRMGPEELTSEAQVLLI
AGSDTISNSTCATVYWVARHLNVQRNLQSELDGALADVSSDEDSFVAPIDKIDNLPYLNAVVDEGLRVHSAVGANLPRTVGPEGATVLGHSFQE
GTILSVPAYSAHRDEQVWGLDCEEFRPERWLEADREQQELMKKAFIPFSVGPRACVGRNLAKMQLLINIATIFRLYKVVLADQDKELEVFDNFV
RKPLNCRVGMQRRDLSSKREWSI 
>56CYP53C (116910) Csu 
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MEFLHLSFDWTTALLVLAVGVALVHVVPWLLDPHGIRSYPGPLLAKFSDAWLGWVAAQGHRSEVVHELHKKYGTFVRLAPNHVSISDPDAIQIV
YAHGNGSLKSNFYDAFVSIQRGLFNTRSRPEHARKRKIVSHIFSQKNVLEFEPHVREHIRTLISQWDRLYELGKKGLSGTEGEGGWQGKNGRVW
LDCLPWWNYLAFDIIGDLAFGAPFGMLHACADSAPVAISHEAAMKNYGDDAAPEVEHFPAVQVLNSRGEYSASMGVLPPHWRPLAKRIPWFRRG
NQAVQRLAGIAVAAVAKRLSAPSDRTDLLSKLQEGKDDEGKLMGKPELTAEALTQLIAGSDTTSNSSCAITYHLAANPHVQEKLQAELDAALGD
GDPVATFDQVKRLPYLEAVINEALRIHSTSGIGLPRIVPQGGLTAAGQYFPEGTVLSVPTYTVHRDKEAWGEDADLFRPERWFEHDEKTLQRAF
NPFSFGPRSCVGRNLANLELLIIIASILHRYHFVLEDPEKHFDTREGFLRKPVECRVGIKRRHD 
>57CYP53C (112429) Csu 
MILDVVHSVLERPLLLVVLLPSVLLAVALVAHLRDPHHLRSYPGPFLASLTDLWLAYKVWVGDRSPGVHELHKKHGTFLRIGPNHISIASPAAL
GVIYSHSHPLLKSDFYDGLATFSAPGTFTVRDRVAHARKRRVVAHLFAPKTVRMFEGALHKYIGQLVQQWDGMYKNVETALPGTATAGKAGDMS
WIVRDGRVWFDCMPWLNFLAFDTIGDLAFGSPFGMLVSGKDTARIAKSLKAAMQTLGSTPSATEKPSTIEEEDIPAISSINRRSEFLIAFASLP
AWIRPIVKRLPMASDGMAATREIMSMAVTTVSRRVRTLYDGDAEERQRPDFLTKLLEGRDEEGSPLSPDELSSEAQTLLIAGSDTISNSTCAIV
YWIARNPDVQKKLQAELDAALADAGEGPIAPVEKTERLLYLNAVIDEGLRVHSTVGANLPRVVGPEGVTILGHTFTEGTVVSVPAYSTHRDENI
WGHDAEFFRPERWLEADKEKRDAMNKAFVPFSVGPRACVGRNLAKMQLLVNIATVFRLYDIVLENPDLPLPVHDNFIRKPLNCHVGVKRRS 
>58CYP53C (151209) Csu 
MLPAELVDCLPGSLPLLFGLFLTALLAVFFAPYILDRHRLRSYPGPFLARFSDLWLASQVWKSHRSEEVHRLHKKYGKCRFLRIGPNHVSVADP
AAIPILYSHSNPLMKSDFYDGFTTFRTPGIFVERDRVAHARKRRVVSHLFAPKTVKAFEPAVQNYVGQLVRQWDRLCKNADAQSVSVMSGVLGS
MTWRAYDGCVWFDCMPWLNFLSFDTIGDLAFGKAFGMVESGKDIARVAKDYTDAMRTYNAKQELPEWTPAYEEEEIPAISSLKERSKYMIFVGT
LPKSLRGIMRFLRSRDHQVMALRRIMSMATSSVARRIRAGREQDRDDFLARLLQARDDDGNPLSPDELSSEAQTLLTAGADTISNSTCATVFWI
ARAPPVKARLQAELDATLGISSTDLGSPVAPIDKIEHLPYLNAVIDEALRIHSTVAAGLPREVGPGGLNVLGHFFPEGAVLSVPTYSAHRDESI
WAPDPDAYRPERWIEADKEKREAMNKAFIPFSVGPRACVGRNLAKIQLLINVATIFRCYDVVLEKPHDPMPVHDDFTRKVIECFIGLKRREI 
>59CYP53C4 (47512) Gsp 
MSFLNPLLALDFATWAALGLAAIVLFHLVPYLVDSHHIRGYPGPLLAKFSDVWLGYVAAQGHRSEKVHELHEQYGTFVRIAPNHLSISDPDALQ
IVYGHGTGTLKSTFYDAFVSIQRGLFNTRSRVQHARKRKIVSNIFAQKNVLEFEPHVRQHLGTLFQQWDKLCDGGKKGLSGTEGEGGWHGSDGR
VWYDCLPWYNYLAFDIIGDLAFGAPFGMLIACKDSAPVAVSCEAAMASYGSAASSKEIQIEHFPAVQVLNDRGEYSASMGVLPPHWRPLAKRIP
WYARGNQAVQRLAGIAVAAVAQRMASPSDRVDLLAKLQEGRDDNGDPMGREELTAEALTQLIAGSDTTSNSSCAITYWLARNPAAQRKLQAELD
GALGSNDDPIASFEDVKRLPYLDAVINEALRIHATSGIGLPRLVPEGGLTVCGRFFPEGTVLSVPTYTIHRDREVWGEDVDAFRPERWFERDKN
LIQKTFNPFSFGPRSCVGRNLANLELLVIVASIFRRYEFVLEDPAAELDTREGFLRKPVECKVGMKRRNA 
>60CYP53C4 (GL08839-P1.1) Glu 
MSLLDPLLAFDFATWAVIGLSAIVLFHLVPYLVDSHHIRGYPGPLLAKFSDVWLGYVAAQGHRSEQVHELHKQYGTFVRIAPNHLSISDPDALQ
VVYGHGTGTLKSTFYDAFVSIQRGLFNTRSRVQHARKRKIVSNIFAQKNVLEFEPHVREHLGTLFQQWDKLCDGGKKGLSGTEGEGGWHGGEGR
VWYDCLPWYNYLAFDIIGDLAFGAPFGMLLACKDSAPVAVSCEAAMASYGSASSSKEIQIEHFPAVQVLNDRGEYSASMGVLPPHWRPLAKRIP
WFAKGNQAVQRLAGIAVAAVAQRLGSPSDRVDLLAKLQEGRDDNGDPMGREELTAEALTQLIAGSDTTSNSSCAITYWLARNQAAQRKLQAELD
GALGSASDDDSIASFEDVKRLPYLEAVINEALRIHATSGIGLPRLVPEGGLTVCGRFFPEGTVLSVPTYTIHRDREVWGEDVDAFRPERWFERD
KNLVQQAFNPFSFGPRSCVGRNLANLELLVIVASIFRRYEFVLEDPTAELDTREGFLRKPVECKVGMKRRNV 
>61CYP53C9 (27837) Pbr 
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MSSLLTSFSLDNVTNLLLVIPGLLVLGHVVFYLVDPYKIRSYPGPLLARFSDLWLGRVAAEGHRSEIVHKLHQKYGTFVRLAPNHVSVSDPDAL
QVVYAHGNGTLKANFYDAFVSIQRGLFNTRSRPEHARKRKIVSHIFSQKSVLEFEPNTRLYVRQLIAQWDRLCELGAKGLSGDEGEGGWKGRNG
RVWLDCLPWYNYLAFDIIGDLAFGHPFGMLQACQDAAPVAVSQEAAMAAYGEGKQFEVTNIPAVRILNDRGMFSASLGVLPPWMRPLAKQLPWF
KKGNAAVKTLAGIAVAAVARRLATPVDRVDLLGKLQDGRDDEGNPMGREELTAEALTQLIAGSDTTSNSSCAITYHLAKNPDVQKKLQAELDEV
LGNDDDPVSTYEEVKKLAYLQAVIDEALRIHSTSGIGLPRVVPEGGLTVCGQFFPEGTVLSVPTYTIHRDTHVWGDDVETFRPERWFEQDDKLI
QKTYNPFSYGPRSCVGRNLASMELLIIISSILRRYEFVLENPSKPLETLEGFLRKPVDCVVGIRRRSL 
>62CYP53C (194181) Abi 
MILDRLSDTFLELYDKLDLQIVAFAVPGTFLAFHLLPWLWDPHGLRAYPGPFIAKFSDIWLTCVSKGAHRSELVHEAHLKYGPVVRIAPNHLSI
ANPEALQIVYAHGNGALKSIFYDAFVSIRRGLFNVRDRNEHTRKRKIVSHIFSQKNVLEFEPHIRMYVAQLQNQWDRLYDMAVKGMSGNDGEGG
WEGRDGRLWLDCLPWANYLAFDIIGDLAFGEPFGMLQAAKDSAVVPKDQKSMMKSYGKEDASIEVMEIPAVQILNGRGEFSLTMGTLPPYWRPI
ARRLPGFRQGAQDVKNLAGIAIAAVAKRLATPTDRNDLLSNLQAGRDSEGKPLGREELTAEALTLLIAGSDTTSNSTCAILYYLARNRGAQEKL
QKELDEHLGTENEFTATEAQVKNLPYLDACINEGLRLHSTSSVGLPREVPEGGMMVCGQFFAEGTVLSVPSYTIHRDRGVWGEDFEAYRPERWF
ERDQTLMQKTFNPFSYGPRACVGRNLASMELLIILASIMRRYDIVLEDPDLILDTREGFLRKPLACRVGIKRRDI 
>63CYP53C (194303) Abi 
MIIETFKNFVAQADTTTLACAIPAAVVLFHVIPWLTDSHSLRKYPGPFFAKFSDFWLAFTSRGGRRSEIIHDYHKKFGPVVRIAPNHVSISDPD
ALNAVYGHGTGTLKSEFYDAFVAMDRGLFNVRDRHDHTRKRKVISHIFAQKSVVAFEPKIAIYVTQLLNQWDRLYDMAVKGGSGNEGEGGWKGK
DGKLYLDILPWMNYLAFDTIGDLAFGEPFGMLAAAKDMAVVPKDQQSAMNSYGKETKEEDILTVPVIEAFNNRGEFNLVMGSLPLHWRPLARRL
PGLAQGSRDFKTVAGIAVAAASKRLSSSTDRIDLMSKLQNSRDSNGNPMSREEMTAEALTLLVAGSDTSSNACAAFLYHVAANPSVQDKLHQEL
DEQLGTEDELVATAEQIKRLTYLEACINEALRIQSVSGIGLPRVVPEGGLEVLGNFFPEGTVLSVPSYSVHRDTKSWGDDTETYRPERWFERDQ
AAMNKAFNPYSVGPRSCVGRNLAAMELSIILASIMRRYEFVLKDEDKPLVISEGFLRKPLSVDLGIKRRDV 
>64CYP53C (1179842) Sla 
MNTILQLNPFQDFHFSFTTALAGVPIIFILVHVFPYLADPFKQRAIPGPLLAKFSDAWLGWVSSQGHRSEVVHKMHLKYGTFVRIAPNHVSVAD
PDALQVVYAHGNGSLKANFYDAFVSIQRGLFNTRNRNEHARKRKIVSHIFSQKNVLEFEPNVRLYVGQLISQWDRLYDSAAKGASGTEGEGGWF
GKDGRLWLDSLPWYNYLAFDIIGDLAFGSPFGMILNAKDSAPVAVSQKDAMKSYGSESTYEVIEIPAVQILNDRGEFSASMGVLPPHWRPLVRL
LPWYRKGGKAVKNLAGLAVAAVAKRLTTPTDRVDLLSKLQEGRDDEGKLMGREELTAEALTQLIAGSDTTSNSSCAITYYLAQNPDAQEKLQKE
LDEALGDDDHPVSTFEQVKRLPYLEAVINEALRVHSTSSIGLPRIVPEGGLIVQGQHFPQGAVLSVPSYTIHRDTTVWGADPDQFRPERWFECD
HAAIQKTFNPFSFGPRACVGRNLASMELLIIISSILRRYHFVLADPEKPFDTREGFLRKPQECRVGIKRRQT 
>65CYP53C (94174) Shi 
MLASLVNAVTNVDGKTCLVAVPVLLVLAHVIPWLVDVHGIRSYPGPFWARFTDLWLGWVAAQGHRSEVVHEMHNKYGPIVRIAPNHISISDPEA
LQIVYAHGNGSLKSNFYDAFVSIHRGLFNTRDRAAHARKRKIVSHIFSQKNVLEFEPHVREYVKSLIAQWDRLYDLAVNGESGTEGEGGWVGRE
GRLWLDCLPWYNYLAFDIIGDLAFGSPFGMLQAAKDSAPVAKSAKDAIAAYGQDEAKVEVVHIPAVQILNDRGEFSASMGVLPPWLRPYVKRYI
PWFSKGDQAVKNLAGLAIAAVSKRLNQPTYRVDLLSKLQEGKDDEGRPMGREELTAEALTQLIAGSDTTSNTSCAITYYLAANPAVQEKLHVEL
DAALGNEDDPASTFEQTKNLKYLQAVIDESIRLHSTSGIGLPRIAPEGGLTVCGKYFPEGTILSVPSYTIHRDVDVWGYDVEAFRPERWFERDA
EMIQKAYNPFSFGPRACVGRNLASMELLIIISSILRRYDFVLEDPTKPFATKEGFLRKPVDCKIGIKRRNL 
>66Cyp53C (37267) Tve 
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MAIFELLASLDLPSWAAIVLAAVVLVHLVPYVLDPHGIRAYPGPFWAKLTDLWLGKIAADGHRSERVHDLHKKYGPFVRIAPNHLSISDPDALP
VVYGHGTGTLKSDFYDAFVSVQRGLFSTRSRPEHTRKRKIVAHSFSQKSVHEFEPHVRENLSKLFKQWDTLCEGGAKGLSGNEGEGGWQGREGR
VWYDCLPWYNYLAFDIIGDLAFGAPFGMLTSGKDSAPIAVSQVDAMAAYGQGGTLKVKHVPAIQVINDRGEYAASVGVLPPHWRPFVKRLPWYN
TGDKAVQNLTGMAIAAVARRMEESDSDHRDLLAKLREARDEDGNPMGREELTAEALAQLVAGSDTTSNSSCAITYYLAKHQRVQEKLQQELDEA
LASEEDEVALFERVKHLPYLEAVINEALRIHSTAGVGLPRVVPAGGLEVCGKFFPEGTVLSVPGYTIHRDKAVWGDDADEFRPERWFGKDKAAL
QKAFAPFSVGPRSCVGRNLAHLELLTFVASIFRRYSFVLENPDEPLPTNEGFLRKPLKCNVGMQRRNV 
>67CYP53C (129211) Tve 
MALLGILSSLDGPSWAALVFAAVVLVHVVPYLLDPHGFRSYPGPFLAKLSDFWLGKVAADGHRSERVHELHEIYGNWTFVRIAPNHLSIADPDA
LQIVYGHGTGTLKSDFYDAFVSIQRGLFNTRSRTDHARKRKIVSHIFSQKNVLEFEPHVRVHLIQLFKQWDRLCAGGARGEAGDEGEGGWRGRD
GRVWYDCLPWYNYLAFDIIGDLAFGAPFGMLTSCKDSAPVAVSQDDAMATYGKDAAYKVEHFPAVQVLNDRGEYSASMGVVPPRWRPLVKRLPW
YNKGNQAVQRLAGIAIAAVARRLSVPESDRHDLLEKLQEGRDDNGDPMGRAELTAEALTQLIAGSDTTSNSSCAITYYLAKYQHVQEKLQKELD
DALGGEDDSVASYEQVKRLPYLDAVINEALRIHATSGIGLPRLVPAGGLEVCGRWFPEGAVLSVPTYTIHRDKAVWGDDVEEFRPERWFEQDKV
AVQKTFNPFSFGPRSCVGRNLANLELLVIVASIFRRYHFVLEDPSAPLATNEGFLRKPLKCIVGMKRRNV 
>68CYP53C (104855) Wco 
MSLLGDIAPQTLDYVGKLTFWLASIPIVIIAAHIVSYLLDPLGLRAFPGPIFARFTSGWLPWIISQNRWSVTVDRLHQKYGTFVRLSPNHVSIA
HPAALPAVYGHGSGAPKAPYYDGFVNFKSRNMFNTLSRSEHARKRRIESHMFSPQSVRALEGTASVHHGNLVSQWDKLYSYVKQAEGGGAKEGQ
LGASVWKVEGGRVWFDCMPCDLAFGAPFGMILAAKDTARFAKSVMAGMAAFGTSSKTSEYAFETDETPVTKLMAERADLVATIGWLPEYWQPIV
RMLPAFRGGRKSTPQLAGLAVAAVAKRLSKPDAREDMLNRLLNARDEDDEPLSREELSAEAAMLIAAGADTVANTSCATTYYLARDQRVQAKLQ
AELDEALKSVDSVAAPYDAIKHLPYLDAVVNEGLRLHATIGAGLPRVVPEGGLTMLGHTFKEGTWVSVPVYHLHRDESIWGENASEFYPERWIE
ASGERKKAMLDAFAPFSVGPRACIGRNLALMQLHKTLATLFYRFSFVLESSDPVRLRSCIRFCSTADSVRNQLPVQDGFARKPRRCMIGIRSRK
L 
>69CYP53C (154237) Wco 
MYGIFVCLSPNHISIVHPVALPAVYGHSSGALKAPFYDAFASFKTRNMFNTISRTGHTRKRRIESQIFSQQSVRELEGTTRVHHIDLVSQWDKL
YSYVKRAESDGVREGFNYWSFDIIGDLAFGDPFGMILAAKDTARSAKSVNASLATFSTSSNTKKFAFEMEELPVTEIIGQRGELITMLGWLPKY
VRPIILMMPGFRSNLQAIPKVAGSAVTAVAKRMNDLDAHADMLNRLLDARDENGEPMSPEELSSEASLIIVAGAITVANTSCAITYYLARDQRV
QAKLQAELDDALKADDSIVAPHDAIKHLPYLDAVVNEGLRLDSPAPGSAYLRGENASEFYPERWVEASGDQKKAMLDAFVPFSIGPRACIGCNL
ASMQLHTVLATLFHRFNVVLESDDPVRSQV 
>70CYP53c (27029) Wco 
MSGLLAPLNLHPAALLLLIPAAVLAVHFVPYLLDPHGIRSYPGPFLAKLSDAWLGWVAAKGHRSEVVHQLHQRYGTFVRIAPNHVSISDPDALS
EVYAHGNGTMKSNFYDAFVSIQRGLFNTRSRPEHARKRKIVSHIFSQKSVLEFEPYTRQHVGALFKQWDRMCELGTKGLFGEEGEGGWHGRDGR
VWFDCLPWYNYLAFDIIGDLAFGAPFGMLQACADAAPVVVSHADAMASYGKGDAPEVAYFPAVQVLNDRGEFSASLGVLPPHWRPLVVRFIPWY
RNGNKAVKRLAGIAIAAVAKRLTAPTDRSDLLAKLQEGKDDDGNPMGREELTAEALTQLIAGSDTTSNSSCAITYYLAANPLVQQKLQRELDEA
LGNDDDPVAMYEQVKRLPYLEAVINEGLRLHSTSGIGLPRIVPEGGLTVRGQFFPEGTVLSVPSYTIHRDREVWGADVDAFRPERWMELDKNAV
QKTFNPFSFGPRSCVGRNLASMELLIIIGSILRRYHFVLEDADKKFDTREGFLRKPVECKVGMKRRSL 
>71CYP53C (138864) Wco 
© Central University of Technology, Free State
CHAPTER 2: GENOME- WIDE IDENTIFICATION, ANNOTATION AND COMPARATIVE ANALYSIS 
OF CYP53A FAMILY IN FUNGI 
90 
 
MSLLRDITVQALSFVDKLIFWLALIPIIGIAMYIVPYFLDPLGLRAFPGPILAKFTIGWLPWVVSQNRWSLTVNRLHQKYGIFVRLSPNHVSIA
HPAALSAVYGYSSGVTKAPYYDVFGDFRAKNLFNIISRTEHTRKRRIVSPMFSQQSVRALEINARVHHNNLVSQWERLYSYVKQAEKGGIREDK
LGASAWRVEDGRVWFDCMPWFSYWSFDTIGDLAFGSPFGMLSAANDTVRVAKSVKASLATFGTSSNAGEFGFETEEMAIEKMLSERGHLISILG
WLPEYWRRIVQMLPAYRFGTEAAPKMAGLAVAAVGKRLNNPAAREDMLNRLLDARDENGKPMSPEELSADAFQLIVAGADTTANTSCATTYYLA
RDQRVQAKLQAELDEALKSIDSAVAPYDAIQNLPYLDAVVNEGLRLYTTVGAGLPRVVPEGGLTVLGHTFKEGTWVSVPIYRLHQDESIWGENV
NEFYPERWIEASGDRKKAMLDAFAPFSMGPRSCIGRNLALMQLHIVLSTLFHRFDFVLESDDPLHVQDSLIRKPKWCMIGIKSRKL 
>72CYP53C (138909) Wco 
MSLLRDITVQALPFVDKLIFWLALIPIISIAVYTVPYLLDPLGLRAFPGPILAKFTIGWLPWIVSQNRWSLTVNRLHQKYGIFVRLSPNYVSIA
HPAALSAVYGHSSGATKAPYYEVFGDFRARNLFNILSRPEHARRRRLEAHMFSLQSVRALEINARVHHNNLVNQWERLYSYVKQAEKGGIREDK
LGASAWRVEDGRVWFDCMPWFSYWSFDTIGDLAFGSPFGMLSAASDTVRVAKSVKASLATFGTSSNAEEFGFETEEMAIEKVLNERGHLITILG
WLPEYWRRIVQMLPAYRFGMEAAPKMAGLAVAAVGKRLNNPAAREDMLNRLLDARDENGKPMSPEELSAEAFVLIIAGADTTANTSCATTYYLA
RDQRVQAKLQAELDEALKSIDSAVAPYDAVKNLPYLDAVINEGLRLHATIGAGLPRVVPEGGLTVLGHTFKEGTWVSVPVYHLHRDESIWGENA
SEFYPERWIEASGDRKKAMLDAFAPFSMGPRSCIGRNLALMQLHIVLSTLFHRFDFVLESDDPLPVQDSFVRKPKRCMIGIKSRKL 
>73CYP53c (138853) Wco 
MPLLDRITTHALDYVCMPTFWLALIPAVLTTVYIVPYLLDPLGLRTFPGPIFAKFTSGWLPWVVSQNRWSVAVDSLHRKYGIFVRLSPNYVSIA
HPVALPAVYGHSSGALKAPFYDALSGFKTRNMFNTLSRTEHARKRRIESHMFSPQSVRALEGIARMHHNDLVSQWDKLYSYVKRAESGAAREGS
LGECAWKVKDGRVWLDCMPWFNYWSFDTIGDLAFGAPFGMILAAKDTARVAKSVKASLATFGTPSQTGKFAFETEELPVIKIVGQRAELVAMFG
WLPEYVWPIILMMPGFRGSRRAIPQVSGLAVAAVAKRMNNPDARADMLNKLLDARDENGEPMSPEELSSEAFLLIVAGSDTVSNTSCATTYYLA
RDQRVQAKLQAELDDALKAVDSVVAPHDAIKHLPYLDAVVNEGLRLHSAVGAGLPRVVPEGGMTVLGHTFKEGTWVSVPIYHLHRDENIWGENA
SVFYPERWIEASGDQKKAMLDAFVPFSIGPRACIGRNLALMQLHIVLATLFRRFNVVLESDDPLPVQDSFGRRPKQCMVGIKPRNL 
>74CYP53C (77097) Wco 
MSLVDDTTAHVPSYPAFWIALIAITVFAVQFVPYLLDPLGLSSFPGPVLAKFSNVWLPWIVSQNRWSVTVDQLHRKYGKTLIYCGAGTFVRLAP
NHVSIAHPAALPAVYGHSSGTLKAPLYDVFGPFRARSIFSTRSRTEHARKRRIESPMFSPQSVRALEGTTRVHHSDLASQWDNLYSYVKQAENG
GSREGMLGESAWKVEDGRVWFDCMPWFNYWSFDTIGDLAFGAPFGMLLAAKDTARVAKSVKAGLATFGTVSRTGEFAFETEEIPVTKLLNKRAE
LVAILGWLPKYWQSIVGTLAVFSGGSNASPKLAGLAVASVAKRLSNPQAREDMLNRLLDARDDNGEPMSPEELSAEAMTLIIAGADTVANTSCA
TTYYLARNQRVQAKLQAELDEALKAVDSEVALYDAVKYLPYLDAVVNEGLRLHATIGAGLPRVVPEGGITVLGHTFKEGTCVSVPIYYLHRDES
IWGANATEFYPERWLDATGERKKAMLDAFTPFSVGPRACIGRNLALMQLHIVIATLFRRFNVVLESDYSLPVQDSFVRKPRWCAIGIKLRKL 
>75CYP53C (154264) Wco 
MPLLASITAYALDYMCMPTFWLALIPAVLTTVYIVPYLLDPLGLRTFPGPIFAKFTSGWLPWVISQNRWSAIVDSLHRKDGIFVRLSPNHISIA
HPVALPAVYGHSSGALKAPFYDAFASFKTRNMFNTLSRTEHTRKRRIESQIFSQQSVRELEGTARVHHIDLVSQWDKLYSYVKRAESGAAREGF
NYWSFDTIGDLAFGDPFGMILAAKDTARSAKSVKASLETFSTSSNTEKLAFETEELPVTKIMGQRGELVAMLGWLPEYVRPIILMMPGFRSNLQ
AIPKVAGLAVAAVAKRMNNPDARADMLNRLLDAPGAITVANTSCATTYYLARDQRVQAKLQTELDDALKAVDSVVAPHGAIKHLPYLDAVVNEG
LRLHSPVGAGLPRVVPEGGMTVLGHTFKEGTWVSVPTYHLHRDENIWGENASEFYPERWIEASGDQKKAMLDAFVPFSIGPRACIGRNLALMQL
HIVLATLFHRFNVVLESDDPVRSQAYALYVAGHAAMGIEAVMLRQKEF 
>76CYP53C (104840) Wco 
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MPLIGDITVQTLPFVGISTIWLALISITGIVTVICVVPYLLDSLGLRAFPGPTLAKFASGWLPWVISQNRWSVTVGRLHEKYGTFVRLAPNHVS
IAHPAALSAVYGHSSGALKAPFYDASGNFKARNMFNTRSRSEHARKRRSESHMFSPQSVRALEGTARVHHGNFVNQWGKLYSYVAQAKSGEAKE
GKLGACAWKVEDGRVWFNCMPWFNYWSFDTIGDLAFGAPFGMLLSAKDTVRVATSVKAGMAAFGTSSTTGKFTLETEEIPATKLLNKRAKLVTT
LGWFPKYWQPIIELLPPFRAGREATPKLAGLAVAAVAKRLSNPDAREDMLNRLLDARDENGEPLSPEELSAEAWLLIIAGADTVANTSCATTYY
LARDQRVQTKLQAELDEALKSIDSAVAPYDAIKHLPYLDAVVNEGLRLHATVGAGLPRVVPEGGLTVLGHTFKEGTWVSVPVYHLHRDESIWGE
NANEFYPERWIEASGDRKKAMLDAFAPFSVGPRACIGRNLALMQLHIVLSTLFHRFDFVLESHDPLPVQDSFVRKPKRCVIGIKSRKL 
>77CYP53A (56813) Ade 
MSSFWLCLAAAALLVLWRWRADPLRNVPGPWLARWTPFWLMYHARRGERYLAVHDAHKKYGPAVRIAPWHVSFASPDAPARVYAQGSAALDKSP
FYRAFYVQGAESLFSTQNRALHAAKRRLLSQPFSYQSIRGFEGFMRESLGRFVRRLDAVCAGECFGDAVRPGGAIDALLWFNYLAFDIISDLAF
GEPLGMVNKGSDLLPAERKDGTIFEEHAAALIDQRGRTAAVVGLMPSIEDITKKLPIPFITAGYKSTESLSRIAVRCVKHRIQSGVTRDDMLER
LIDGVREKQGGEVSEEEVVTEAMLLLTAGADTTANSLTAILYFILTRPDVYKKLMAELDSINAPTAELDTGTTIDGLPTHDQVKNLPYLNAVIE
EGLRLFATNAFGLPRVSSREGFELDGWTIPAGVEVSAPAYTIQRDPRIWGPDADDYRPERWIDETDSGLKKHMLTFGMGPRACIGKNLAYVQMQ
LALATSLLRYEFLLSPKAQLRSIEGFMHKPVELWVGIRRRHQPTA 
>78CYP53C (70450) Ade 
MEDLLRLAVYLALAGSIGTTLFVLVPYFKDEHGVRDIPGPLAAHLSNLWLAYWSSQGKRSEMVHEQHLKCGKLVRIAPNHISVNDPDALPIVYG
HGTGTLKSEFYDAFVSIQRGLFNTRSRTQHTRKRKIVSHVFSQKNVLGFEPNLHSALSRFVSQWDRMCAAGVKGGRGNEQDGWHGDGQRVWMDC
LPCAYNYLAFDIIGDLAFGSPFGMLDACADSANAAVGGVNALKDGKPMQTVSVPAIRILNERGEFSATMGVLAPWMRPLVLKLPWFARGLSAVR
ALAGLAIAAVGRRLAEPSDRNDLLAKLQDAKDDDGMPMGPEELTAEALTQLIAGSDTTSNSSCAIAYYVARYPRVQLKLQQELDAALPNDGVTT
YEQVKRLPYLTAVINEGLRLHSTSAMGLPRIVPEGGLTVAGRFFTEGSILSVPSYTIHRDPEVWGEDFDKFRPERWSEGDQTLIQKTFNPFSWG
PRACVGRNLAMMELLLIVSTTFRRYHLVLESDDEASQTREGFLRKPVLCRIGLKRRSPV 
>79CYP53A (105834) Cpu 
MKPDPLADVPGPLLARWTPLWLGYYARIGQRFTAVHKLHMEYGPIVRIAPNHISVADKDALDLVYAQGSNAFDKSTFYHAFVSDKASVFSTTDR
HDHAQKRRLVSNIFAAKSLQDCTPFIRDIVDSFVVQLDRLAAKNEELNLLYWFHFLAFDVLSDLAFGQRIGMVEKGSDAVTVQKRDGSVSTENA
IALVDEREHLGAVLGVHPSFKFWSKFLPDPFFIQGRKSSDGLVDFARRQVSRRIDNRLQRNDILDKLIRARVADDQEIVGENFADLVAETVTLL
IAGSDTTSNSETAIMHLLFTNPRVYNKLIGILEEAVDEELPTADHVRDIPYLDAVINEGLRYHATTAIGLHRAVHEKGAMFGGKYFPPGTEMSV
PAWTIQHDPEIWGDPEVFRPERWIENPDLKKYLMTFGKGPRACLGRHLAYMEMRLVLSTVLLRYDLQLKSQVMETTEGFMHKPNEMFVRLSRRE
RKGAAVQAQAQA 
>80CYP53C (127772) Cpu 
MDSVIATLKDLVPINLNFDFDALLDRLRSISPSQLAAGVPVCLLLYFLVPWLWDPYHQRSIPGPFLAKFSNAWLGWVSAHGHRSEIVHELHKKY
GPVVRIAPNHVSVADPEALQVVYAHGNGSLKSDFYDAFVSIHRGLFNTRDRQQHARKRKIVSGIFSQKNVLEFEPHVRLYVGQLMEQWDRLCAR
AEKGESGDEGEGGWQGRGGKLWLDCLPWYNYLAFDIIGDLAFGSPFGMIHSAKDSAPVAVSHADAMSAYGSSASNIKVVHIPAVQILNDRGEYS
AAMGVLPPAIRPFMQRFVPWYRKGGKAVRNLAGIAVAAVAKRLNEPSDRVDLLRRLQEAKDDEGNPMGREELTAEALTQLIAGSDTTSNSSCAI
TYYLALHPEIQTKLQRELDDALGTDDDPVSTFDAVKRLPYLDSVINEALRLHSTSSIGLPRIAPEGGLALRGLWFPPGAILSVPSYTIHRDAGV
WGADTEAFRPERWAEEERRDAVQRAFNPFSFGPRACVGRNLASMELLVIVSSILRRYTFVLEDAAKPFDTREGFLRKPVECRVGIRRRV 
>81CYP53C (83844) Cpu 
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MDVQQLIQHLPQNVDLTSAAAASFAAFLAVHLGPYAWDRYHLKSIPGPFWAKFSDAWLAWVAANGHRSEEVHKLHEKLGPVVRIAPNHISIADP
DALQIIYAHGSNTLKKSNFYDAFVSIRRAIFNTREKADHARKRKIVANTFSQKNVIEFEPRVRIYVGQIIDQWDRLSKLAAADGSGDEGESGWY
GKDERLWLDVLPWMNYLAFDIIGDLAFGQPFGMILKAKDSAPVAVSQDAAMDSYGKECKVIEVPAVKILNDRGDYNATLGTMPPWVRPYVRKLP
WFSQGSEAAASVAGMAVAAVSRRLTTPTDRVDILSKLQQGKDENGEIMGPEELTAEALTHLVAGSDTTANSSCAIIYYLAAYPHVQEKLQKELD
EALGSEDEPVTTYEQVKRLTYLEVVILEVLRLHSTIGLGLPRMAPEGGLTVHGTYFPEGTILSVPTYTLHRDKRVWGDDPEIFRPERWFEENSA
KMHKAFNTFSFGPRACVGRNLANLELLIIVSSLLRRYDFVLKNPGDALGTCEGFLRKPTDCWVGLRRRAL 
>82CYP53C (52716) Dsp 
MSSLLDYFPTPFSSNALLLYGGLAVLLLVASHLVPWVADPFGYRKKHIPGPFLAQLSDVWLARVAAQGHRSEIIHGLHQKYGKVVRIAPNHISL
SEPGALQIVYAHGNGALKSDFYEAFVSIRKNIFSTRDRAEHTRKRKIVSHIFSQKSVLEFEPYIRQALGKLVKQWDSLLSDDRKLASHRLRPNE
NGTAWFDCLNWYNYLAFDIIGDLAFGEPFGMINSGADSASVAIHGDDPTHLASGEKKLEIVRVPAVKILNDRGEYSASMGCLPIWIRPYAKKIP
WYAKGNQAVKNLAGIAIAAVDKRLATPTDRVDLLARLQQGKDEQGNLMARSELTAEALAQLIAGSDTTSNSSCAITYWLAKYPDAQRKLQKELD
EALGDDEDVPTYEQLKRLRYLDAVVNEGLRIHSTSSLGLPRIVPEGGLEVSGIHFPAGSVLSVPSYTIHRDTAIWGPDPDIYRPERWFEQDAEG
IQATFNAFSFGPRACVGKNLASMELLLIVATIFHRYEFALLSQDQPLETREGFLRKPVSCYVGMKRRST 
>83CYP53C (55106) Dsq 
MSLVDRLLNSEPATWAVVGFTAVLLIHFVPYLADPHHIREYPGPLLAKLSDIWLGYVAAQGHRSERVHELHKQYGTFVRIAPNHLSISDPEALQ
VVYGHGTGTLKSDFYDAFVSIQRGLFNTRSRVQHARKRKIVSNIFAQKNVLDFEPHVRQHLANLFRQWDKLCEGGKNGLSGDEGEGGWQGRDGR
VWYDCLPWYNYLAFDIIGDLAFGAPFGMLDACKDSAPVAVSHKAAMAAYGSSDSSKEIQIEHFPAVQVLNDRGEYSAAMGVLPPHWRPLAKKIP
WYSKGNQAVQKLAGIAVAAVAQRFANPSDRADLLSKLQEGRDDNGDPMGREELTAEALTQLIAGSDTTSNSSCALTYWLAKNQAAQRKLQQELD
AALGSDDDPVASYEQVKRLPYLEAVINEALRIHATSGIGLPRLVPEGGLTVCGKFFPEGTVLSVPTYTIHRDKAVWGEDVDDFRPERWFEQDKN
LVQKTFNPFSFGPRSCVGRNLANLELLVIVASIFRRYHFVLENPNAQLETREGFLRKPVECKVGMKQRHT 
>84CYP53C (154594) Fme 
MQMISNISPWYFCLLPAAVLVLLVVPYFIDPYWIRRNEVRGPFLASLTSLWFGWNATRGHLSQVVHDLHKKFGTFVRLSPNHVSISDPDALQTI
YGHGKGLMKSDYYDAFKGLRPSIFSTRDRAFHAWKRKAISHIFSPKSVIDFEPYIHLHLTELFEQWDKLYDGGKRGLSGVEGEGWNGRQGRVWF
NIMPWFNYLTFDIIGDLAFGAPFGMIRKGKDAAPVAVDLKAAIAQYGQAGIDGQDLEKPAIQVKEVPAVQILNDRTFLASHQAAFPKPLRPLLA
LLPQYAEMAKHSDEFIGFAVAAVAKRLVFPTERVDILSKLQQSKDENGNPQSREDLTTDGITQLVAGSDTVANTSCGITYHIASNPCVQAKLQA
ELDDALGKDMEDPVVTYAQIKNLPYLEAVLNEGQRVYSTAALGLQRIVPEGGLTISGKWFPEGTIVSVPTYTIHRDPKVWGEDVDVFRPERWLE
GDHSAMSKTLNTFSIGPRACVGRNLALLELHIFIASIFYRYELVLEEPDKPLETHEGFIRKPLTCRVGMKRRDV 
>85CYP53C (143663) Fme 
MILIILRVFVDIGYRIWLFLPWIFLVVHLIPYLVDRYHIRRNGITGPSLARFSDAWLGWVVANGRQSEVVHEMHKKFGPVVRLAPNHVSISDPG
ALHVIYGHGSGLLKSGYYEPFTAVRPSIFSTRSREVHSKKRKIISHVFSQKSVLEFEPFVHLHLAELFEHWDKMCDGGKEGLSGTESEGGWKRR
GGQAWFDIMPWFNYLAFDIIGDLAFGSPFGMVRNAKDAAPIAVDRKSAMAQYGPVITDNRGLEKPVIDVREVHAISVLENRMRLSAQMGVLPAW
WRPIVRQLPRFAQGVQNSKDLVDLAVAAVAKRMAYPTQRDDILSKLQQSRDEYGRPLTQEDLTTDAITQLVAGSDTISISSCGIAYHLAANPDV
QSKLQKEIDDALGGFDDPMVTYAQIKHLQYLEAVINEGLRVHPTPGLGLPRVVPEGGLNVCGKWFPEGTILSVPTYTIHRNTGVWGEDANVFRP
ERWFEGDQAAMQKVFNAFSFGPRACIGRNLAMMELYIIIASIFHRYELILEEPNKPLEIHEAFMRKPVACHVGLKRRGA 
>86CYP53C (149618) Fme 
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MSMSSGIVQELLNVTFWLWFFLLAIIFAVHLDAYFIDSHRIRRNGISGPFLARFSGAWLGWVVFQGRQSEVVHSLHKKFGTFVRLSPNHVSISD
PDALRLVYGRGNGALKSDYYDAFLAVRPSIFTTRSKEEHARKRTAIAHAFSQKSVLEFEPYIRLHVAELFNQWDRMCNRGKNGLSGTEGEGGWI
GQGGRVWFDIMPWFHYLAFDVMSDLAFGASFGMVRNAKDAAPIAVDQRAAMAQYQGTRVDSLDLEKPSIDVKEVPAVTMLNAHIKVSARMAAVP
PRWRPILQRLPCFARDMRASEDLVALAVAAVARRLVFPAERIDVLSKLQETEDEHGRVSNMEDLTTDAFTQLVAGSDTVSSTACGIAHCVAANS
RVRAKLQQELDVVFGGSYDPVATYAQIKRLPYLEAVIIEGLRVHSTSGLGLPRTVPNGGLIVCGKWFSEGTVLSVPTYTIHRDPIVWGEDADAF
RPDRWFERDQTILQKAFSPFSFGPRACIGRELAIMELCIFVSSIFHRYDLELEAPDKPLTIREDFIRKPVACRVGMKRRNI 
>87CYP53C (94457) Fme 
MVPNIAHNFLLGYSWILLLLPAIILVVHLVSYFVDSKHIRRNDIPGPTLAKVSGSWLGRVALEGRQSEVVHELHKKFGTFVRLSPNHVSISDPE
ALQVVYGHGNGMLKSEYYDAFAAPNLRRSVFDTRSREEHARKRKAISHIFSQKSVLEFEPYIHTHLTDFFKQWDKLCDGGRKGFSGIEGEGGWK
GHDGRVWFNAMPWYNYLSFDIISDLAFGTPFGMIRKARDAVPVAIDHKAAMAQYGQIDTEYRDVKKLVIDTREVPAIQVVNEQGEGVAQIAAFP
PLWVPFLRCLPRFAKGMRRVEDFIGLVVLAVANRLAFPTERVDILSKLQQGKGEDGVPLTKEELTSEALVQLIAGSDTTSNTTCAITYYVAANP
HVQTKLQKELDNALGHSENHVATYSQIKQLSYLDAVVNEGLRVHSTVGIGLPREVPEGGITVLGKSFPEGTVLSVPIYTIHRDPKVWGKDVDSF
RPERWIEGDKAAMQKVFSPFSVGPRACTGRNLALMSLHIFIASIFRRYDIVLEQPDKPLEVHDAFARKPNSCRIGLKRRDV 
>88CYP53C (115179) Fme 
MLPNILDALAQLNTSQLCASALAVAAVVYLQPYLVDSHFIRRNGITGPFFARFSDAWLGWVAAHGNRSVVVHKLHKKYGLFVRLAPNHVSISDP
EALHIVYGHGSGTLKSDYYDAFLAIRHTVLTTRDREDHSMKRKLVAPIFSQKSVLGFEPCVHSHVTELFEQWDKLCDGGKQGLTGNAGKGGWKG
RDGRVWFDALPWLYYMCFDIIGDLVLGAPFNMVHKGTDTVPVALEPSAVIAQYGQSSITGSHDTEKPICAVKEAPAMELMNGRSAVIASLGVLP
PWWRPIASLFPWYARGNRDVGDLAGFATLAISKRLARPTEPLGLLSALLELKDDEGKPLSKEQLSADGLLLLIAGSDMVANPTCAVLYQIIANP
PVQAKLQKELDDALGAPSPSDDSVSTYSQINHLPYLEAVINEALRVHPMVGLGLPRVVPASGLTVCGKHFPEGTVLSVPTYTIHRDKEVWGEDA
DTFRPERWFEGDKSTMQKVFNAYSYGLRACAGRVLANVELQIFISSIFRRYEFVLEEPENPVEVFEGFIMRPKSCRVGMKRRAI 
>89CYP53C (24265) Fme 
MILKILYSVFFTNYLWLCTGLTAAFFLVHVVPYLFDKHHIRRNDISGPLLARFSDAWLGWVAAQGPRSEVVHQIHKKYGKFVRLAPNHVSIAYP
EAIGEIYGHGNGTLKTDFYDAFLSIDRTIFTTRSREEHTRKRKVIAHGFSQKSISQLEPYIRLHVAELFEKWDKLYDGGRKGLTGVEGHNSWEG
HDGRVWFNAMPWLNYLAFDIIGDLAFGAPFGMLRNAKDAAPTAVDQKAAMSENGQVNIQDLEKPVVAVREVPAVKVLNGRSEYSASMGVLPPRW
RPIARLLPWYAEGSKDVEDLAGLAVAAVAKRLAIPTDRADILSKLQQGRHEDGSPMSREELTADALTVLIAGSDTTSNSTCALMYYITSNPRVQ
AKLQKELDEALVSFDDPVTSYDLVNHLPYLDAVIHEGLRVHSTLGVGLPRLVPEGGLTVCGKWFPEGTVLSAPTYTIHRDPKVWGEDADVFRPE
RWLERDHATLLKVFNTFSYGPRACIGRNVATMELFIFISSIFRRYDLVLEEQNKPLEVHEGFIRKPMACRVGMKRRNV 
>90CYP53C (130308) Fme 
MIASIFYSTFFTKYLWICAGLTAGFLVVHVVPYLLDKHHIRRNGITGPFLAMFSDAWLGWVAAQGRRAEVVHEKHKKYGKFVRLAPNHVSIADP
EAIGDIYGHGNGTLKTDFYDAFISIGVTVFTTRSREEHTRKRKVISHGFSQKSVSEFEPYIRLHVSELFEQWDELYDGGRKGLTGVEGEGGWKG
HDGRVWFNAMPWCNYLAFDIISDLAFALPFGMLRNAKDAALTAVDQKAAMSENGQVNTDMQDIEKPVVAVREVPAVKVLNGRSEYSASMGVLPP
WWRPIVRLLPWYADGSQDVEDLAGLAVAAVAKRLAIPTDRTDLLSKLQQGRHEDGRPLNREELTADALTQLIAGSDTTANSSCAVLYHIISSPR
VQAKLQKELDEALASLDDPVASYDLVKHLPYLDAVIHEGLRVHSTSGNGLPRLVPEGGLTVCGKWFPAGTVLSAPTYTIHRDPKVWGEDADVFR
PERWLERGQATLLKAFNTFSYGPRACIGRNVATMELFIIVSSIFRRYEFVLEEPHKPLEVHEGFIRKPMACRVGMKRRNV 
>91CYP53C (162664) Fme 
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MTAVILSQSTMLPNILGITVHSVFLFFTLLGVLVLVVHLVPYFIDPYHIRSNDIKGPSLAGFSGTWLGWVAVSGHQSIVVHQLHKKFGTFLRLA
PNHVSISDVEALQAVYGQGSGTLKSNYYDAFVAFRPSIFETRSKAEHSRKRKAIAHVFSQKSVAEFEPFVRLHLAELFEQWDKMCDGGKKGISG
AEGEDGWNGHDGRVWFNVAPWFNYLGFDITGDLAFGFPFGMVCNASDTVQITVDQKASMDKYGQKDADQGSGKSAIETETKEIQAVKVLNNRTN
FDAHAGSFPPRFRPFMRRLPRFSECLQSSEDLAGFTVTAVARRLAFPSYRTDILSKLQQSKDEHGKPFSKEEVTSDAQTMLIAGSDTVSNTSSA
TAYYIAKNPGVQIRLQKELDEAFAASDDAVATYAQIKDLPYLAAVVNEGLRLHAPVGVGLQRVVPKGGLTVCGKWFPEGTILSVPTYTIHRDPG
VWGEDADAFRPERWLECDQSVMQKAFNPFSIGPRACIGRNLALMELQLFASSIFHRYEIVLEGVDKPEYACMPPNHVSISDPEALHVVYGHGSR
TLKSDYYEVFNSVRPSIFSTRSRTEHARKRKAISHAFSLKSVLEFEPYIHIHITFFLGQLDKLCDGKLNIPLDTEDDMCWEGQGGRVSFDIMPW
LNYLAFDIIGACVWISIRYVRNASNTAPVAVDQKACLARRSKIGADTDSFESEHIEVKEIERFSGRTPGEFTVAAVAKRLAFPTERANVLSNLF
LTKDEQGRLPSREDLTQDAITQLVAGSDTDSSKSVKACQAPDGAERCKGLPRVIGESGLTVCGKRFPEGTCVSVPSYTIHRDPLVWGEDVDVFR
PERWFERDPSIMQNAFNAFSFGPRFYDIILEEPDKSLEIHKTFIRRPIACHIGLKRQYD 
>92CYP53C (128292) Fme 
MGFTGVSTLTNALARVDLISLAVAVPLVLILGLIVPYFVDPHCIRNNGITGPLSARFSDAWLGWVAAQGHRSEVVHEMHKKYGTFVRLAPNHVS
ISDPAALQIVYAHGNGTLKSSFYDAFVSIRRGLFNTRSRPEHTRKRKIVSHIFSQKSVLEFEPHIRLHVGELFTQWDKLCDGGKRGLKGTEGDG
WEGHDGWVWFDCLPWFNYLAFDIIGDLAFGSPFGMILKGKDAAPVAKDQKAAIAGYGRESASEKSACDVTELPAVQVLNDRGEYSASMGVLPPW
WRPFVRRIPWYANGNRAVKNLAGLAVAAVAKRLANPTDRTDLLSKLQEGKDDEGRPMGREELTAEALTQLIAGSDTTSNSSCAITYHLAHNPHV
LKRLQQELDTALAGEDDPVATFQQVKSLPYLDAVINEVLRIHSTSGIGLPRLVPEGGLTVCGKTFPEGTVLSVPTYTIHRDKEVWGEDVEAMRP
ERWLEGDQAAIQKTFNPFSFGPRACVGRNLASMELLIIIASIFRRYEFVLEKPDEQFDTREGFLRKPLRCRVGMRRREL 
>93CYP53NS (92916) Fme 
MSDIIAPFLPVKRFVASLPFAACILCLALLKIVLFFIAYFKARGQFPGPPVSSLWSGNLSESMADDVHDKWRTWHRKYGPVFQTWNGLFSRVVY
VGDPRIISKIGNSNWPKFHAQYSGFKPLSGSALFAQMDQERWKQQRKGLAPAFQPITVNDQYPMLQRYLTEFIEVIDAAARSGSVIDLSTLHVL
LTLDFVGEVAFGAELNALRDGASCRILQIFHDILPELMKCGLFPLRSQIPIMESTRRMHRSIKELRGMAHVAVKNARSSEEKSAVQPGSKRIYE
ILAQLSVNLKLLHVLVTFLPLLFQLRNPEILAKVRTELDEVLPPDSEIPTVEQASRLRYLHLVIKETLRYNGPGFGTFRYTSKDVEINGVTLPA
NTTLALWNPQVHRDPKLWGPDSDEFRPERWLVSTGSTSSEFSRFIPPPGSYFPFSYGPRKCLGEGLAILEMSLTLATLFKRYDLKLQEGFVMEF
LPSFTLCSKNGLPVTARVRAQV 
>94CYP53C (86809) Fpi 
MSIVQQLIDFTRGNPLLVLAALPVVLVVAKVVHYLADSSDLRSYPGPFLAKFTDAWIFWTVSSNRWSHSVEDAHIKYGPIVRIAPNHISIADPK
ALATVYGHSTGFTKANWYNAFSEFAAKNIFNTRSRSEHARKRRMEAHMFAPQSIRAVEPISHAHVNELLRQWDGLISRVAKAQQGGPNGGHIGA
TTWNVQDGRVWIDCMPWLNFWSFDTIGDLAFGLPFGMLKSGRDTAKVAKSAEEGFKAIDAMSKGGDALVVEEEEIPYIEYLSARAERNACLAWL
PPVWARVVLTLPAFSGYALTGRKLAALSIMAVARRLANPNPREDMLQKLLEARDEEGKPLSPQEMSSEAFLLIIAGSDTIANTTCGTTYYLARD
KRVQAKLQAELDGALASVDSEVVPYDAVKDLPYLDAVIHEGQRLHSTVGAGLPREVPTGGATILGHHFREGITLSVPIYRLHRDESIWGPDAAE
FRPERWIEASPERKKLMMDAFAPFSVGPRACIGRSLAIMQLHIIVATLLRRYDFALQSDEPLRVRDSFARRPQECMVGITRRK 
>95CYP53C (48859) Fpi 
MSIVQQLTNFTRGNPLLVLAALPVVLVVAKVVHYLVDSSDLRSYPGPFLAKFTDAWIFWTVSRNRWSRSVEDAHIKYGPIVRIAPNHISIDDPK
ALAMVYGHSTGFMKSNWYDIFAAFSVSNIFDTRSRSEHARKRRMEAHMFAPQSIRAVEPISHSHVNELLRQWDGLISRVAKAQQGGPNGGHIGA
TTWNVQDGRVWIDCMPWLNFWSFDTIGDLAFGLPFGMLKSGRDTAKVAKSAEDALKAIDTVSKGGDVLAIEEEEIPYIEYQSARAETDACLAWL
PPIWVRILGKLPMFSVHALTGQKLAALSIMAVARRIADPNPREDMLQKLLEARDEEGKPLSPQEMSAEAFVLIIAGSDTIANTTCGTTYYLARD
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KRVQAKLQAELDGALASVDSEVAPYDTVKDLPYLDAVIHEGQRLYSTIGAGLPREVPAGGATILGHHFKEGTTISVPIYRLHRDESTWGPDAAE
FRPERWIEASPERKKLMMDAFAPFSVGPRACIGRSLAIMQLHIIVATLFHRYDFTLQSDEPLRVRDSLARRPLECMVGITRRKGELGYGSFEL 
>96CYP53C (1025718) Fpi 
MSSVVDQLTGLPVAAWAGLVVAAVVLVHLVPLITDPYQVRSYPGPFLAKISDAWLGWVAAQGHRSEVVHELHQKHGKFVQIAPNHVSVSDPDAL
QVIYAHGNGTLKSTFYDAFVSIQRGLFNTRSRPEHARKRKIVSHIFSQKSVLEFEPYTRMHIKKLMNQWDRLYDLAMKGGSGEEGEGWQGRDGR
LWLDILPWYNYLAFDIIGDLAFGAPFGMLDACADAAPVAISHEKAMSSYGETDTPEITYFPAVQILNDRGEYSASLGVLPPHWRPIVKLLPWYR
KGNKAVQRLAGIAIAQVAKRLAMHTDRSDLLGKLQEGKDDEGNPMGREELTAEALTQLIAGSDTTSNSSCAITYHLAANPMVQQKLQRELDEAL
GNDDDPVSTFEQVKRLPYLEAVINEGLRLHSTSGIGLPRLVPEGGLTVCGRFFPEGTVLSVPSYTIHRDQDVWGSDADAFRPERWFEQDEKAIQ
KTFNPFSFGPRSCVGRNLASMELLIILSSILRRYHFVLEHPEQGLDTKEGFLRKPVECRVGIKRRTV 
>97CYP53 (1116154) Fpi 
MPSLPLGLKIPQLSALEICGIVTALFLVSYLRRRSDPIHAIPTVGPSWPLLSYLGAWRYFRDAKGMILEGCSKYEVFKIPLSDQWLVVVSGRDM
NDELRKYPDDTMSALEAQKWVVQTEYTLGNNNPDATAKKCISGPLTHKLGHVLPDVVDEMIHSFNDIMPDAEHDWQTVPALETMIKIIARVTNR
VFVGMPFCRNEMLLETAVEFAKDVMKTKFIVNLFPDVLKPIVGHRLPWTTARRRKMAEILGDTVRERRRQMLEYGTDYEGKPDDYLTWVVEEDL
KNRGKGESIDGVMEVIAASNFAAIHTSSMAMAHALYYLCAMPQYIKPLKQEAEEKIKEHGWTKTAMDAMWKTDSFFKESLRLNGVNHLSLFRKS
MKDVVLSNGTVIPAGTIVVATSTGTHLQEALYKDAAEFRPFRFSDVREKGGADAQKQQFHIPTAEYIAFGHGKHACSGRWFAAAEVKAILAYIL
LNYDFKLEKPGGRPENMNLGPSILPHPRAKVMFRKRKASRA 
>98CYP53C (80617) Gtr 
MLSGILNADVSNILILLVAVVAVAHIVPYFTDPHAIKSYPGPWLAKFSDAWLGKVSAQGHRSEVVHDLHKKYGTFVRLAPNHLSIADPEALQTV
YAHGNGSLKSDFYDAFVSIRRGLFNTRDRAEHARKRKIVSHIFSQKSVLEFEPHVRLYVRQFIEQWDRLCGLAAKGERGEEGNGWEGREGRLWL
DCLPWYNYLAFDIIGDLAFGSPFGMLKACKDSAPVAVSHADAMAAYGKDDSAVQVRSLPAVQILNDRGEYSASMGVLPVWFRPVVQRLHPWYRN
GNKAVKDLAGLAVAAVAKRLRNPTDRVDLLSKLQEGKDDEGKPMGREELTAEALTQLIAGSDTTSNSSCAITYYLALHPRVQEKLQAELDEALG
NDDDPVSTFEQVKRLKYLEAVINEALRVHSTSGIGLPRVVPEGGLTVLGRTFPEGTIMSVPTYTIHRYEEVWGPDVDEFRPERWFEIDQAQINK
AFNPFSYGPRACVGRNLASMELMIIVSSIFRRYHFVLEEPEKKFETREGFLRKPVECRVGIKRRN 
>99Cyp53A (101387) Pst 
MQNSTLFSSATHNLPEAMQDYTWLVFLPAVVVGYIVAVSRDPLQKVPGPLLARWSNLWQAFYTRFGIRYKAIHAVHKTYGPVVRISPNHVSIAD
MSLLPSIYGQGMAAFNKSPFYDAFLSEKPSIFSTRDKQEHAQKRRNYSGAFAPKTIRSYTTTVHRFLEELLVKLDKRAALPGEPDKAPIDMLIW
SNYLVFDIMSTLAFGTPLGMLEKESDVLQAGSPKGAIENTDVREHYLTVIGWAPALAYIARLIPDPFFQKGSKSSDELRDIARMCIKQRLASGS
DDAKSDILGHLIAAHMEYKNHLDVEELTSEALTLLIAGTDATSNAITAIIHALSVNPRPLAKLREELDEALSPGGLQGPTSDLNDLPYLNACIH
EAIRLHSPTGMGLPRIVPEGGLTYRDYYFPPGTDVSVPTWTMSRDRAAWGEDADVFRPERWIEDPSLTKYFMAFSSGTRGCLGKSLAILELKMI
VATLLQRYDITPQSLVLQTTEKLMHKPTHDWVRLRRRNVD 
>100Cyp53C (68781) Pst 
MVLSDPLTLAGLGLAAVVVAHIGAYLLDPHNIRDIPGPTLAKFSDAWLGWVAAKGHRSEVVHEMHAQYGPVVRIAPNHVSIAEPQALQIVYAHG
NGSLKSNFYDAFVSIQRGLFNTRNRADHARKRKIVSAIFSMKNVLEFEPHVREYVGLLIKQWDRLCAEAVKGGSGDEGEGGWRGESGRLWLDCL
PWYNYLAFDIIGDLAFGQSFGMLHACKDSAPVALSQDEAMKAYGSASGYKVVSIPAVQILNDRGEFSASIGVLPPAWRPFVKNLIPWYRNGSKA
VKNLAGLAVAAVAKRLDRDTLNGGSDRVDLLAKLQQGKDDEGKPMGREELTAEALTQLIAGSDTTSNSSCAITYHLAANPNVQAKLHAELDEAL
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GTDDDPVAIFDQVKRLTYLQAVIDETLRIHSTSGIGLPRIVPAGSGGMHVAGHFFPEGTVLSVPTYTIHRDKEVWGEDVEVFRPERFLEGDQAV
IQKTFNPFSFGPRACVGRNLANMELLIIIASILRRYHFVLEHPEKPFDTREGFLRKPVECKVGIKRRSA 
>101CYP53A15 (ACF15219.1) Clu 
MFLTSLLLTPYTILLLPVLFYLLPYLRNWRIRDIPAPFPAAWTNLWLLYQCRRGRRFLAVHEAHQKLGKLVRIQPNHVSIADADAITQVYGHGN
GFLKSEYYDAFVSIRRGLFNTRDRAEHTRKRKTVAHTFSAKSVLQFEQYIHHNLQELQNQWDRRAESVKGGWYEMDALNWFNYLAFDVIGDLAF
GEPFGMLKKGRDEAEVARGGKITYAPAIEVLNRRGEVSGTVGIFPAIKPYAKYFPDPFFSQGMKAVENLAGIAIARVNARLEKPSDRVDLLARL
MEGRDENGNKLGREELTAEALTQLIAGSDTTSNTSCALLYHCLQHPEVVQKLQNELDAALPNPDAVPSYAQVKDLPYVDAVIKETMRIHSTSSL
GLPRVIPPGPGVTILGRHFPQGTVLSVPAYTIHHSTEIWGPDADTFRPERWEKVTEQQKAAFIPFSYGPRACVGRNVAEMELALIVATVFRRYE
FELRQGEMETREGFLRKPLALQVGMRKRSFA 
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CHAPTER 3 
STRUCTURAL ANALYSIS OF CYTOCHROME P450 
MONOOXYGENASE CYP53A FROM THE 
THERMOPHILIC FUNGUS THIELAVIA TERRESTRIS 
3.1. Introduction  
Fungi consist of large number of lower eukaryotes that are adapted to diverse ecological 
niches. Recent studies revealed that cytochrome P450 monooxygenases (CYPs/P450s) play a 
key role in their adaptation to diverse ecological niches (Syed et al., 2014). Genome 
sequencing analysis of fungal organisms revealed presence of a large number of P450s/P450 
families in their genomes (Nelson, 2011). Among the different families CYP53 family is 
distributed in the phyla ascomycota and basidiomycota and is also one of the CYP families 
that display evolutionary conservation (Yoshida et al., 1997; Ichinose, 2012). CYP53 
members are involved in para-hydroxylation of benzoic acid and its derived phenolic 
compounds (Faber et al., 2001). The resultant phenolic compounds are then further 
metabolized and degraded via the -ketoadipate pathway (Harwood and Parales, 1996). 
Benzoic acid and its derived phenolic compounds naturally possess antifungal inhibitory 
properties (Amborabe et al., 2002; Podobnik et al., 2008). It is of great importance to study 
the three dimensional (3D) structure of a protein/enzyme, whereby information pertaining to 
highly conserved amino acid residues which interact with the substrate, often indicating 
structural and functional importance, is gained (Ashkenazy et al., 2010). Among different 
methods employed in understanding the protein structure, is 3D modelling also known as 
homology modelling. 3D modelling is gaining momentum due to its simplicity compared to 
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nuclear magnetic resonance (NMR) or X-ray crystallography. In this method, a 3D model of 
a protein is generated experimentally using a template usually a homologous protein whose 
structure has been elucidated via by crystallography. The 3D model of the protein generated 
helps us to understand the structure and function of the protein, its dynamics and its 
interaction with a ligand or substrate, especially in drug discovery and design, a core aspect 
of pharmaceutical research. There are no crystal structures available for CYP53 family 
members. Moreover, homology models for CYP53 members are few in number with the only 
available 3D model being that of CYP53A15 of Cochliobolus lunatus (Podobnik et al., 
2008).  
In Chapter 2 it was found that the ascomycete CYP53 members are highly conserved in 
terms of their primary structure and they can serve as common alternative drug target against 
pathogenic ascomycetes. In order to validate CYP53 as a common alternative drug target one 
should locate the positions of the conserved amino acid residues in the structure, as P450s 
have a typical three-dimensional fold where substrate recognition sites (SRS) play a key role 
in identification and catalysis of substrates (Gotoh, 1992; Podust et al., 2001). Furthermore, 
no thermostable P450 or its structure from the domain eukaryote has been reported to date. 
Biotechnologically, identification and characterization of thermostable eukaryoticP450s will 
have great potential. Especially, if the 3D model of CYP53 from a thermostable eukaryote 
could be constructed, whereby this will not only serve to validate the CYP53’s ability to 
serve as a common alternative drug target, but also provide useful information on factors 
contributing to thermostablity for eukaryotic P450s. Furthermore, analysis of the CYP53 
model from a thermostable eukaryote will help in engineering this P450 for the production of 
human valuables at an industrial scale. Considering the potential biotechnological importance 
as mentioned above, in this chapter , the main focus was 3D modelling of CYP53A from the 
thermophilic fungus Thielavia terrestris (an ascomycete) (Syed et al., 2014), followed by 
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identification of SRS regions and the active site cavity to map the conserved amino acid 
residues identified in Chapter 2.  
 
3.2. Materials and methods 
3.2.1. Homology modelling 
3D modelling of a CYP53 member P450 namely; CYP53A (protein ID: 2107910) from T. 
terrestris (Tter) was carried out using the methodology as previously described (Syed et al., 
2013), with minor modifications. The Basic Local Alignment Search Tool (BLAST) was 
used for selecting the closest homologues (template) available in the Protein Data Bank 
(PDB) (www.pdb.org). The best and closest homologue hit observed from the PDB, was that 
of the recently crystallized full-length P450 protein CYP51 from the species Saccharomyces 
cerevisiae (Monk et al., 2014). Therefore, the protein structure of the P450 from S. 
cerevisiae, CYP51 was used as a template (abbreviated as Scer). The coordinates of the 
crystal structures of CYP51 (PDB ID: 4LXJ) were used as templates to construct the models 
of CYP53A (Monk et al., 2014). 
The 3D model of CYP53A of Tter was generated using the homology modelling 
program Modeller 9v11 (Sali and Blundell, 1993). The modelling was performed with default 
parameters using the “allHmodel” protocol to include hydrogen atoms and the “HETATM” 
protocol to include prosthetic group HEM (heme). The 3D model accuracy was then 
validated using DFire (Zhou and Zhou, 2002), QMEAN (Benkert et al., 2011), and Verify3D 
(Lüthy et al., 1992). Heme-binding residues were identified using 3DLigandSite (Wass et al., 
2010). Structure alignment between the template and CYP53A of T. terrestris was performed 
using PROMALS3D (Pei et al., 2008). PROMALS3D aligns multiple protein sequences 
and/or structures, gathered from advanced database searches, secondary structure prediction, 
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3D structures or user-defined constraints and will give a conservation index (Pei and Grishin, 
2001). The conservation index follows numbers from 4 and above, where 9 is the most 
conserved amino acid across the sequences obtained (Pei and Grishin, 2001). P450 
characteristic secondary structure annotations and SRS in the modelled P450 were identified 
according to their alignment with the template P450 and standard SRS localization regions, as 
described in the literature (Gotoh, 1992; Podust et al., 2001). Protein models were visualized 
using PyMOL Molecular Graphics System, Version 1.7.1.1. Schrödinger, LLC 
(http://www.pymol.org/). The models of CYP53A from Tter and the template of CYP51 from 
S. cerevisiae (4LXJ) were then presented as a figure. 
 
3.2.2. Active site residue mapping 
CASTp programme was used to identify the amino acid residues lining the active site cavity 
of CYP53A Tter (Dundas et al., 2006). CYP53A Tter in this study was used as a 
representative of all ascomycetes. The protein active site cavity in the 3D-model of CYP53A 
of Tter, generated in this study, was also predicted using CASTp programme (Dundas et al., 
2006). The cavity showing the highest volume and covering the most SRS regions was 
selected, whereby the program automatically listed the residues lining the active site. The 
active site cavity structure and the residues lining the cavity were then presented as a figure 
using PyMOL Molecular Graphics System, Version 1.7.1.1. Schrödinger, LLC 
(http://www.pymol.org/). 
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3.3. Results and discussion 
3.3.1. Homology modelling 
To date P450s belonging to CYP53 members have not been crystallized. A study from 
Podobnik et al. 2008, resulted in the modelling of CYP53A15 from C. lunatus and further 
identification of amino acid residues involved in substrate binding (Podobnik et al., 2008). 
Since the CYP53A15 model was constructed, many other P450 crystal structures have been 
resolved. Therefore, the best template could be selected for, given the appropriate 
opportunity. In the present study a CYP53 member was selected, CYP53A from T. terrestris 
that was recently identified and characterized as a representative of ascomycete CYP53 
P450s (Syed et al., 2014).  
To identify the role of amino acids conserved as observed for ascomycete CYP53 
members (Chapter 2), CYP53 homology modelling studies was performed to map these 
conserved/variant residue locations in the protein structure. In the present study, CYP53A 
from T. terrestris was selected as a representative of ascomycetes CYP53 P450s. The 3D-
model of the CYP53 P450 (Figure 3.1) was constructed and validated as described in 
materials and methods. As shown in Table 3.1 all the parameters employed in assessing the 
quality of the model were favourable suggesting that the model of the CYP53 P450 was of 
good quality. 
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Figure 3.1. Structural analysis of CYP53A Tter. The 3D-model for CYP53A from 
T. terrestris (CYP53 Tter) was constructed based on the template CYP51 from S. cerevisiae 
(CYP51 Scer) (PDB ID: 4LXJ) from PDB Data Bank (www.pdb.org). The heme prosthetic 
group is shown in black colour and the bound substrate for CYP51 Scer in green colour. 
Alpha-helices and beta-strands are shown with blue and red. The membrane helix (MH) and 
the trans-membrane helix (TMH) are indicated in the models.  
CYP51 Scer CYP53 Tter 
 
 
 
 
 
 
 
 
 
 
Table 3.1. Validation of CYP53A Tter 3D-model. The CYP53A Tter model was based on 
the template CYP51 (PDB ID: 4LXJ) from S. cerevisiae and was generated using Modeller.  
 
CYP 
name
a
 
Sequence 
Identity 
(%)
b
 
Length
c
 Coverage
c
 
(%) 
dDFIRE
d
 DFIRE2d
d
 QMEAN6 
score
e
 
Average 
Verify3D score 
 SDf 
 
CYP53A 
Tter 
16 510 100% -1101.04 -849.785 0.57 0.23  0.22 
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Table notes: 
a 
CYP53A Tter was based on the template CYP51 (lanosterol 14α-demethylase) (PDB ID: 
4LXJ) from Saccharomyces cerevisiae and was generated using Modeller (Monk et al., 
2014).  
b
 Sequence identity between CYP53A Tter and the template CYP51 (PDB ID: 4LXJ). 
c
 Number of P450s amino acids modelled and their percentage compared to the full-length 
P450s.  
d 
dDFire and DFIRE2 pseudo-energy (lower values signify a better model) (Zhou and Zhou, 
2002). 
e
 QMEAN6 composite score ranging from 0 to 1 (higher values signify a better model) 
(Benkert et al., 2011).  
f
 Verify3D scores ranges from -1 (bad score) to +1 (good score) (Lüthy et al., 1992). This 
program analyses the compatibility of an atomic model (3D) with its own amino acid 
sequence (1D). 
 
3.3.2. Secondary structure analysis of CYP53A Tter 
As shown in Figure 3.1, CYP53A Tter showed all P450 motifs in the same way as CYP51 of 
S. cerevisiae (Monk et al., 2014). An interesting observation was that although CYP51 
possessed both a membrane helix (MH) and transmembrane helix (TMH), only the 
transmembrane helix was seen in CYP53A Tter (Figure 3.1). This suggests that CYP53A 
Tter is a biotopic membrane protein with one transmembrane helix. Structural alignment 
between CYP53A Tter and CYP51 (4LXJ) Scer was performed using PROMALS3D. A 
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detailed secondary structure analysis including heme-binding residues, substrate binding 
residues and substrate recognition sites (SRS) namely, SRS1 to SRS6 is shown in Figure 3.2. 
 
 
 
Figure 3.2. Secondary structure analysis of CYP53A Tter and CYP51 (4LXJ). P450 
characteristic notations for alpha helices (shown in red font) and beta-strands (shown in blue 
font) with SRS regions mapped as per the template (4LXJ) (Gotoh, 1992; Podust et al., 2001; 
Monk et al., 2014). Highlighted amino acid residues in green and turquoise appear in contact 
with the heme and substrate. 
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3.3.3. Active site cavity and its amino acid residues identification  
Active site cavity and the identification of amino acids lining the active site were performed 
using the model generated (CYP53A Tter) in this study. The aim of active site cavity 
mapping of conserved amino acid residues is to investigate how many of these conserved 
residues fall in active site cavity. The active site cavity and its amino acids were shown in 
Figure 3.3. Furthermore, the number of conserved amino acids present in the active site 
cavity is also estimated and their percent is shown in Table 3.2. As shown in Figure 3.2, 
CYP53A Tter a member of ascomycetes possesses conserved amino acid residues throughout 
the protein structure, at P450 signature motifs such as EXXR and CXG. CASTp was used to 
understand how many of these conserved amino acids are part of the active site cavity of 
CYP53A Tter (Figure 3.3 and Table 3.2) (Dundas et al., 2006). 
 
 
Figure 3.3. CYP53A Tter active site cavity mapping and analysis of the nature of the 
active site amino acids. Left-hand side: Mapped active site cavity (space filled) with the 
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protein backbone presented in line style; Right-hand side: A figure of the conserved residues 
lining the cavity mapping. Different colours correspond to their conservation index, 9 
(conserved residues) – red, conservation index 7 – blue, conservation index 6 – cyan, 
conservation index 5 – green and residues with no conservation index – grey. The heme 
group is shown in grey dots.  
 
Table 3.2. Analysis of amino acid conservation in CYP53A Tter active site cavity. Active 
site cavity residues were identified using CASTp (Figure 3.3) (Dundas et al., 2006). 
Conservation of amino acid residues in ascomycete species CYP53 P450s was identified 
using PROMALS3D (Pei et al., 2008). Conservation index 9 means amino acid is conserved. 
CYP53A Tter P450 amino acids and their numbering are presented in the table.  
Conservation 
index 
Amino acids Number 
of Amino 
acids 
Percentage (%) 
contribution in 
active site cavity 
9 R76, P79, G99, L101, K102, Y106, 
F117, R120, R122, H125, R129, F136, 
L192, P241, E311, T314, A318, T322, 
L370, S382, G387, L388, P389, 
R390,G409, S413, F449, P451, F452, 
C459, G461, R462, A465, E466, K498 
35 28 
7 L51, H81, N98, L116, N118, 
V132,V188, I189, L227, A235, T236, 
L243, L288, L313, G319, D321, 
N325, S326, V364, L378, P393, 
G398, V399, P408, V411, L412, 
S453, R457, A458, M467, E468, 
G494 
32 26 
6 Q78, R365, V392, F406, V464, M469 6 5 
5 F100, D104, F105, S111, T119, F144, 
I148, A193, A221, A223, I224, I226, 
N228, E232, A310, Q315, I317, S320, 
T323, V374, T383, G385, V460, L496 
24 19 
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As shown in Figure 3.3 and Table 3.2, there are 125 amino acids lining the active site 
cavity, with 35 (28%) that are conserved (conservation index 9) and 62 amino acid residues 
(50%) that are moderately conserved (conservation index 5-7) across the CYP53 members of 
ascomycetes. Overall, the high conservation of amino acids (78%) in the active site cavity 
and in the rest of the protein structure (Figure 3.3) strongly suggests that the active site cavity 
and overall structure of CYP53 members of ascomycete species are highly conserved. 
Considering the structural conservation, any inhibitor developed against one of the CYP53 
members could possibly act as common inhibitor against CYP53 members of ascomycete 
species and hence could act as a common anti-fungal (towards pathogenic ascomycetes) 
agent. Future studies include use of the 3D model of CYP53 Tter to identify factors 
responsible for thermostability of this eukaryotic P450.  
 
3.4. Conclusion 
In this study, structural analysis of CYP53A from Thielavia terrestris (Tter) was performed. 
The 3D model of CYP53A Tter generated in this study was found to be of high-quality after 
it was validated using appropriate parameters. Secondary structure analysis revealed that 
CYP53A Tter is a biotopic membrane protein, whereby one transmembrane helix transverses 
the phospholipid bilayer joining two domains within the membrane (Zviling et al., 2007). It 
was also found that 125 amino acid residues lining the active site cavity of CYP53A Tter 
None N48, W49, L52, R57, Y61, V74, 
S103, I112, L152, A185, I219, E225, 
I239, L240, Q242, S371, N375, S384, 
I386, E391, R394, Q397, P407, 
T410,K470, L471, R492, F495 
28 22 
Total  125 100 
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protein, whereby 78% of these amino acids are highly conserved. Due to the highly 
conserved nature of the amino acids lining the active site cavity of CYP53A Tter, results 
from active site residue mapping suggest that any inhibitor developed for this family, could 
act against a wide range of animal and plant pathogenic ascomycetes. Therefore, based on the 
3D model generated, CYP53 family members can act as a potential anti-fungal drug target. 
CYP53A Tter model developed in this study will be used to identify factors responsible for 
thermostability of eukaryotic P450.  
Currently, immune-compromised individuals with HIV (Human Immunodeficiency 
Virus) or those who are on treatment with immuno-suppressant drugs such as transplant 
recipients and cancer  patients, are at a high risk of invasive fungal infections (Berne et al., 
2012). Unfortunately, most azole inhibitors developed have been derived from fungal 
CYP51, which not only target fungal CYP51 enzymes but also those from mammals that 
catalyze xenobiotic compounds leading to toxicity and adverse side effects in patients (Berne 
et al., 2012). Therefore, CYP53 could be a promising novel therapeutic drug target due to its 
potential high substrate specificity and also because no homologs present in mammals (Berne 
et al., 2012). 
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CHAPTER 4 
STRUCTURAL ANALYSIS OF CYTOCHROME P450 
REDUCTASE (CPR) FROM THE THERMOPHILIC 
FUNGUS THIELAVIA TERRESTRIS 
4.1. Introduction  
Thielavia terrestris, is a sedentary and thermophilic organism. Like many other fungal 
species, T. terrestris is also dependent on innate metabolic processes to thrive in the 
environment (Lah et al., 2008). Recent studies on recombinant enzymes involving biomass-
hydyolyzing activity suggests that T. terrestris is one of the most efficient thermophilic 
fungal organisms to be used for biomass decomposition from moderate to high temperatures 
(Berka et al., 2011). In such complex biochemical activities, cytochrome P450 proteins have 
a critical function to perform, mainly in primary and secondary metabolic processes 
(Bernhardt, 2006). Most microsomal P450 systems in eukaryotic organisms consist of a P450 
and one or more redox partners (Yadav and Loper, 2000; Denisov et al., 2005). NADPH-
dependent cytochrome P450 oxidoreductase or cytochrome P450 reductase (CPR) (EC 
1.6.2.4; CPR), is a diflavin reductase protein that serves as an electron donor to numerous 
P450s (Yadav and Loper, 2000). The number of CPRs present in ascomycetes ranges from 
one to four (Lah et al., 2008).  
In Chapter 1 of this thesis, different types of CPR classes were explored, indicating 
that CPRs are involved in electron transfer during diverse catalytic reactions (Denisov et al., 
2005). Electrons are transferred in a specific trajectory from NADPH (nicotinamide adenine 
dinucleotide phosphate) to FAD (flavin adenine dinucleotide) to FMN (flavin 
mononucleotide) and finally to the heme group in the P450 enzyme (Yadav and Loper, 2000). 
© Central University of Technology, Free State
CHAPTER 4: STRUCTURAL ANALYSIS OF CPR FROM THIELAVIA TERRESTRIS 
113 
 
Co-regulation of both the P450 and CPR has been suggested to play an essential role in 
achieving optimized P450 activity (Sutter et al., 1990; van den Brink et al., 1996; Ohkuma et 
al., 1995). According to Lah et al., (2008) most studies conducted on CPR: P450 systems, 
give more focus to P450s and not on the redox partner due to P450s, having more diversity 
compared to their reductase counterparts that are perceived as extremely conserved and fully 
characterized in terms of functionality (Lah et al., 2008). However, the question lies in the 
fact, is the structure of CPR similar in all organisms? If not, how do these structures differ in 
terms of the environment or conditions the organism is exposed to? To understand the 
function of a protein, it is important to study the structure of the protein, hence only then can 
the true function of the protein be known. Currently, there are no crystal structures and 3D 
homology models that exist that give a better indication of the structure of CPR in 
thermophilic fungi (Table 4.1.). 
 
Table 4.1. Information on crystal structures of cytochrome P450 reductases from the 
Protein Data Bank (www.pdb.org). Few crystal structures exist that provide us with insight 
into the mechanisms of CPR activity. From the table it can be observed that CPR from 
eukaryotic organisms have been characterized. 
CPR Species Ligand(s) Literature 
NADPH Cytochrome 
P450 (Oxidoreductase) 
Rattus norvegicus FMN, FAD and NADPH Wang et al., 1997; 
Hamdane et al., 2009; 
Hubbard et al., 2014; Xia 
et al., 2011 
Polyketone reductase 
(CPR-C2) 
Candida parapsilosis NADPH Qin et al., 2014 
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Polyketone reductase 
(CPR-C1) 
Candida parapsilosis NADPH Qin et al., 2013 
Oxidoreductase Homo sapiens FMN Zhao et al., 1999 
NADPH Cytochrome 
P450 (reductase) 
Saccharomyces 
cerevisiae 
FMN, FAD and NADPH Lamb et al., 2006 
NADPH Cytochrome 
P450 
Homo sapiens FAD, NADPH Xia et al., 2011(a), (b) 
 
Thermophilic fungi possess an array of thermostable enzymes that can be used in 
future for the production of human valuable goods at elevated temperatures in the form of 
cell factories, and as such serve as potential and indispensable biotechnological reservoirs 
(Berka et al., 2011). In this study, the first report on structural analysis of CPR from the 
thermophilic fungus and ascomycete T. terrestris is described, and is therefore a critical step 
in the molecular characterization of thermophilic P450 systems in T. terrestris. Moreover, in 
expanding the knowledge pertaining to structural analysis on thermophilic fungi, this will 
also enable us to understand the function of this protein for future studies, especially P450 
monooxygenation mechanisms and metabolic manipulations in T. terrestris and other 
thermophilic fungi. 
4.2. Materials and Methods 
4.2.1. Selection of template 
In order to build T. terrestris CPR (protein ID: 2115296) 3D model, a template (protein 
whose crystal structure has been elucidated) needed to be identified. Basic Local Alignment 
Search Tool (BLAST) search was performed to select the crystal structure of the closest 
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homolog available in the Protein Data Bank (PDB) (www.pdb.org). The protein that showed 
highest percent identity was selected as a template for construction of CPR Tter model.  
 
4.2.2. Homology modelling and 3D model validation 
The 3D model of CPR Tter was generated using the homology modelling program 
Modeller 9v11 (Sali and Blundell, 1993). The Ramachandran’s map using PROCHECK 
(Programs to Check the Stereo Chemical Quality of Protein Structures) (Laskowski et al., 
1993), and ERRAT graphs (Colovos and Yeates, 1993) were used to analyse the final 
structure of CPR Tter. ERRAT assesses the distribution of different types of atoms with 
respect to one another in the protein model. The WHAT IF program was used to analyse and 
also identify residue packing and atomic contact for the detection of bad packing of side 
chain atoms or unusual residue contacts (Vriend, 1990). The Z-score of Ramachandran’s plot 
was predicted using the WHAT_CHECK software (Hooft et al., 1996).  
The quality and accuracy of 3D model was then validated and carefully examined using 
available bioinformatics software: DFire (Zhou and Zhou, 2002), QMEAN (Benkert et al., 
2011), and Verify3D (Lüthy et al., 1992). The protein models generated was visualized using 
YASARA program (http://www.yasara.org/) (Krieger, 2004).  
 
4.2.3. Active site identification and ligand docking 
The 3D model was used for the identification of active sites and for the docking of ligand 
residues (FMN, FAD and NADPH). The active site was predicted using an alpha shape 
algorithm to determine potential active sites in 3D protein structures in MOE site finder 
(Edelsbrunner et al., 1995). Docking studies against the CPR was performed using dock 
module implemented in MOE2012 (Eldridge et al., 1997). 
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4.3. Results and Discussion 
To date CPR belonging to thermophilic eukaryotes has not been crystallized or modelled. 
Structural analysis of CPR from thermophilic eukaryotes is necessary in order to understand 
the molecular basis of thermostablity of this protein. Furthermore, if eukaryotic P450s could 
be utilized at an industrial scale they need a thermostable electronic partner which is CPR. As 
discussed in Chapter 1, a study revealed the presence of a large number of thermostable 
P450s in T. terrestris (Syed et al., 2014b). Considering the thermophilic nature of this fungi 
and the presence of a large number of thermostable P450s, it is reasonable to predict that 
CPR from this fungus could be thermostable. Characterization of CPR from T. terrestris 
(CPR Tter) will pave the way for further utilization of this protein towards the generation of 
human valuable  products. In this study, bioinformatics programs were used to understand its 
structural properties. This study marks the beginning of our understanding of CPR from 
thermophilic organisms. 
4.3.1. CPR Tter modelling and 3D model validation 
The 3D model of the CPR Tter (Figure 4.1) was constructed based on the template 
cytochrome P450 reductase (2BPO) from S. cerevisiae (Scer) (Figure 4.1). The S. cerevisiae 
CPR is the top hit during BLAST analysis at PDB. This indicates that this yeast CPR can 
serve as the best template for the modelling of CPR Tter due to its high percent identity. The 
3D model of CPR Tter was constructed using Modeller programme as described in materials 
and methods. Validation of the CPR Tter model was performed as described in materials and 
methods. As shown in Table 4.2 all the parameters employed in assessing the quality of the 
model were favourable suggesting that the model of CPR Tter was of good quality. 
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Figure 4.1. Three dimensional structure of cytochrome P450 reductase from T. 
terrestris. Three dimensional structure of the reductase was generated with Modeller as 
described in materials and methods. Alpha helices are represented in red and beta sheets are 
in yellow colour. FAD is represented in magenta, FMN is represented in green and NAP is 
represented in orange colour. 
 
Table 4.2. Validation of CPR Tter 3D-model.  
Cytochrome 
P450 
Reductase 
(CPR) 
name
a
 
Sequence 
Identity 
(%)
b
 
Length
c
 Coverage
c
 
(%)  
dDFIRE
d
 DFIRE2d
d
 QMEAN6 
score
e
 
Average 
Verify3D 
score SDf 
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Table notes: 
a
CPR Tter was based on the template CPR (PDB ID: 2BPO) from Saccharomyces cerevisiae 
and was generated using Modeller (Yermalitskaya et al., 2006).  
b
 Sequence identity between CPR Tter and the template CPR Scer (PDB ID: 2BPO). 
c
 Number of P450s amino acids modelled and their percentage compared to the full-length 
P450s.  
d
dDFire and DFIRE2 pseudo-energy (lower values signify a better model) (Zhou and Zhou, 
2002). 
e
 QMEAN6 composite score ranging from 0 to 1 (higher values signify a better model) 
(Benkert et al., 2011).  
f
 Verify3D scores ranges from -1 (bad score) to +1 (good score) (Lüthy et al., 1992). This 
program analyses the compatibility of an atomic model (3D) with its own amino acid 
sequence (1D). 
4.3.2. Comparative structural analysis of CPR Tter and CPR Scer  
Comparative analysis of 3D model of CPR Tter with CPR Scer (2BPO) revealed 
conservation of structural features between both CPRs. (Figure 4.2). As shown in Figure 4.2 
CPR Tter showed all features present in CPR Scer except few differences in the structure. 
Some of the regions present in CPR Scer (yellow coloured regions in Figure 4.2) are absent 
in CRP Tter. Compared to CPR Scer, a small extra loop was present in CRP Tter (Figure 
4.2). Overall, CPR Tter showed all features that are characteristic of CPR proteins.  
CPR Tter 43 551 91% -1144.90 -904.063 0.609 0.36 ± 0.24 
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Figure 4.2. Superimposition of CPR Tter with the template (CPR Scer) generated using MOE 
software. CPR Tter is represented in blue and CPR Scer is represented in red. Extra regions 
of the CPR Scer and the CPR Tter are represented in yellow and green colours. 
 
4.3.3. Identification of amino acids binding to cofactors in CPR Tter 
The main role of CPR is to transfer electrons to the P450. In order to perform this electron 
transfer CPR should accept electrons from its electron donors and then transfer electrons to 
the P450. CPR performs this action with the help of cofactors. The characterized CPRs such 
as CPR Scer showed presence of two FMN and one FAD as prosthetic groups and it can bind 
one NADPH molecule (electron donor) (Yermalitskaya et al., 2006). In order to unravel the 
nature of cofactors and amino acids responsible to bind these cofactors ligand docking study 
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was carried out as described in materials and methods. Ligands (FMN, FAD and NADPH) 
were docked in the CPR Tter model (Figure 4.3).  
As shown in figure 4.3, CPR Tter showed that it was capable of binding to two 
molecules of FMN, one molecule of FAD and one molecule of NADPH. The binding of a 
number of cofactors by CPR Tter is consistent with reported CPRs where authors suggested 
CPRs binds two molecules of FMN simultaneously (Lamb et al., 2006). The amino acids 
involved in binding of these cofactors (Figure 4.2) are conserved in CPR Tter when 
compared to the amino acids from different CPRs (Lamb et al., 2006). Overall, CPR Tter 
showed characteristic structure and cofactors of other CPRs (Lamb et al., 2006) indicating it 
is capable of transferring electrons to P450s. Future studies involves cloning, expression and 
functional analysis of CPR Tter, where its capability to transfer electrons to P450s will be 
assessed.  
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Figure 4.3. Ligand protein interactions of FAD (top left panel), FMN (top right panel), FMN 
(bottom left) and NAP(D) (bottom right panel) with the CPR Tter predicted using MOE 
software. Amino acids with potential to interact with ligands were shown in the figure. 
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4.4. Conclusion 
In this study, structural analysis of cytochrome P450 reductase from T. terrestris (CPR Tter) 
was performed using homology modelling and ligand docking. The 3D model of CPR Tter 
was constructed based on the template (CPR from S. cerevisiae). 3D model validation and 
examination was performed using bioinformatics tools to assess the protein model using 
specific parameters, which revealed that the model was of a good quality. Comparative 
analysis and ligand docking studies revealed conservation of characteristic features of CPRs 
in CPR Tter. In future studies CPR Tter will be functionally characterized and its 
thermostablity will be assessed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© Central University of Technology, Free State
CHAPTER 4: STRUCTURAL ANALYSIS OF CPR FROM THIELAVIA TERRESTRIS 
123 
 
REFERENCES 
Benkert, P; Biasini, M; Schwede, T. (2011). Toward the estimation of the absolute quality of 
individual protein structure models. Bioinformatics, 27(3): 343–350. 
Berka, R. M., Grigoriev, I.V., Otillar, R., Salamov, A., Grimwood, J., Reid, I., Ishmael, N., 
John, T., Darmond, C., Moisan, M., Henrissat, B., Coutinho, P. M., Lombard, V., Natvig, D. 
O., Lindquist, E., Schmutz, J., Lucas, S., Harris, P., Powlowski, J., Bellemare, A., Taylor, D., 
Butler, G., de Vries, R. P., Allijn, I. E., van den Brink, J., Ushinsky, S., Storms, R., Powell, 
A. J., Paulsen, I. T., Elbourne, L. D H., Baker, S. E., Magnuson, J., LaBoissiere, S., 
Clutterbuck, A. J., Martinez, D., Wogulis, M., Lόpez de Léon, A., Rey, M. W., Tsang, A. 
(2011). Comparative genomic analysis of the thermophilic biomass-degrading fungi 
Myceliophthora thermophila and Thielavia terrestris. Nature biotechnology, 29(10), 922-927. 
Berman, H.M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T.N., Weissig, H., Shindyalov, 
I.N., Bourne, P.E. (2000). The Protein Data Bank. Nucleic Acids Research, 28(1): 235-242. 
Bernhardt, R. (2006). Cytochromes P450 as versatile biocatalysts. J Biotechnol., 124(1): 128-
145. 
Chemical Computing Group Inc. Molecular Operating Environment (MOE). 2008. Available 
at: http://www.chemcomp.com/. [Accessed: 21st April 2015]. 
Colovos, C., Yeates, T. O. (1993). Verification of protein structures: patterns of non-bonded 
atomic interactions. Protein Science, 2(9), 1511-1519.  
Denisov, I. G., Makris T. M., Sligar , S. G., Schlichting, I. (2005). Structure and Chemistry of 
Cytochrome P450. Chem. Rev., 105: 2253-2277. 
© Central University of Technology, Free State
CHAPTER 4: STRUCTURAL ANALYSIS OF CPR FROM THIELAVIA TERRESTRIS 
124 
 
Edelsbrunner, H., Facello, M., Fu, P., Liang, J. (1995). Measuring proteins and voids in 
proteins. In System Sciences, Proceedings of the Twenty-Eighth Hawaii International 
Conference, 5: 256-264.  
Eldridge, M. D., Murray, C. W., Auton, T. R., Paolini, G. V., Mee, R. P. (1997). Empirical 
scoring functions: I. The development of a fast empirical scoring function to estimate the 
binding affinity of ligands in receptor complexes. Journal of computer-aided molecular 
design, 11(5): 425-445. 
Hamdane, D., Xia, C., Im, S. C., Zhang, H., Kim, J. J. P., Waskell, L. (2009). Structure and 
function of an NADPH-cytochrome P450 oxidoreductase in an open conformation capable of 
reducing cytochrome P450. Journal of Biological Chemistry, 284(17), 11374-11384. 
Hooft, R. W., Vriend, G., Sander, C., Abola, E. E. (1996). Errors in protein structures. 
Nature, 381(6580), 272-272.  
Hubbard, P. A., Shen, A. L., Paschke, R., Kasper, C. B., Kim, J. J. P. (2001). NADPH-
cytochrome P450 oxidoreductase structural basis for hydride and electron transfer. Journal of 
Biological Chemistry, 276(31), 29163-29170. 
Krieger, E. 2004. Yet Another Scientific Artificial Reality Application (YASARA). 
Available at: http://www.yasara.org/. [Accessed: 27th April 2015]. 
Lah, L., Kraševec, N., Trontelj, P., Komel, R. (2008). High diversity and complex evolution 
of fungal cytochrome P450 reductase: cytochrome P450 systems. Fungal Genetics and 
Biology, 45(4), 446-458. 
Lamb, D.C., Kim, Y., Yermalitskaya, L.V., Yermalitsky, V.N., Lepesheva, G.I., Kelly, S.L., 
Waterman, M.R., Podust, L.M. (2006). A second FMN binding site in yeast NADPH-
© Central University of Technology, Free State
CHAPTER 4: STRUCTURAL ANALYSIS OF CPR FROM THIELAVIA TERRESTRIS 
125 
 
cytochrome P450 reductase suggests a mechanism of electron transfer by diflavin reductases. 
Structure, 14(1), 51-61. 
Laskowski, R. A., MacArthur, M. W., Moss, D. S., Thornton, J. M. (1993). PROCHECK: a 
program to check the stereochemical quality of protein structures. Journal of applied 
crystallography, 26(2), 283-291.  
Lüthy, R., Bowie, J.U., Eisenberg, D.R. (1992). Assessment of protein models with three-
dimensional profiles. Nature, 356 (6364): 83– 85. 
Ohkuma, M., Masuda, Y., Mee Park, S., Ohtomo, R., Ohta, A., Takagi, M. (1995). Evidence 
that the expression of the gene for NADPH-cytochrome P-450 reductase is n-alkane-
inducible in Candida maltosa. Bioscience, biotechnology, and biochemistry, 59(7), 1328-
1330. 
Qin, H.-M., Yamamura, A., Miyakawa, T., Kataoka, M., Maruoka, S., Ohtsuka, J., Nagata, 
K., Shimizu, S., Tanokura, M. (2013). Crystal structure of conjugated polyketone reductase 
(CPR-C1) from Candida parapsilosis IFO 0708 complexed with NADPH. Proteins: 
Structure, Function, and Bioinformatics, 81(11), 2059-2063. 
Qin, H.-M., Yamamura, A., Miyakawa, T., Kataoka, M., Nagai, T., Kitamura, N., Urano, N., 
Maruoka, S., Ohtsuka, J., Nagata, K., Shimizu, S., Tanokura, M. (2014). Structure of 
conjugated polyketone reductase from Candida parapsilosis IFO 0708 reveals conformational 
changes for substrate recognition upon NADPH binding. Applied microbiology and 
biotechnology, 98(1), 243-249. 
Sali, A., Blundell, T.L. (1993). Comparative protein modelling by satisfaction of spatial 
restraints. J Mol Biol., 234(3): 779-815. 
© Central University of Technology, Free State
CHAPTER 4: STRUCTURAL ANALYSIS OF CPR FROM THIELAVIA TERRESTRIS 
126 
 
Sutter, T. R., Sanglard, D., Loper, J. C., Sangard, D. (1990). Isolation and characterization of 
the alkane-inducible NADPH-cytochrome P-450 oxidoreductase gene from Candida 
tropicalis. Identification of invariant residues within similar amino acid sequences of 
divergent flavoproteins. Journal of Biological Chemistry, 265(27), 16428-16436. 
Syed, K., Porollo, A., Lam, Y.W., Grimmett, P.E., Yadav, J.S. (2013) CYP63A2, a 
catalytically versatile fungal P450 monooxygenase capable of oxidizing higher-molecular-
weight polycyclic aromatic hydrocarbons, alkylphenols, and alkanes. Appl Environ 
Microbiol., 79(8): 2692–702.  
van der Brink, J. M., Van Den Hondel, C. A. M. J. J., Van Gorcom, R. F. M. (1996). 
Optimization of the benzoate-inducible benzoate p-hydroxylase cytochrome P450 enzyme 
system in Aspergillus niger. Applied microbiology and biotechnology, 46(4), 360-364. 
Vriend, G. (1990). WHAT IF: a molecular modeling and drug design program. Journal of 
molecular graphics, 8(1), 52-56. 
Wang, M., Roberts, D. L., Paschke, R., Shea, T. M., Masters, B. S. S., Kim, J. J. P. (1997). 
Three-dimensional structure of NADPH–cytochrome P450 reductase: prototype for FMN-and 
FAD-containing enzymes. Proceedings of the National Academy of Sciences, 94(16), 8411-
8416. 
Xia, C., Hamdane, D., Shen, A.L., Choi, V., Kasper, C.B., Pearl, N.M., Zhang, H., Im, S.C., 
Waskell, L., Kim, J.J. (2011a). Conformational changes of NADPH-cytochrome P450 
oxidoreductase are essential for catalysis and cofactor binding. Journal of Biological 
Chemistry, 286(18), 16246-16260. 
© Central University of Technology, Free State
CHAPTER 4: STRUCTURAL ANALYSIS OF CPR FROM THIELAVIA TERRESTRIS 
127 
 
Xia, C., Panda, S. P., Marohnic, C. C., Martásek, P., Masters, B. S., Kim, J. J. P. (2011b). 
Structural basis for human NADPH-cytochrome P450 oxidoreductase deficiency. 
Proceedings of the National Academy of Sciences, 108(33), 13486-13491. 
Yadav, J. S., Loper, J. C. (2000). Cytochrome P450 oxidoreductase gene and its differentially 
terminated cDNAs from the white rot fungus Phanerochaete chrysosporium. Current 
genetics, 37(1), 65-73. 
Yermalitskaya, L.V., Kim, Y., Waterman, M.R., Podust, L.M. (2006). Crystal Structure of 
the Yeast Cpr Triple Mutant: D74G, Y75F, K78A. PDB ID: 2BPO. Available at: Accessed 
http://www.rcsb.org/pdb/explore/explore.do?structureId=2bpo. [Accessed: 19th April 2015]. 
Zhao, Q., Modi, S., Smith, G., Paine, M., McDonagh, P.D., Wolf, C.R., Tew, D., Lian, L.Y., 
Roberts, G.C., Driessen, H.P. (1999). Crystal structure of the FMN-binding domain of human 
cytochrome P450 reductase at 1.93 [Angstrom capital A, ring] resolution. Protein science, 
8(02), 298-306. 
Zhou, H., Zhou, Y. (2002). Distance-scaled, finite ideal-gas reference state improves 
structure-derived potentials of mean force for structure selection and stability prediction. 
Protein Sci., 11(11):2714 –2726. 
 
 
© Central University of Technology, Free State
CHAPTER 5: CONCLUSION 
128 
 
CHAPTER 5 
CONCLUSION 
Cytochrome P450 monooxygenases, indeed have remarkable catalytic activity and varied 
substrate recognition, whereby the capabilities of these enzymes as biocatalysts have been 
encouraged for the synthesis and production of biotechnological products for human 
utilization. However, P450s have limitations, which include thermal and chemical, as well as 
in vitro instability. Currently, there is on-going research that aims at exploring and 
identifying more robust and alternative P450s that would highly adapt and be able to survive 
extreme industrial conditions and that would also be stable in vivo. Apart from 
biotechnological importance, P450s have been utilized as drug target against pathogens. 
However, study revealed that pathogens are developing resistance and novel drugs targets 
need to be identified such that cross-reactions or adverse effects in humans can also be 
minimized.  
This study focused on CYP53 family in fungi. The role of this P450 family as a 
common alternative anti-fungal drug target has been evaluated. Furthermore, structural 
aspects of CYP53A and its redox partner, cytochrome P450 reductase (CPR), from the 
thermophilic fungus Thielavia terrestris have been elucidated. This study marks the 
beginning of our understating on thermostable P450s from eukaryotes. 
CYP53A and CPR from T. terrestris (Tter) have been structurally characterized in 
this study. Prior to 3D structural analysis, phylogenetic analysis of CYP53 members was 
performed across the fungal phyla to explore the role of a P450 family (CYP53) in serving as 
a common drug target against pathogenic ascomycetes and in basidiomycetes, in terms of the 
wood-degradation process. CYP53A Tter is a member of Ascomycota, and like the CYP53 
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family, is involved in the detoxification of the toxic molecule benzoate. Phylogenetic findings 
suggested and revealed that this P450 family could serve as a potential common anti-fungal 
drug target against ascomycete pathogens, because the primary protein structure and gene-
structure organization of CYP53 is highly conserved. Furthermore, it was also identified that 
CYP53 P450s can play a supplementary function in basidiomycetes in the generation of the 
wood-degrading oxidant, veratryl alcohol, and degradation of other wood-derived 
compounds. It was suggested that this additional role of basidiomycetes seems to have taken 
place due to extensive duplication of CYP53 members in their genomes (paralogous 
evolution). During gene duplication, widespread changes in the primary protein structure 
ensued to enhance/acquire novel functions for the enrichment of the protein, such as wood 
degradation. 
3D protein modelling and appropriate 3D protein structure validation was conducted 
for both CYP53A and CPR. This study was the first report on structural analysis of CPR and 
CYP53A from T. terrestris. Validation results for 3D models of CYP53A and CPR indicated 
that the protein models were of high quality. Structure analysis indicated that CYP53A Tter is 
a biotopic membrane protein. During active site cavity mapping, it was found that 125 amino 
acid residues lining the active site cavity of CYP53 members, where 78% of the amino acids 
present are highly conserved. Owing to the fact that the lining of the active site residue of 
CYP53 members (CYP53A Tter used as model P450) is of a highly conserved nature, this 
suggests that any inhibitor designed for this particular family, could act as common drug 
target against animal and plant pathogenic ascomycetes.  
Currently, immune-compromised individuals with HIV (Human Immunodeficiency 
Virus) or on treatment with immune-suppressive drugs are at a high risk of invasive and 
opportunistic fungal infections. Unfortunately, most azole inhibitors developed have been 
derived from fungal CYP51, which targets fungal and mammalian CYP51 enzymes. Due to 
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the presence of azole inhibitors, in vivo, xenobiotic compounds are also being metabolised 
leading to toxicity and adverse side effects in such patients such as anaphylaxis. Moreover, 
due to the prolonged use of azole inhibitors from CYP51, patients develop drug resistance. 
Therefore, other fungal drug inhibitors need to be identified to circumvent these major 
medical dilemmas. Therefore, CYP53 could be a promising novel therapeutic drug target due 
to its potential high substrate specificity and it also does not share any homologs in mammals.  
Structural analysis of CPR from T. terrestris revealed conservation of basic features 
of CPR proteins in this redox partner as well. Molecular docking analysis of CPR model 
revealed amino acids responsible for binding of co-factors such as FMN, FAD and NADPH. 
Overall, this is first report on structural analysis of CPR from a thermostable eukaryote. The 
structure of CYP53A and CPR from T. terrestris forms the basis for future study focusing on 
unravelling the factors responsible for thermostability of an eukaryote P450 and their 
characterization towards use of these enzymes for production of human valuable chemicals at 
an industrial scale.  
© Central University of Technology, Free State
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Abstract
Cytochrome P450 monooxygenases (CYPs/P450s) are heme-thiolate proteins whose role as a drug target against
pathogenic microbes has been explored because of their stereo- and regio-specific oxidation activity. We aimed to assess
the CYP53 family’s role as a common alternative drug target against animal (including human) and plant pathogenic fungi
and its role in fungal-mediated wood degradation. Genome-wide analysis of fungal species revealed the presence of CYP53
members in ascomycetes and basidiomycetes. Basidiomycetes had a higher number of CYP53 members in their genomes
than ascomycetes. Only two CYP53 subfamilies were found in ascomycetes and six subfamilies in basidiomycetes,
suggesting that during the divergence of phyla ascomycetes lost CYP53 P450s. According to phylogenetic and gene-
structure analysis, enrichment of CYP53 P450s in basidiomycetes occurred due to the extensive duplication of CYP53 P450s
in their genomes. Numerous amino acids (103) were found to be conserved in the ascomycetes CYP53 P450s, against only
seven in basidiomycetes CYP53 P450s. 3D-modelling and active-site cavity mapping data revealed that the ascomycetes
CYP53 P450s have a highly conserved protein structure whereby 78% amino acids in the active-site cavity were found to be
conserved. Because of this rigid nature of ascomycetes CYP53 P450s’ active site cavity, any inhibitor directed against this
P450 family can serve as a common anti-fungal drug target, particularly toward pathogenic ascomycetes. The dynamic
nature of basidiomycetes CYP53 P450s at a gene and protein level indicates that these P450s are destined to acquire novel
functions. Functional analysis of CYP53 P450s strongly supported our hypothesis that the ascomycetes CYP53 P450s ability
is limited for detoxification of toxic molecules, whereas basidiomycetes CYP53 P450s play an additional role, i.e. involvement
in degradation of wood and its derived components. This study is the first report on genome-wide comparative structural
(gene and protein structure-level) and evolutionary analysis of a fungal P450 family.
Citation: Jawallapersand P, Mashele SS, Kovacˇicˇ L, Stojan J, Komel R, et al. (2014) Cytochrome P450 Monooxygenase CYP53 Family in Fungi: Comparative
Structural and Evolutionary Analysis and Its Role as a Common Alternative Anti-Fungal Drug Target. PLoS ONE 9(9): e107209. doi:10.1371/journal.pone.0107209
Editor: Kap-Hoon Han, Woosuk University, Korea, Republic of
Received May 10, 2014; Accepted August 8, 2014; Published September 15, 2014
Copyright:  2014 Jawallapersand et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: The authors confirm that all data underlying the findings are fully available without restriction. All relevant data are within the paper and its
Supporting Information files
Funding: KS, PJ, and SSM thank the Central University of Technology (CUT), Bloemfontein, Free State for a grant from the University Research and Innovation
fund (to KS and SSM) and Masters in Technology research fellowship (to PJ). SSM also thanks the National Research Foundation (NRF), South Africa for the
research grant. NK and RK thank the Slovenian Research Agency Program P1-0104. SBP thanks the University Grants Commission (UGC), New Delhi, India for
selecting for the UGC-Faculty Recharge Programme. The funders had no role in the study design, data collection and analysis, decision to publish or preparation
of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* Email: khajamohiddinsyed@gmail.com (KS); nada.krasevec@ki.si (NK)
Introduction
Among microorganisms, fungi, the largest biological kingdom
comprising diverse lower eukaryotic microorganisms, have
acquired a special place owing to their ability to be pathogens
for not only humans but also other animals and plants (Table 1).
These lower eukaryotes develop or are constantly developing new
strategies to adapt to diverse ecological niches. In order to develop
novel drugs by identifying potential novel drug targets and
harnessing their potentials for the production of human valuables,
a large number of fungal genomes have been sequenced and many
fungal genome sequencing projects are currently in progress.
Efforts of the Broad Institute of MIT and Harvard (http://www.
broadinstitute.org/), Wellcome Trust Sanger Institute (https://
www.sanger.ac.uk/), and Joint Genome Institute (JGI) United
States Department of Energy (US-DOE) (http://genome.jgi.doe.
gov/programs/fungi/index.jsf) resulted in genome sequencing of a
large number of fungal species.
Genome sequencing analysis of fungal species revealed the
presence of a large number of cytochrome P450 monooxygenases
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Table 1. Genome-wide comparative analysis of CYP53 family in fungi.
Species Lifestyle CYP53 subfamily Total count
A B C D H NS
Ascomycota
Magnaporthe grisea Plant pathogen 1 1
Neurospora crassa Model organism 1 1
Neurospora discreta Distantly related to Neurospora crassa 1 1
Fusarium graminearum Plant pathogen 3 3
Fusarium solani f. batatas
(Nectria haematococca)
Plant pathogen and animal pathogen
(opportunistic human pathogen)
2 2
Fusarium verticillioides Plant pathogen and animal pathogen
(opportunistic human pathogen)
2 2
Fusarium oxysporum Plant pathogen and animal pathogen
(opportunistic human pathogen)
2 1 3
Neosartorya fischeri Animal pathogen (including human) 1 1
Aspergillus nidulans Model organism for study of eukaryotic
cell biology
1 1
Aspergillus fumigatus Animal pathogen (opportunistic human
pathogen)
1 1
Aspergillus terreus Human, animal and plant pathogen 1 1
Aspergillus oryzae Economically important, used for fermentation 2 2
Aspergillus flavus Plant and animal pathogen (human pathogen) 1 1
Aspergillus niger Plant and animal pathogen (human pathogen) 1 1
Aspergillus clavatus Animal pathogen (human pathogen) 1 1
Coccidioides immitis Animal pathogen (human pathogen) 1 1
Histoplasma capsulatum Animal pathogen (human pathogen) 0 0
Uncinocarpus reesii Non-pathogen 1 1
Mycosphaerella fijiensis Plant pathogen 1 1
Zymoseptoria tritici (formerly named as
Mycosphaerella graminicola)
Plant pathogen 1 1
Thielavia terrestris Non-pathogen 1 1
Myceliophthora thermophila Non-pathogen 1 1
Cochliobolus lunatus Plant and animal pathogen (human
pathogen)
1 1
Total count 28 1 29
Basidiomycota
Phanerochaete chrysosporium Model white rot fungus – study of wood
degradation
1 1
Postia placenta Model brown rot fungus – study of wood
degradation
1 7 8
Ustilago maydis Plant pathogen 1 1
Cryptococcus neoformans Animal pathogen (human) 0
Cryptococcus gattii Animal pathogen (human) 0
Laccaria bicolor Symbiotic fungus (ectomycorrhizas) 0
Malassezia globosa Animal pathogen (human) 0
Puccinia graminis Plant pathogen 1 1
Sporobolomyces roseus Non-pathogen 1 1
Phanerochaete carnosa Model white rot fungus - study of soft wood
degradation
6 1 7
Bjerkandera adusta Wood-degrading white rot fungus 1 7 8
Ceriporiopsis subvermispora Wood-degrading white rot fungus 4 4
Ganoderma sp. Wood-degrading white rot fungus 1 1
Ganoderma lucidum Medicinal mushroom (wood-degrading
white rot fungus)
1 1
Phlebia brevispora Wood-degrading white rot fungus 1 1
CYP53 Family in Fungi
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(P450s) in their genomes, with some exceptions. P450s are heme-
thiolate proteins ubiquitously present across the biological
kingdoms [1]. In fungi P450s are known to be involved in both
primary and secondary metabolic processes [2,3] and in the
degradation of xenobiotic compounds [4]. P450s have been
explored as anti-fungal drug targets owing to their key role in
fungal physiology through involvement in stereo- and regio-
specific oxidation of substrates [5]. Among fungal P450s CYP51,
also known as sterol 14a-demethylase, the highly conserved P450
across the biological kingdoms [6], is the primary target of
conventional antifungal azole drugs [7]. CYP51 performs
demethylation of lanosterol, a key step in biosynthesis of cell
membrane ergosterol [6]. Studies have indicated that fungal
organisms are developing resistance to azole drugs [8,9].
Furthermore, the currently available anti-fungal drugs have
limitations because of similar metabolic pathways between fungi
and other organisms (mainly mammals) and hence researchers are
in search of alternative novel fungal drug targets [10].
Research on fungal P450s revealed that the P450 family CYP53
can serve as a novel alternative anti-fungal drug target [11].
CYP53 family members are well known as benzoate para-
hydroxylases that are involved in the detoxification of a benzoate
molecule [12]. Benzoate is a naturally occurring anti-fungal plant
material [13] and also a naturally occurring intermediate in the
degradation of aromatic compounds in fungi [14–16]. Benzoate
exhibits its toxicity by disruption of the membrane, inhibiting
essential cellular processes, changing pH balance and inducing
stress response in fungi [13,17]. CYP53 P450-mediated para-
hydroxylation of benzoate is the only known pathway in fungi that
ultimately channels this toxic compound into the b-ketoadipate
pathway [18]. Furthermore, the CYP53 gene was found to be
essential for fungal species’ survival [19]. The CYP53 gene-knock
out fungal strain growth was found to be inhibited by the
accumulation of toxic intermediate benzoate [19]. This clearly
suggests that this P450 is critical in the survival of fungal species,
by playing a key role in the detoxification of benzoate.
Considering the fungal resistance to the currently available
drugs, especially CYP51 enzyme-based azoles [8], and a
preliminary study suggesting that CYP53 P450 family members
can serve as novel alternative fungal drug targets [11], in the
present study we aimed to understand the role of CYP53 members
in fungal physiology per se, performing comparative evolutionary
and structural analysis of CYP53 members to check their
distribution and structural conservation in fungi. In this way we
can determine whether this P450 family can serve as a common
drug target against a broad range of fungal pathogens. Further-
more, we also explored its role in adaptation of basidiomycetes to
diverse ecological niches such as colonization on wood.
Materials and Methods
Genome data mining and annotation of CYP53 members
Fifty-one fungal species were selected for the analysis of CYP53
member P450s. As shown in Table 1, 23 species from ascomycota
and 28 species from basidiomycota were included in this analysis.
CYP53 members of the basidiomycete species, such as Phaner-
ochaete chrysosporium, Phanerochaete carnosa, Bjerkandera adusta,
Ganoderma sp., Phlebia brevispora, and Ceriporiopsis subvermis-
pora, and ascomycete species, such as Thielavia terrestris and
Myceliophthora thermophila, were retrieved from an author’s
contributed and original work that has been published and is
publicly available [4,20-25]. CYP53 members in the remaining 20
ascomycetes were obtained from the Cytochrome P450 Webpage
[26]. Two basidiomycete species, namely Agaricus bisporus and
Serpula lacrymans CYP53 members, were obtained from the
Fungal Cytochrome P450 Database (FCPD) [27]. CYP53 members
belonging to Postia placenta were taken from published literature
[28].
Table 1. Cont.
Species Lifestyle CYP53 subfamily Total count
A B C D H NS
Agaricus bisporus Litter-degrading fungus 2 2
Serpula lacrymans Model fungus known as dry rot fungus – study
of dry wood degradation
1 1
Stereum hirsutum Wood-degrading white rot fungus 1 1
Trametes versicolor Wood-degrading white rot fungus 2 2
Wolfiporia cocos Wood-degrading brown-rot fungus 9 9
Auricularia delicata Wood-degrading white rot fungus 1 1 2
Coniophora puteana Wood-degrading brown rot fungus 1 2 3
Dacryopinax sp. Wood-degrading brown rot fungus 1 1
Dichomitus squalens Wood-degrading white rot fungus 1 1
Fomitiporia mediterranea Wood-degrading white rot fungus 9 1 10
Fomitopsis pinicola Wood-degrading brown rot fungus 4 4
Gloeophyllum trabeum Wood-degrading brown rot fungus 1 1
Punctularia strigosozonata Wood-degrading white rot fungus 1 1 2
Total count 3 2 52 7 7 2 73
Total CYP53 members in fungi 31 2 52 8 7 2 102
Twenty-three species from ascomycota and 28 species from basidiomycota were used in this study. Identification of CYP53 members in fungal species was carried out
as described in the ‘‘Materials and methods’’ section. If no CYP53 member was found in the species, the space was left blank. The abbreviation NS indicates a new
subfamily. Fungal species capable of causing diseases in humans were indicated with the word ‘‘human’’ in the table.
doi:10.1371/journal.pone.0107209.t001
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To identify CYP53 members in the basidiomycete species, such
as Wolfiporia cocos, Auricularia delicata, Coniophora puteana,
Dacryopinax sp., Dichomitus squalens, Fomitiporia mediterranea,
Fomitopsis pinicola, Gloeophyllum trabeum, Punctularia strigo-
sozonata, Stereum hirsutum, and Trametes versicolor, genome
data mining was performed as described by one of the authors in
his recent publications [24,29], with slight modifications. Blast
analysis was performed at the respective species’ genome data base
Figure 1. Phylogenetic analysis of CYP53 family in fungi. The tree was constructed with 101 CYP53 P450s belonging to six different CYP53
subfamilies. Phylogeny was inferred using the minimum evolution method [33] and the tree was constructed with MEGA (5.05) software [32]. For
details on construction of the tree and the parameter employed for tree construction see the section ‘‘phylogenetic analysis’’ under ‘‘Materials and
methods’’. For ease of visual identity, the tree branch color, protein name, protein ID (parenthesis) and species name were presented in unique color
as per sub-family. Fungal species’ names were indicated with three letters, where the first letter is taken from the genus name and the other two
letters from the species name. Abbreviations: Abi, Agaricus bisporus; Acl, Aspergillus clavatus; Ade, Auricularia delicata; Afl, Aspergillus flavus; Afu,
Aspergillus fumigatus; Ani, Aspergillus nidulans; Aor, Aspergillus oryzae; Ate, Aspergillus terreus; Bad, Bjerkandera adusta; Cim, Coccidioides immitis; Clu,
Cochliobolus lunatus; Cpu, Coniophora puteana; Csu, Ceriporiopsis subvermispora; Dsq, Dichomitus squalens; Fgr, Fusarium graminearum; Fme,
Fomitiporia mediterranea; Fox, Fusarium oxysporum; Fpi, Fomitopsis pinicola; Fve, Fusarium verticillioides; Glu, Ganoderma lucidum; Gsp, Ganoderma
sp.; Gtr, Gloeophyllum trabeum; Mfi, Mycosphaerella fijiensis; Mgr, Magnaporthe grisea; Mth, Myceliophthora thermophila; Ncr, Neurospora crassa; Ndi,
Neurospora discreta; Nfi, Neosartorya fischeri; Nha, Nectria haematococca; Pbr, Phlebia brevispora; Pca, Phanerochaete carnosa; Pch, Phanerochaete
chrysosporium; Pgr, Puccinia graminis; Ppl, Postia placenta; Pst, Punctularia strigosozonata; Shi, Stereum hirsutum; Sla, Serpula lacrymans; Sro,
Sporobolomyces roseus; Tte, Thielavia terrestris; Tve, Trametes versicolor; Uma, Ustilago maydis; Ure, Uncinocarpus reesii; Wco, Wolfiporia cocos.
doi:10.1371/journal.pone.0107209.g001
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that is publicly available [30], using P. chrysosporium CYP53C2
(protein ID: 130996). Considering the presence of CYP53
members in low copies (one or two numbers) in ascomycetes
and basidiomycetes, the top 20 hits’ proteins were selected for
further analysis. The hit proteins were subjected to the NCBI
Batch Web CD-Search Tool [31] to separate proteins belonging to
the P450 superfamily. This software groups the proteins into
different superfamilies based on the conserved domain character-
istics of the protein family. The proteins that are grouped under
the P450 superfamily were selected for further assignment to the
P450 family and subfamily. Assigning the family and subfamily
names to the P450 proteins was performed in the same way as
described by one of the authors in his recent study [24,29]. Briefly,
individual proteins were blasted against all named fungal P450s at
the Cytochrome P450 Webpage [26]. A family and subfamily were
assigned to the P450 proteins based on standard International
P450 Nomenclature criteria, i.e..40% homology for a family and
.55% homology for a subfamily. Among the selected proteins
those grouped under the CYP53 family were used in the analysis.
The Cytochrome P450 Webpage [26] was visited to check for the
presence of CYP53 members, if any, in the basidiomycetes
Ustilago maydis, Cryptococcus neoformans, Cryptococcus gattii,
Laccaria bicolor, Malassezia globosa, Puccinia graminis and
Sporobolomyces roseus. A CYP53 member for Cochliobolus
lunatus was obtained from one of an author’s contributed work,
which is publicly available [11].
Phylogenetic analysis
Phylogenetic analysis of CYP53 members was carried out using
the Molecular Evolutionary Genetics Analysis (MEGA) software
[32] in the same way as described in one of the author’s recent
publications [24,25]. Phylogenetic analysis was inferred using the
minimum evolution method [33]. The minimum evolution
method is widely used in P450 research, based on pairwise
distance algorithms for the reconstruction of phylogenies
[24,25,37]. In this study we used the minimum evolution method
for phylogenetic analysis of CYP53 member P450s. The evolu-
tionary distances were computed using the Poisson correction
method [34] and are in the units of the amino acid substitution per
site. The minimum evolution tree was searched using the close-
neighbor-interchange algorithm [35]. The neighbor-joining algo-
rithm [36] was used to generate the initial tree.
Intron-exon analysis
Gene structure organization of CYP53 family members was
carried out as described by an author in his recent publication
[25]. Briefly, each CYP53 member gene was accessed at its
genome data base at the JGI, US-DOE (http://genome.jgi.doe.
gov/programs/fungi/index.jsf; accessed on 5 Feb, 2014) or Broad
Institute of MIT and Harvard (http://www.broadinstitute.org/;
accessed on 5 Feb, 2014). For each P450 the size of the exons and
the location of introns were recorded. A schematic diagram
showing horizontal lanes representing the exons and vertical lanes
representing the introns’ location were drawn. The length of the
horizontal lane corresponds to the gene length. CYP53 members
that showed high conservation in terms of the size of exons and the
location of introns were shown in the figure.
Analysis of homology
To identify the percentage homology between CYP53 mem-
bers, we performed ClustalW2 multiple sequence analysis [38].
CYP53 members in FASTA format were included in the analysis
and the result summary showing the percentage identity matrix
was downloaded. After the file had been downloaded, the results
were converted into table format and checked for the percentage
homology between CYP53 members.
Table 2. Analysis of homology between CYP53 members in fungi.
CYP name Species name Homology (%) CYP name Species name
Ascomycota
CYP53A4 (7508) Neurospora crassa 98 CYP53A4 (88466) Neurospora discreta
CYP53A (2107910) Thielavia terrestris 91 CYP53A (2301715) Myceliophthora thermophila
CYP53A19 (9543) Fusarium verticillioides 98 CYP53A19 (14206) Fusarium oxysporum
CYP53A8 (12085) Fusarium graminearum 95 CYP53A19 (9543) Fusarium verticillioides
CYP53A8 (12085) Fusarium graminearum 95 CYP53A19 (14206) Fusarium oxysporum
CYP53A20 (6367) Fusarium verticillioides 99 CYP53A20 (10443) Fusarium oxysporum
CYP53A7 (10227) Fusarium graminearum 97 CYP53A20 (6367) Fusarium verticillioides
CYP53A7 (10227) Fusarium graminearum 97 CYP53A20 (10443) Fusarium oxysporum
CYP53A12 (8190) Neosartorya fischeri 98 CYP53A12 (3003) Aspergillus fumigatus
CYP53A12 (3003) Aspergillus fumigatus 94 CYP53A21 (1341) Aspergillus clavatus
CYP53A13 (5958) Aspergillus oryzae 99 CYP53A13 (26719) Aspergillus flavus
Basidiomycota
CYP53C4 (47512) Ganoderma sp. 95 CYP53C4 (GL08839-P1.1) Ganoderma lucidum
CYP53D3 (60352) Postia placenta 95 CYP53D5 (46728) Postia placenta
CYP53C (104855) Wolfiporia cocos 67 CYP53C (154237) Wolfiporia cocos
The percentage (%) homology between CYP53 members was obtained from the Cytochrome P450 Webpage [26] based on their highest hit to reference proteins and
also estimated using ClustalW2 [38]. P450s showing more than 90% homology were selected and presented in the table. A detailed report on the percentage homology
between identified proteins and hit proteins at Cytochrome P450 Webpage [26] was presented in Table S1. As shown in the table, a higher number of CYP53 members
from ascomycota showed more than 90% homology, suggesting high conservation of the primary structure in ascomycete species CYP53 members compared to
basidiomycete species CYP53 members. For each P450 protein IDs were shown in parenthesis.
doi:10.1371/journal.pone.0107209.t002
CYP53 Family in Fungi
PLOS ONE | www.plosone.org 5 September 2014 | Volume 9 | Issue 9 | e107209
© Central University of Technology, Free State
Analysis of amino acid conservation
The number of amino acids conserved in CYP53 members
across the fungi and between ascomycota and basidiomycota was
determined using PROfile Multiple Alignment with predicted
Local Structures and 3D constraints (PROMALS3D) [39].
PROMALS3D aligns multiple protein sequences and/or struc-
tures, with enhanced information from database searches,
secondary structure prediction, 3D structures or user-defined
constraints and it will also give a conservation index [40]. The
conservation index follows numbers above 4, where 9 is the
invariantly conserved amino acid across the input sequences.
Homology modeling
3D-modelling of CYP53 member P450s namely; CYP53A
(protein ID: 2107910) from T. terrestris (Tter) and CYP53C2
(protein ID: 130996) from P. chrysosporium (Pchr) was carried out
as described by one of the authors in his publication [41], with
slight modifications. The Basic Local Alignment Search Tool
(BLAST) was used for selecting the closest homologues (template)
available in the Protein Data Bank (www.pdb.org; accessed on 5
Feb, 2014). Among the hits at the PDB databank, recently
crystallized full-length P450 protein CYP51 from Saccharomyces
cerevisiae [42] was superior. Hence this P450 was used as a
template. The coordinates of the crystal structures of CYP51 (PDB
ID: 4LXJ) [42] were used as templates to build the models of
CYP53 P450s. 3D-models of the Pchr and Tter were generated
using the homology modeling program Modeller 9v11 [43]. The
modelling was performed with default parameters using the
‘‘allHmodel’’ protocol to include hydrogen atoms and the
‘‘HETATM’’ protocol to include prosthetic group HEM (heme).
The 3D-model’s accuracy was validated using DFire [44],
QMEAN [45], and Verify3D [46]. Heme-binding residues were
identified using 3DLigandSite [47]. Structure alignment between
the template and CYP53A of T. terrestris and the CYP53C2 of P.
chrysosporium was performed using PROMALS3D [39]. P450
characteristic secondary structure annotations and substrate
Figure 2. Analysis of amino acid conservations in CYP53 family members of ascomycota (A) and basidiomycota (B). Analysis of amino
acid conservations was carried out using PROMALS3D [39]. CYP53A from Thielavia terrestris and CYP53C2 from Phanerochaete chrysosporium were
presented as a representative of ascomycota (A) and basidiomycota (B) CYP53 members. The residues conserved in CYP53 members of ascomycota
(A) and basidiomycota (B) are shown with the conservation index [40] on top of the amino acid residue. Complete alignment of CYP53 members of
ascomycota and basidiomycota and a conservation index for the amino acids was presented in Fig. S1.
doi:10.1371/journal.pone.0107209.g002
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recognition sites (SRS) in modelled P450s were identified
according to their alignment with the template P450s and
standard SRS localization regions, as described in the literature
[48,49]. Protein models were visualized using PyMOL Molecular
Graphics System, Version 1.7.1.1. Schro¨dinger, LLC (http://
www.pymol.org/; accessed on 5 Feb, 2014).
Active site cavity residues mapping
To identify the amino acid residues lining the active site cavity
CASTp was used [50]. The CYP53A of T. terrestris (abbreviated
as Tter) 3D-model generated in this study was used to predict the
protein active site cavity using CASTp. The cavity showing the
higher volume and covering the SRS regions was selected and the
program automatically listed the residues lining the active site. The
active site cavity structure and the residues lining the cavity were
presented as a figure using PyMOL Molecular Graphics System,
Version 1.7.1.1. Schro¨dinger, LLC.
Results and Discussion
CYP53 distribution in fungi
The CYP53 family is one of the P450 families apart from
CYP51 and CYP61 that are conserved between the phyla
ascomycota and basidiomycota [2,27]. In this study we screened
51 fungal species belonging to ascomycota (23 species) and
basidiomycota (28 species) for analysis of CYP53 family members
in their genomes. Genome data mining of ascomycetes (23 species)
and basidiomycetes (28 species) revealed the presence of one to
nine copies of CYP53 members in their genomes (Table 1). The
CYP53 family member count ranged from one to three in
ascomycetes and one to ten in basidiomycetes. The basidiomycete
species F. mediterranea showed the maximum number of CYP53
members (10 CYP53 P450s) in its genome. No CYP53 member
was identified in the ascomycete Histoplasma capsulatum and in
the basidiomycetes C. neoformans, C. gattii and M. globosa or the
symbiotic L. bicolor (Table 1). Overall, ascomycete species showed
a lower number of CYP53 member P450s in their genomes
compared to basidiomycete species (Table 1), suggesting a possible
duplication of CYP53 members after the phylum divergence.
Moreover, our analysis revealed the complete absence of CYP53
member P450s in phyla zygomycota and chytridiomycota.
Furthermore, in ascomycota only species belonging to subphyla
pezizomycotina showed CYP53 members in their genomes and
CYP53 member P450s were not found in species of the subphyla
saccharomycotina and taphinomycotina, which is in accordance
with the smaller size of the P450ome in relation to the growth form
of the fungus [51]. Overall, contrary to the established assumption
that this family is conserved in fungi, our study showed that
CYP53 is not conserved across the fungal species. In future,
further genome sequencing analysis of species belonging to
chytridiomycota and zygomycota and the subphylum taphrino-
mycotina could be performed that may provide more information
on the presence of this protein family in their genome. However,
considering the life style and small size genomes of saccharomy-
cotina species, the absence of CYP53 family members is expected.
Analysis of the CYP53 family suggested the dominance of
specific CYP53 subfamilies in ascomycota and basidiomycota
(Table 1). Ascomycete species showed only the CYP53A subfamily
in their genomes, with the exception of Fusarium oxysporum,
which showed a single copy CYP53 member belonging to the
CYP53D subfamily (Table 1). In contrast to ascomycete species,
basidiomycete species showed divergence in CYP53 subfamilies.
Five subfamilies were observed in basidiomycetes, i.e. CYP53A,
CYP53B, CYP53C, CYP53D, and CYP53H (Table 1). Our
analysis of CYP53 members in basidiomycetes revealed the
presence of two new CYP53 subfamilies in P. carnosa and F.
mediterranea. Among the CYP53 subfamilies observed for
basidiomycota, the CYP53C subfamily was dominant, with 52
members, followed by CYP53D (eight members) and CYP53H
(seven members). A single copy of CYP53A members was found in
A. delicata, P. strigosozonata, and C. puteana (Table 1). Consid-
ering the presence of CYP53A and CYP53D subfamilies in both
phyla, one can assume that after the divergence of phyla,
ascomycete species might have lost CYP53 subfamilies such as
CYP53B, C and H. On the other hand, basidiomycete species
enhanced CYP53 numbers in their genome, possibly by genome
duplication of CYP53 members in view of the possible require-
Figure 3. Analysis of amino acid conservations in CYP53C subfamily of basidiomycota. Analysis of amino acid conservations was carried
out using PROMALS3D [39]. CYP53C from Fomitopsis pinicola is presented as a representative of CYP53C members. The residues conserved in CYP53C
members are shown with the conservation index [40] on top of the amino acid residue. Complete alignment of CYP53C members of basidiomycota
and a conservation index for the amino acids was presented in Fig. S1.
doi:10.1371/journal.pone.0107209.g003
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ment of these P450 family members to adapt to diverse ecological
niches.
Phylogenetic analysis of CYP53 P450 family
In order to understand the evolution of the CYP53 family and
its distribution in fungi, we performed evolutionary analysis of the
CYP53 family using the minimum evolution method [33].
Minimum evolution analysis of CYP53 members showed subfam-
ily-specific and species-specific alignment/grouping of CYP53
members (Fig. 1), suggesting that after divergence of phyla
(ascomycota and basidiomycota) CYP53 members have been
subjected to phylum-specific amino acid changes in their structure.
The most striking feature was that CYP53 members belonging to a
particular basidiomycete species were grouped together (Fig. 1).
This clearly indicates that paralogous evolution of CYP53
members, possibly via genome duplication, occurred in basidio-
mycete species. In a recently published study [25], we observed the
same phenomenon of genome duplication of member P450s in
basidiomycete species. Furthermore, we also showed that these
P450 duplications were necessitated by the fungal species to adapt
to diverse ecological niches [25]. Interestingly, CYP53D1 of F.
oxysporum (ascomycete) did not align with its counterpart present
in P. placenta (basidiomycete) (Fig. 1), suggesting that extensive
changes specific to phyla might have occurred in their primary
structure.
High conservation of primary structure of CYP53
members in ascomycota
From the above study it is highly positive that after divergence
of ascomycota and basidiomycota, CYP53 members have been
subjected to phyla-specific changes or conservation in their
primary structure. In order to understand these phyla-specific
changes or conservations in CYP53 members, we followed two
methods. Firstly we analyzed the percentage homology and
secondly we deduced amino acids conserved in CYP53 members
in both ascomycetes and basidiomycetes.
Figure 4. Gene-structure analysis of CYP53 family in (A) ascomycete species and (B) basidiomycete species. Intron-exon analysis was
carried out as described in the ‘‘Material and methods’’ section. Horizontal lines indicate gene size and vertical lines indicate introns. For each CYP53
gene the size of the exons (base pairs) and protein ID from the JGI US-DOE [30] is shown in the figure. Abbreviations: Acl, Aspergillus clavatus; Afl,
Aspergillus flavus; Afu, Aspergillus fumigatus; Ani, Aspergillus nidulans; Aor, Aspergillus oryzae; Ate, Aspergillus terreus; Bad, Bjerkandera adusta; Cim,
Coccidioides immitis; Clu, Cochliobolus lunatus; Csu, Ceriporiopsis subvermispora; Fgr, Fusarium graminearum; Fme, Fomitiporia mediterranea; Fox,
Fusarium oxysporum; Fpi, Fomitopsis pinicola; Fve, Fusarium verticillioides; Mfi, Mycosphaerella fijiensis; Mgr, Magnaporthe grisea; Mth, Myceliophthora
thermophila; Ncr, Neurospora crassa; Ndi, Neurospora discreta; Nfi, Neosartorya fischeri; Nha, Nectria haematococca; Pca, Phanerochaete carnosa; Ppl,
Postia placenta; Tte, Thielavia terrestris; Ure, Uncinocarpus reesii; Wco, Wolfiporia cocos.
doi:10.1371/journal.pone.0107209.g004
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ClustalW2 analysis of CYP53 members revealed a high
percentage homology among CYP53 members (Table 2) in
ascomycota; some of the members showed .90% homology
compared to CYP53 members in basidiomycota. The observed
high percentage homology in CYP53 members of ascomycota
(Table 2) might be due to the dominance of a single CYP53A
subfamily. It is noteworthy that although the CYP53C subfamily is
dominant in basidiomycota (Table 1), most of its members seem to
be subjected to major amino acid changes, as the percentage
homology between CYP53C members is not high with exception
of a few P450s, as observed for CYP53A members for ascomycota
(Table 2).
To link the high percentage homology observed for CYP53
members of ascomycetes towards conservation of amino acid in
their primary structure, we performed amino acid conservation
studies using PROMALS3D (Figures 2 and 3; Fig. S1). PRO-
MALS3D analysis of CYP53 members across fungi suggested
conservation of eight amino acids (Fig. S1A). Conservation of only
eight amino acids in CYP53 members across fungi is understand-
able, considering the high diversity of CYP53 members across
fungal species (five subfamilies and two new subfamilies). The most
striking difference was observed in the number of amino acids
conserved in the CYP53 members of ascomycota and basidiomy-
cota (Figures 2 and 3 and Fig. S1). A hundred and three amino
acids were found conserved in CYP53 members of ascomycota
compared to CYP53 members of basidiomycota, which showed
only seven amino acids conserved in their primary structure
(Fig. 2). This strongly suggests that the observed high percentage
homology between CYP53 members of ascomycota is due to the
high conservation of amino acids in their primary structure.
One can argue that the high conservation of amino acids (103
amino acids) in CYP53 members of ascomycota (Fig. 2A) is due to
the presence of a single CYP53A subfamily whereas five
subfamilies and two new subfamilies exist in basidiomycota. To
rule out this argument, we present two types of evidence. Firstly,
we collected CYP53A members from ascomycete species belong-
ing to 11 different genera (Table 1), suggesting the high diversity of
host species, which should thus reflect in CYP53A primary
structure as well. However, this was not true, as ascomycete
CYP53 members showed high conservation in the primary
structure (Fig. 2). Secondly, we estimated the number of amino
acids conserved in the CYP53C subfamily alone (Fig. 3), the
subfamily that is dominant in basidiomycota. Interestingly, our
analysis revealed conservation of only 20 amino acids in CYP53C
subfamily members in basidiomycota (Fig. 3), further strengthen-
ing our hypothesis that basidiomycota CYP53 members have been
subjected to extensive primary structure changes. Further studies
were carried out to map the location of conserved amino acids to
extrapolate the effect of the conservation in CYP53 substrate
specificity or catalytic activity, if any.
Gene conservation and genome duplications of CYP53
members
The above study indicated high conservation of CYP53
members’ primary structure (at a protein level) in ascomycetes
compared to basidiomycetes. To gain insight into this aspect, we
further analyzed the gene structure of CYP53 members (Fig. 4).
Analysis of the size of exons and the location of introns indicated
high conservation of the gene-structure in CYP53 members
belonging to both fungal phyla ascomycota (Fig. 4A) and
basidiomycota (Fig. 4B). Gene structure analysis suggested that
some ascomycete species, such as F. oxysporum, Fusarium solani f.
batatas (Nectria haematococca), Fusarium verticillioides, and
Fusarium graminearum, contain two types of ortholog P450s in
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Figure 5. Structural analysis of CYP53 P450s. 3D-models for CYP53C2 from Phanerochaete chrysosporium (CYP53 Pchr) [4] and CYP53A from
Thielavia terrestris (CYP53 Tter) [24] were constructed based on the template CYP51 from Saccharomyces cerevisiae (CYP51 Scer) (PDB ID: 4LXJ) [42].
The CYP51 Scer crystal structure was downloaded from the Protein Data Bank (www.pdb.org) with ID: 4LXJ. The overall structures of P450s were
presented using PyMOL Molecular Graphics System, Version 1.7.1.1. Schro¨dinger, LLC (http://www.pymol.org/). The parameters used for validation of
3D-models of CYP53 Tte and CYP53 Pchr were presented in Table 3. The heme prosthetic group is shown in black color and the bound substrate for
CYP53 Scer in green color. Alpha-helices and beta-strands are shown with blue and red. The membrane helix (MH) and the trans-membrane helix
(TMH) are indicated in the models. P450 characteristics secondary structure notations are presented in Fig. 6.
doi:10.1371/journal.pone.0107209.g005
Figure 6. Structural alignment of CYP53C2 (Pchr) and CYP53A (Tter) models with CYP51 (4LXJ) using PROMALS3D [39]. 3D-models
for CYP53C2 from Phanerochaete chrysosporium (Pchr) [4] and CYP53A from Thielavia terrestris (Tter) [24] were constructed using the template CYP51
(4LXJ) from Saccharomyces cerevisiae [42]. P450 characteristic notations for a-helices (shown in red font) and b-strands (shown in blue font) and SRS
were mapped as per the template (4LXJ) [42] and published literature [48,49]. Residues highlighted in green and turquoise appear in contact with the
heme and substrate.
doi:10.1371/journal.pone.0107209.g006
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their genome. The first type contains a single intron and the
second one contains three introns (Fig. 4A). Paralog P450s were
found in F. graminearum (protein IDs: 10234 and 10227) and
Aspergillus oryzae (protein IDs: 2107 and 5958), suggesting the
genome duplication of these P450s. Overall, ascomycete species
CYP53 members showed simple gene structure with single and
triple introns (Fig. 4A).
It is evident from Fig. 4B, especially considering the exon sizes
and location of introns, that basidiomycete species enriched
CYP53 members in their genome by genome duplications
(paralogous evolution). The high conservation in the size of exons
and location of introns of CYP53 members of basidiomycetes
strongly suggests that CYP53 members are genome-duplicated. In
comparison to ascomycete species, CYP53 members of basidio-
mycete species showed more introns in their structure (Fig. 4B).
An interesting discovery we made was that basidiomycete species
selectively enriched a single type of CYP53 member in their
genome (Fig. 4B). In support of this argument, we present a few
examples: (i) in P. placenta we observed two orthologs, of which
one duplicated seven times while no duplication was observed for
the second ortholog (protein ID: 110015); (ii) in W. cocos three
orthologs were found: one ortholog duplicated seven times
whereas no duplications were observed for the remaining two
orthologs (protein IDs: 138909 and 27029); (iii) in F. pinicola, P.
carnosa and F. mediterranea two orthologs were found in their
genomes; in these species one ortholog was duplicated whereas no
duplication was observed for the second ortholog (protein ID:
1025718 (F. pinicola); protein ID: 183190 (P. carnosa); protein ID:
162664 (F. mediterranea); (iv) B. adusta showed three ortholgos;
two orthologs (protein IDs: 318949 and 118978) have remained
the same since the divergence of this species.
From the above results it is clear that the higher number of
CYP53 members in basidiomycetes is due to the genome
duplication of selective CYP53 members. Despite the conservation
of gene structure and the paralogous evolution of CYP53 members
in basidiomycete species, the low percentage of homology among
them suggests that during the genome duplication events,
extensive changes in the primary structure occurred. Most of the
changes might be destined to acquire novel functions to serve
Figure 7. Analysis of amino acid conservations in CYP53
member P450s. 3D-models of CYP53C2 from Phanerochaete chrysos-
porium (Pchr) and CYP53A from Thielavia terrestris (Tter) as a
representative of basidiomycota and ascomycota CYP53 member
P450s are shown in the figure. The conserved residues among CYP53
members of two different phyla identified in this study (Fig. 2) are
highlighted with red and shown in stick form. The heme-prosthetic
group is presented in black. The models are presented using PyMOL
Molecular Graphics System, Version 1.7.1.1. Schro¨dinger, LLC (http://
www.pymol.org/).
doi:10.1371/journal.pone.0107209.g007
Figure 8. CYP53A Tte active site cavity mapping and analysis of the nature of the active site amino acids. The active site cavity and
amino acid residues surrounding the cavity were identified using CASTp [50]. Conservation of amino acid residues in ascomycete species CYP53
P450s were identified using PROMALS3D [39] (Fig. 2). The CYP53A Tte model was used as a representative of ascomycete CYP53 members. The figure
on the left shows the mapped active site cavity (space filled) and the protein backbone is presented in lines style, in the right-hand figure the
conserved residues lining the cavity mapping. Different colors correspond their conservation index [40], 9 (conserved residues) – red, conservation
index 7 – blue, conservation index 6 – cyan, conservation index 5 – green and residues with no conservation index – grey. The heme group is shown
in grey dots. For details on the conserved nature of amino acid residues lining the active site cavity, see Table 4. The activity center is represented
using PyMOL Molecular Graphics System, Version 1.7.1.1. Schro¨dinger, LLC (http://www.pymol.org/).
doi:10.1371/journal.pone.0107209.g008
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fungal species (basidiomycete) to adapt to diverse ecological niches.
In this direction, we further investigated whether amino acid
changes play any role in CYP53 substrate specificity and/or
catalytic activity.
Structure and amino acid conservation analysis of CYP53
members
Primary structure analysis and gene-structure organization
studies suggested that ascomycete CYP53 members are highly
conserved and basidiomycete CYP53 members are subjected to
evolutionary pressure to change their primary structure compo-
sition. To identify the role of amino acids conserved as observed
for ascomycete CYP53 members (Fig. 2) and variants as observed
for basidiomycete CYP53 members (Figures 2 and 3) in CYP53
substrate specificity and/or catalytic activity, we performed
comparative CYP53 homology modeling studies to map these
conserved/variant residue locations in the protein structure. In the
present study we selected two CYP53 members, CYP53A from T.
terrestris that was recently identified and characterized in an
author’s laboratory [24] as representative of ascomycete CYP53
P450s and CYP53C2 from the model white rot P. chrysosporium
(abbreviated as Pchr) [4] as representative of basidiomycete
CYP53 P450s. The 3D-models of CYP53 P450s were constructed
and validated as described in materials and methods. As shown in
Table 3 all the parameters employed in assessing the quality of the
models were favorable suggesting that models of CYP53 P450s
were of good quality.
As shown in Fig. 5, CYP53A Tter and CYP53C2 Pchr showed
all P450 motifs in the same way as CYP51 of S. cerevisiae [42].
Interestingly the membrane helix (MH) and transmembrane helix
(TMH) found in CYP51 were also observed in CYP53C2 Pchr
(Fig. 5). However, CYP53A Tter showed only the membrane helix
(Fig. 5). This suggests that CYP53A Tter and CYP53C2 Pchr are
biotopic membrane proteins with one transmembrane helix. A
detailed secondary structure analysis including heme-binding
residues, substrate binding residues and substrate recognition sites
(SRS1-SRS6) is shown in Fig.6.
After successful construction and analysis of 3D-models of
CYP53C2 Pchr and CYP53A Tter we proceeded to map the
conserved amino acids observed for CYP53 members of ascomy-
cota and basidiomycota (Fig. 2) to investigate the role of these
residues in substrate specificity and/or catalytic activity. As shown
in Fig. 7, CYP53 members of ascomycetes possess conserved
amino acid residues throughout the protein structure, whereas
CYP53 members of basidiomycetes show conservation at P450
signature motifs such as EXXR and CXG. In order to understand
how many of these conserved amino acids are actually part of the
active site cavity, we identified the active site cavity of CYP53 Tter
using CASTp (Fig. 8 and Table 4) [50]. As shown in Fig. 8 and
Table 4, among 125 amino acids lining the active site cavity, 35
(28%) are conserved (conservation index 9) and 62 amino acid
residues (50%) are moderately conserved (conservation index 5–7)
across the CYP53 members of ascomycetes. Overall, the high
conservation of amino acids (78%) in the active site cavity and in
the rest of the protein structure (Fig. 2) strongly suggests that the
active site cavity and overall structure of CYP53 members of
ascomycete species are highly conserved. Considering the struc-
tural conservation, any inhibitor developed against one of the
CYP53 members could possibly act as common inhibitor against
CYP53 members of ascomycete species and hence could act as a
common anti-fungal (towards pathogenic ascomycetes) agent. On
the other hand, basidiomycete CYP53 members showed much less
conserved residue in their structure (Figures 2 and 7), suggesting
basidiomycete members have been subjected to evolutionary
pressure to acquire novel functions to help the organism adapt to
diverse ecological niches.
Functional significance of CYP53 family and its potential
role as a common anti-fungal drug target
CYP53 family members play a key role in fungal primary
metabolism, i.e. the b-ketoadipate pathway [12,19], and secondary
metabolism, i.e. detoxification of phenolic compounds [28,52].
The b-ketoadipate pathway is a convergent pathway for aromatic
compound degradation [18] that is widely distributed in soil
bacteria and fungi. Fungal-mediated degradation of aromatic
compounds such as phenylalanine, toluene, and cinnamic acid
leads to the formation of benzoate [14–16]. As part of the b-
ketoadipate pathway CYP53 is involved in detoxification of this
Table 4. Analysis of amino acid conservation in CYP53A Tter active site cavity.
Conservation
index Amino acids
Number of
Amino acids
Percent (%) contribution in
active site cavity
9 R76, P79, G99, L101, K102, Y106, F117, R120, R122, H125, R129, F136,
L192, P241, E311, T314, A318, T322, L370, S382, G387, L388, P389, R390,
G409, S413, F449, P451, F452, C459, G461, R462, A465, E466, K498
35 28
7 L51, H81, N98, L116, N118, V132,V188, I189, L227, A235, T236, L243, L288,
L313, G319, D321, N325, S326, V364, L378, P393, G398, V399, P408, V411,
L412, S453, R457, A458, M467, E468, G494
32 26
6 Q78, R365, V392, F406, V464, M469 6 5
5 F100, D104, F105, S111, T119, F144, I148, A193, A221, A223, I224, I226,
N228, E232, A310, Q315, I317, S320, T323, V374, T383, G385, V460, L496
24 19
None N48, W49, L52, R57, Y61, V74, S103, I112, L152, A185, I219, E225, I239,
L240, Q242, S371, N375, S384, I386, E391, R394, Q397, P407, T410,K470,
L471, R492, F495
28 22
Total 125 100
Active site cavity residues were identified using CASTp [50] (Fig. 8). Conservation of amino acid residues in ascomycete species CYP53 P450s was identified using
PROMALS3D [39] (Fig. 2). Conservation index 9 means amino acid is conserved. CYP53A Tter amino acid residues were used as a representative of ascomycete CYP53
members. CYP53A Tter P450 amino acids and their numbering are presented as representative of ascomycetes CYP53 P450s. Abbreviation Tter indicates Thielavia
terrestris.
doi:10.1371/journal.pone.0107209.t004
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toxic compound and key intermediate molecule. CYP53 hydrox-
ylates benzoate to 4-hydroxybenozate [12], the prime reaction in
the benzoate metabolism that subsequently leads to protocatech-
uate as the ring fission substrate [53]. This reaction is critical for
fungal organisms in order to detoxify the benzoate; to date this
hydroxylation reaction carried out by CYP53 is the only way to
detoxify this compound. Further support of CYP53’s critical role
in fungal primary metabolism can be obtained from a study where
CYP53 deletion proved to be lethal for fungal organisms’ survival
(19). This suggests that the CYP53 family can serve as a novel
alternative drug target against fungal pathogens, especially
ascomycete pathogens. Results from this work showing high
conservation of the primary and tertiary structure of CYP53
members (Figures 2 and 7) across the ascomycetes (consisting of
animal and plant pathogen fungal species) indicate that any
inhibitor developed against a CYP53 member could serve as a
novel common drug against a large number of pathogenic
ascomycete fungi. Results from authors laboratory showed
inhibitors directed at this P450 effectively inhibited CYP53 activity
[11] and also growth inhibition of different fungal species such as
C. lunatus, Aspergillus niger and Pleurotus ostreatus [54].
Furthermore, this P450 family offers an advantage over the
CYP51 family, the currently exploited target against fungal
infections, as CYP53 does not have a homolog in higher
eukaryotes. This will offer researchers the opportunity to design
selective and potent inhibitors of pathogenic fungi.
Overall, the facts discussed above, such as (i) the critical role of
CYP53 in fungal primary metabolism, (ii) high conservation of the
primary and secondary structure of CYP53 members in ascomy-
cetes and (iii) CYP53 not having any homolog in higher eukaryotes
(advantage over CYP51 family), strongly support our hypothesis
that the CYP53 family can be a potential novel alternative anti-
fungal drug target and an inhibitor designed against this P450
family can serve as a common drug against pathogenic ascomy-
cetes.
The most interesting aspect of the CYP53 family’s role in
basidiomycete fungi extends beyond detoxification of benzoate.
Our study showed that most of the ascomycetes contain a single
CYP53 member in their genomes, whereas basidiomycetes showed
multiple CYP53 members (Table 1). Results from this study
(Fig. 4B) revealed that the number of CYP53 members increase in
basidiomycete species genomes by duplication of CYP53 members
after speciation (paralogous evolution). Here we propose the
critical role of these CYP53 members in basidiomycetes that
forced basidiomycetes to enhance this P450 family member in
their genomes.
First, basidiomycetes are well known for their role as bio-
degraders of wood [55]. Wood is composed of many aromatic
compounds, including benzoic acid derivatives and other phenolic
compounds, among others eugenol, isoeugenol and guaiacol [56].
Most of these compounds are anti-fungal and toxic to fungi [13].
The multi-factorial phenomenon of toxicity of these compounds,
including membrane disruption, inhibition of essential metabolic
reactions, changes in pH homeostasis, and accumulation of toxic
anions, has been proposed toward fungi [17]. If basidiomycete
species want to colonize on wood they need an enzyme that can
detoxify the benzoate molecule, as this molecule is an intermediate
in detoxification of wood components comprising many aromatic
compounds. Since there is an enormous need for successful wood
colonization, wood-degrading basidiomycetes amplified their
CYP53 members in their genomes.
Secondly, synthesis of aryl-metabolites, including veratryl
alcohol by basidiomycete fungi, involves the formation of benzoate
and para-hydroxybenzoic acid as intermediate molecules [14].
Veratryl alcohol is a secondary metabolite and plays a key role in
lignin-peroxidase-mediated oxidation of wood components [57].
In a recent study, veratryl alcohol was shown to be the dominant
extracellular ligninolytic oxidant in decaying wood [58]. The
presence of a high number of CYP53 members and the generation
of benzoate and para-hydroxybenzoate as an intermediate in the
biosynthesis of veratryl alcohol suggest that in basidiomycete
species CYP53 members also play a role in the generation of
veratryl alcohol and help basidiomycete species directly in the
degradation and subsequent colonization of wood.
Thirdly, demethylation of stilbene, a class of molecule found in
plants, by CYP53D subfamily members from P. placenta
(basidiomycete) [28] indicates that CYP53 family members play
a critical role in the detoxification or degradation of plant
compounds and help fungi in the colonization of wood. It is
noteworthy that CYP53D members are present in the highest
numbers (seven P450s) in P. placenta and are all evolved via
paralogous evolution (Fig. 4B). This strongly indicates that P.
placenta duplicated CYP53D members in its genome in order to
colonize successfully on wood.
The above-mentioned role of CYP53 in wood-degrading
basidiomycete species physiology (primary or secondary metabo-
lism) is based on the available data and further experimentation
would provide more insight into this aspect.
Collectively, the above results indicate that in ascomycetes the
CYP53 role is limited to the detoxification of toxic molecules,
whereas in basidiomycetes CYP53 plays an additional role, i.e.
involvement in the generation of veratryl alcohol and degradation
of wood-derived compounds.
Conclusion
In this advanced scientific era, understanding of animal
(including human) and plant pathogenic fungal organisms in
terms of controlling their causative diseases and developing
effective drugs is still poorly understood. Currently available drugs
and drug targets are becoming ineffective because fungal species
develop resistance. Genome sequencing analysis of the fungal
species gives researchers the opportunity to look for novel drug
targets against these pathogens and to search for novel enzymes for
the generation of human valuables. The present study is such an
example; we explored fungal genome sequencing results to
understand the role of a P450 family (CYP53) in serving as a
common drug target against pathogenic ascomycetes and in
basidiomycetes, particularly in terms of the wood-degradation
process. The CYP53 family plays a key role in the detoxification of
the toxic molecule benzoate and this family has proven to be
essential for the organism’s survival. Our findings suggest that this
P450 family can serve as a common anti-fungal (toward
pathogenic ascomycetes) drug target in view of its highly conserved
protein structure in ascomycetes. The most striking features of
ascomycete CYP53 P450s were a large number of amino acids
conserved in their active site cavity (78%), strongly indicating that
any inhibitor developed for this family can act against a wide range
of animal and plant pathogenic ascomycetes. We also identified
that CYP53 P450s can play an additional role in basidiomycetes,
i.e. in the generation of the wood-degrading oxidant veratryl
alcohol and degradation of wood-derived compounds. This
additional role of basidiomycetes seems to have enriched this
P450 family by extensive duplication of CYP53 members in their
genomes (paralogous evolution). During the duplication process
extensive changes in the protein primary structure occurred to
enhance/acquire novel functions, such as involvement in wood
degradation.
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Supporting Information
Figure S1 Comparative-structural analysis and subse-
quent identification and estimation of conserved amino
acids of CYP53 family members in fungi. Amino acid
conservation was observed at three levels, i.e. (i) kingdom level
(Fig. S1A), (ii) phylum level: ascomycota (Fig. S1B) and
Basidiomycota (Fig. S1C) and (iii) family level (Fig. S1D). The
first line in each block shows conservation indices for positions
with a conservation index above 5. Each representative sequence
has a magenta name and is colored according to PSIPRED [1]
secondary structure predictions (red: alpha-helix, blue: beta-
strand). A representative sequence and the immediate sequences
below it with black names, if there are any, form a closely related
group (determined by the option ‘‘Identity threshold’’). Sequences
within each group are aligned in a fast way. The groups are
aligned using profile consistency with predicted secondary
structures. The last two lines show a consensus amino acid
sequence (Consensus_aa) and consensus-predicted secondary
structures (Consensus_ss). Representative sequences have magenta
names and they are colored according to predicted secondary
structures (red: alpha-helix, blue: beta-strand). If the sequences are
in aligned order, the sequences with black names directly below a
representative sequence are in the same pre-aligned group and are
aligned in a fast way. The first and last residue numbers of each
sequence in each alignment block are shown before and after the
sequences respectively. Consensus-predicted secondary structure
symbols: alpha-helix: h; beta-strand: e. Consensus amino acid
symbols are: conserved amino acids in bold and uppercase letters;
aliphatic (I, V, L): l; aromatic (Y, H, W, F): @; hydrophobic (W, F,
Y, M, L, I, V, A, C, T, H): h; alcohol (S, T): o; polar residues (D,
E, H, K, N, Q, R, S, T): p; tiny (A, G, C, S): t; small (A, G, C, S,
V, N, D, T, P): s; bulky residues (E, F, I, K, L, M, Q, R, W, Y): b;
positively charged (K, R, H): +; negatively charged (D, E): 2;
charged (D, E, K, R, H): c.
(PDF)
Table S1 Analysis of homology between CYP53 mem-
bers in fungi. Annotation of CYP53 P450 family members in
fungi. Hit proteins were blasted at the Cytochrome P450 Webpage
[26]. CYP53 members were assigned to subfamilies based on their
percentage homology to reference proteins. The reference proteins
were also included in the table.
(XLSX)
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